Endocrine Block Study Products

40
 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 (/+1*2-/ -(2$3'()7-)&$ -.(&1+. 3/'&$% 0/33/$+/( 3)+$2*)$+ 72-.42,3 "#$%/)0++8+/% 50)06$&%7 "@-/(&)%3= -.,(&)% .&(0&$/= 2$% 3&0/ 5)-20)$3 E(//*, %)EE13/ 2'(&33 -./ '/** 0/06(2$/ "8.,(&)% .&(0&$/3 2(/ H3.1--*/%I 2'(&33 -./ '/** 0/06(2$/ 6, '.27/(&$/ 7(&-/)$3 !C2(()/("0/%) 2-/% -(2$37&(- "9*%0)$+- 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 ! )07&(-2$- E&( '.)*%(/$ ! <)+. )$ 3-(/$1&13 /9/(')3/ "W)-.&1- 3*//7 ! %/'(/23/% '&(-)3&*= 7(&*2'-)$= 2$% ?< X )$'(/23/% 8@< '213)$+ )$'(/23/% -.,(&)% 2'-)5)-,

Transcript of Endocrine Block Study Products

Page 1: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 1/40

"#$%& $& '#(&)%*#&+&,- ./,0 1

"#$%&'()$&*&+," -./ '&001$)'2-)&$ 2$% '&$-(&*3,3-/0 4)-.)$ 2 *)5)$+ &(+2$)30 6, 6)&0&*/'1*/3 -.2-&5/(*273 2** 6&%, 3,3-/03

"8./ 6&%, 62*2$'/3 )$-/($2* 2$% /9-/($2* '.2$+/3 -&-./ 6&%, -& 02)$-2)$ .&0/&3-23)3

:()02(, #$%&'()$/ ;(+2$3"<,7&-.2*2013= :)-1)-2(,= :2(2-.,(&)%3= >%(/$2*3=?&$2%3= :)$/2*= 8.,(&)%= 2$% :2$'(/23@/'&$%2(, #$%&'()$/ ;(+2$3"</2(-= A)%$/,= >%)7&3/= 8.,013= 2$% ?B -(2'-8(2$3)-&(, #$%&'()$/ ;(+2$3"C&(713 *1-/10 2$% 7*2'/$-3

"./0&'()$/ D /$%&'()$/

8,7/3 &E '/**"-&"'/** '&001$)'2-)&$

2034%/#0 50)06$&%7"F/06(2$/"6&1$% (/'/7-&(3 2(/ .)+.*, 52()26*/ 2$%.&(0&$/ 37/')E)'"G)&0&*/'1*/3 6)$%)$+ -& 0/06(2$/"6&1$% (/'/7-&(3*#(*%0)$+- (/+1*2-/ -(2$3'()7-)&$ -.(&1+. 3/'&$%0/33/$+/( 3)+$2*)$+ 72-.42,3

"#$%/)0++8+/% 50)06$&%7

"@-/(&)%3= -.,(&)% .&(0&$/= 2$% 3&0/ 5)-20)$3 E(//*,%)EE13/ 2'(&33 -./ '/** 0/06(2$/"8.,(&)% .&(0&$/3 2(/ H3.1--*/%I 2'(&33 -./ '/**0/06(2$/ 6, '.27/(&$/ 7(&-/)$3

! C2(()/("0/%)2-/% -(2$37&(-"9*%0)$+- (/+1*2-/ +/$/ -(2$3'()7-)&$

:&%3&#0 /)$*&# *7 (060#(0#$ &# $;0)&#)0#$%/$*&# /#( $;0 %0)06$&% (0#7*$- /$ $;0 7*$0&< /)$*&#"J&'2**)$+"2'-)$+ 6)&0&*/'1*/3 %& $&- (/7(/3/$- -./3,3-/0)' '&$'/$-(2-)&$ 3)$'/ -./, 6)$% (27)%*, 4)-.

(/'/7-&(3 17(/+1*2-/% 2- 3)-/ &E (/*/23/ '213)$+ */33-& /3'27/ )$-& 3,3-/0)' ')('1*2-)&$"@,3-/0)' '&$'/$-(2-)&$3 &E .&(0&$/3 (/7(/3/$-*/5/* &E .&(0&$/ 2'-)$+ &$ -)331/3 %)3-()61-/%-.(&1+. /$-)(/ 6&%,K

./$$0%#7 &< =0)%0$*&#"J&'2*)L/% MG1(3-N" *&'2**,"2'-)$+ .&(0&$/3 2(/(/*/23/% (27)%*, )$ (/37&$3/ -& *&'2* 3-)01*) *)O/ 2./0&((.2+/":1*32-)*/ P/*/23/" 02$, .&(0&$/3 2(/ '&$-)$1&13*,3/'(/-/% )$ (/+1*2(= (/7/2-/% 3.&(- 61(3-3 Q/2'.

61(3-D71*32-)*/ (/*/23/R E(&0 2 623/*)$/'&$'/$-(2-)&$

"C)('2%)2$ (.,-.0" .&(0&$/3 3/'(/-/% )$ 2 ST .&1(

72--/($ 4)-. %2)*, .)+. 2$% *&4"#7)3&%)' P/*/23/" 3/'(/-/% )$ (/37&$3/ -& 2 3,3-/0)'3-)01*13

U8.)3 )3 2$ /7)3&%)' (/*/23/= 2$% 2*3& )- )3 6)7.23)'V"@*//7 ','*/3 '2$ 2EE/'- -./ ')('2%)2$ (.,-.0 &E.&(0&$/ 3/'(/-)&$K @*//7 %/7()52-)&$ 2EE/'-3.&(0&$/ 3/'(/-)&$ )$ ')('2%)2$ (.,-.0K@17(2'.)2302-)' $1'*/)= 7)$/2* +*2$%= 2$% ')('2%)2$+/$/3 (/+1*2-/ ')('2%)2$ (.,-.0K

"C&(-)3&* )3 .)+./3- )$ -./ 0&($)$+ 4./$ 4/ 42O/ 172$% %/'(/23/3 -.(&1+.&1- -./ %2,

"F/*2-&$)$ )3 .)+./3- 2- $)+.-

"?< )3 .)+./3- 2- $)+.- ! )07&(-2$- E&( '.)*%(/$! <)+. )$ 3-(/$1&13 /9/(')3/

"W)-.&1- 3*//7 ! %/'(/23/% '&(-)3&*= 7(&*2'-)$= 2$%?< X )$'(/23/% 8@< '213)$+ )$'(/23/% -.,(&)%2'-)5)-,

Page 2: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 2/40

"#$%& $& '#(&)%*#&+&,- ./,0 >

"<&(0&$/3 '2$ 3/'(/-/ )$ 0&(/ -.2$ &$/ -,7/ &E72--/($ ! >** .25/ 71*32-)*/ 02$$/( /9'/7- -.,(&)%3)$'/ )- .23 -& 6/ '&$3-2$- E&( 0/-26&*)30

"<,7&-.2*20)'":)-1)-2(,">%(/$2* 29)3">C8<" ')('2%)2$ )$ 71*32-)*/ 02$$/("C&(-)3&*" ')('2%)2$ )$ 71*32-)*/ 02$$/(W)-. 2'1-/ 3-(/33Y">C8< 2$% C&(-)3&*! /7)3&%)'-& 3-)01*2-/ 2%(/$2* +*2$%3W)-. '.(&$)' 3-(/33">C8< */5/*3 )$'(/23/ */2%)$+ -&)$'(/23/% C&(-)3&*

>0&1$- &E .&(0&$/ 252)*26*/ )3 %/7/$%/$- &$20&1$- 6%&(8)0( 6, -./ /$%&'()$/ +*2$%= 20&1$--.2- )3 ?<%00@ -& 6)$% -& (/'/7-&(3 E&( '/**1*2((/37&$3/= 20&1$- -.2- )3 4&8#( -& 3/(10 7(&-/)$3=20&1$- &E -)0/ -./ .&(0&$/ )3 2'-)5/ )$ ')('1*2-)&$2$% 26*/ -& '213/ 2$ /EE/'- Q ;/+<A+*<0R= 2$% -./ 20&1$-(0,%/(0( )$-& 4/2O/( 0/-26&*)-/3 -.2- 02, &( 02,$&- 6/ 2'-)5/K

U>** 7/7-)%/3 2(/ HE(//I /9'/7- B?Z"[ X ?<U>** 7(&-/)$3 )$ .,7&-.2*20)'"7)-1)-2(, 29)3 2(/

7(&-/)$3 Q)$ -./ 6(2)$ 623)'2**,VR?/$/(2* Z1$'-)&$3 &E G&1$% :(&-/)$3"G&1$% .&(0&$/3 2(/ 7(&-/'-/% E(&0 /$L,02-)'6(/2O%&4$ 2$% (/$2* /9'(/-)&$"G)$%)$+ 7(&-/)$3 61EE/( -./ '&$'/$-(2-)&$ &E E(//.&(0&$/3"G)$%)$+ 7(&-/)$".&(0&$/ '&07*/9/3 E&**&4F)'.2/*)3"F/$-&$ O)$/-)'3

<&(0&$/">*610)$ '&07*/9 2'-3 23 3.1--*/ 3,3-/0"8./ '&07*/9 %)33&')2-/3 /23)*, ! )3 6)&252)*26*/"<&(0&$/ )3 252)*26*/ 2- '/**1*2( (/'/7-&(3\ -2(+/-"C&07*/9 )3 2 %/*)5/(, 3,3-/0 -& -2(+/- -)331/3

<&(0&$/"37/')E)' 6)$%)$+ +*&61*)$3 6)$% .&(0&$/34)-. .)+. 2EE)$)-, -& '(/2-/ 2 (/3/(5/">$%(&+/$3 2$% #3-(&+/$

! @/9 .&(0&$/ 6)$%)$+ +*&61*)$ Q@<G?R"C&(-)'&)%3 2$% :(&+/3-/(&$/

! C&(-)'&)% 6)$%)$+ +*&61*)$ QCG?R"8.,(&)% .&(0&$/3

! 8.,(&)% 6)$%)$+ +*&61*)$ Q8G?R

"8./ *)5/( 0/-26&*)L/3 .&(0&$/"<&(0&$/"6)$%)$++*&61*)$ '&07*/9/3 2$% 2 02]&()-, &E -./0 2(/'&$]1+2-/% 4)-. ,+8)8%&#*(0 &( 78+</$0K

U?*&61*)$"6)$%)$+ )$'(/23/ */2%3 -& */33 252)*26)*)-,V8./ 3)-/= (2-/= 2$% 20&1$- &E .&(0&$/ %/+(2%2-)&$%/-/(0)$/ -./ (/37&$3/

"#$%&-./*)2* '/**3 %& -./ 02]&()-, 2- 3)-/ &E%/+(2%2-)&$"^/+(2%2-)&$ .277/$3 )$ 6*&&% 5/33/*3 )$ -./*)5/(= O)%$/,= *1$+= 2$% -2(+/- -)331/37()02()*,K BC*D0% /#( E*(#0- /%0 3/*#F

"J&'2* %/+(2%2-)&$ %/'(/23/3 3,3-/0)'/EE/'-3

"J&'2* 7(&%1'-)&$= *&'2* 2'-)&$= 2$% *&'2*%/+(2%2-)&$ 2(/ )07&(-2$- E&( 2 7(&7/(*&'2*)L/% /EE/'-K

"F&3- .&(0&$/3 %/+(2%/% 6, *)5/( &( O)%$/,"G)&2'-)5/ 7/7-)%/3 02, 6/ )$-/($2*)L/% 2$% %/+(2%/%*&'2**,"2/G&%*$- &< 30$/4&+*$07 4*+0 &% )&#G8,/$0( /#(0H)%0$0( 4- I*(#0- *# $;0 8%*#0

2J5 D 0/-26&*)' '*/2(2$'/ (2-/ D -&-2* (2-/ &E(/0&52* &E 2 .&(0&$/:/+<A+*<0D -./ -)0/ E&( 2 '&07&1$% -& *&3/ _ &E )-3E1$'-)&$2* 2'-)5)-,

S #9-(/0/3Y["<)+. FCP 2$% @.&(- <2*E"*)E/" 6)&0&*/'1*/ )33-&(/%= &( -./ 6&%, )3 '&$3-2$-*, 7(&%1')$+ -./.&(0&$/S"J&4 FCP 2$% J&$+ <2*E"*)E/" 6)&0&*/'1*/ )3 (/2%)*,252)*26*/ 2$% -./ 6&%, $//%3 -& 3-&(/ &( 7(&%1'/ */33

K0#0%/+ 58+07 &< ;/+<A+*<0 &< 4*&3&+0)8+07[" C&)/++-A/)$*#, 4*&3&+0)8+07 ;/D0 7;&%$ ;/+<A+*<0(80 $& %/6*( 4*#(*#, /#( 30$/4&+*73 &< +&)/++-A6%&(8)0( (0,%/(*#, 0#L-307 S"=3/++ 606$*(07 /%0 +&)/+ /#( ;/D0 7;&%$07$ ;/+<A+*D07 $-6*)/++- `"<,7&-.2*20)' .&(0&$/3 .25/ 3.&(- .2*E"*)5/3T":-(%&6;*+*) 4*&3&+0)8+07 ;/D0 7;&%$0% ;/+<A+*<07*#)0 ;-(%&6;&4*) 4*&3&+0)8+07 $-6*)/++- 4*#( $&70%83 6%&$0*#7M N;*); 0H$0#(7 ;/+<A+*<0 a":(&.&(0&$/3 2$% 0/-26&*)-/3 -,7)'2**, .25/ *&$+/(.2*E"*)5/3 -.2$ 2'-)5/ 6)&0&*/'1*/\.&(0&$/

Page 3: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 3/40

:&%3&#0 =-#$;07*7 ./,0 1

:*2302 '&$'/$-(2-)&$ &E .&(0&$/3"F&3- .&(0&$/3 */5/*3 2(/ *&4"<&(0&$/"6)$%)$+ 7*2302 7(&-/)$3 %& $&- '&$-()61-/-& 6)&*&+)'2* /EE/'-= 3)$'/ -./ '&07*/9 $//%3 -&%)33&')2-/ 6/E&(/ /$-/()$+ -)331/"Z(// .&(0&$/= $&- -&-2* '&$'/$-(2-)&$ %/-/(0)$/3-./ 6)&*&+)'2* /EE/'-

:*2302 */5/* %/7/$%3 &$Y"P2-/ &E .&(0&$/ 3/'(/-)&$AO3&8#$ &< 4&8#( ;&%3&#0PP"P2-/ &E 0/-26&*)L/%\/9'(/-/% .&(0&$/U^/E)')/$', )$ 6)$%)$+ %&/3 $&- 2EE/'- .&(0&$/2'-)5)-,= 3)$'/ &$*, E(// .&(0&$/ .23 6)&*&+)'2* /EE/'-

":(&-/)$ 6)$%)$+ 7(&-/'-3 .&(0&$/ E(&0 /$L,0/%/+(2%2-)&$"8&-2*= E(//= 2$% 6&1$% .&(0&$/ '2$ 6/ 0/231(/%"G)$%)$+ 7(&-/)$ '2$ 6/ 0/231(/% -&&":(&-/)$ 6)$%)$+ )3 )07&(-2$- E&( -.,(&)% 2$% 3-/(&)%

8/3- E&( 0/231()$+ .&(0&$/ */5/*3 (/b1)(/ .)+.!"#!$%$&$%' 2$% .)+. !(")$*$)$%' ! O#$*4&(*07

Q*#( ;&%3&#0 /#( *,#&%0 &$;0%7

5/(*&*338#&/77/- B3/*#+- <&% ;&%3&#07F">%% 72-)/$- 3/(10 -& 2$-)6&%, 2$% (2%)&*26/*/%.&(0&$/ '&07*/9"P2%)&*26/*/% .&(0&$/ )3 %)37*2'/% 6, .&(0&$/ )$72-)/$-N3 3/(10"<&(0&$/3 2(/ 3/72(2-/% E(&0 '&07*/9/3"F/231(/ (2%)&2'-)5/ QE(//R .&(0&$/3D 0/231(/0/$-

=/#(N*); O77/- /#( 'C"=O B3/*#+- <&% 6%&$0*#7F"B00&6)*)L/ 2$ 2$-)6&%, -& -/3- -16/ &( 6/2%3 )$ -/3--16/">%% 72-)/$-N3 6*&&%= -./$ 423.K 8./ 72-)/$-N3 7(&-/)$3.&1*% 6)$% -& 3-2-)&$2(, 2$-)6&%,">%% -./ (2%)&*26/*/% 2$-)6&%, -& -/3- -16/K 8./3/'&$% 2$-)6&%, 013- 6)$% -& ̂ BZZ#P#c8 (/+)&$ &E7(&-/)$K"F/231(/ -./ (2%)&2'-)5)-, &( /$L,0/ 2'-)5)-,U#JB@>D /$L,0/"*)$O/% )001$&3&(6/$- 2332,

"8/3-&3-/(&$/ 2$% C&(-)3&* 2(/ 3,$-./3)L/% E(&0'.&*/3-/(&* 02)$*, )$ 37/')2*)L/% /$%&'()$/ +*2$%3

"W.2- O)$%3 &E (/2'-)&$3 .25/ -& -2O/ 7*2'/ )$-./3/ /$%&'()$/ +*2$%3 -& '&$5/(- '.&*/3-/(&* )$-&'&(-)3&* &( -/3-&3-/(&$/d P/2% 2%(/$2* 6)&'./0

"@-/(&)% .&(0&$/3= -.,(&)% .&(0&$/3= (/-)$&)' 2')%='2*')-()&*= 2$% %)/-2(, *)7)%3 6)$% -& )$-(2'/**1*2((/'/7-&(3 -& 6/'&0/ -(2$3'()7-)&$ E2'-&(3

"8.,(&)% .&(0&$/3Y B$'(/23/ 0/-26&*)' (2-/3 2$%.25/ %/5/*&70/$-2* /EE/'-3

"8.,(&9)$/ Q8TR"8())&%&-.,(&$)$/ Q8`R

:2(2'()$/ 2+/$-3Y :(&3-2+*2$%)$3":(/'1(3&( )3 >(2'.)%&$)' 2')%"C,'*&&9,+/$23/ 2%%3 2 ','*)' ()$+ 2$% 2%%3 &9)%23/3-& E&(0 7(&3-2+*2$%)$3 Q:?#S= :?ZSR

C2-/'.&*20)$/3">'- 23 .&(0&$/3 2$% $/1(&-(2$30)--/(3

"#7)$/7.()$/ ! 2%(/$2* 0/%1**2 7(&%1'/3"^&720)$/ ! 6(2)$ 7(&%1'/3

C2-/'.&*20)$/ 3,$-./3)3Y

C2-/'.&*20)$/ )$2'-)52-)&$Y

"82O/$ 62'O 17 )$-& $/(5/ -/(0)$2* )$ .)+."2EE)$)-,c2e '&-(2$37&(-= -./$ /$L,0/ 2'-)52-)&$ &''1(3K84& /$L,0/3 '&07*/-/ (/3- 2$% '2$ 2'- )$ 3/b1/$'/["F&$&20)$/ &9)%23/ QF>;R %&/3 &9)%2-)5/%/20)$2-)&$ )$ -./ $/(5/ -/(0)$2*S"C2-/'.&*";"0/-.,*-(2$3E/(23/ QC;F8R 0/-.,*2-/3

:/7-)%/ 2$% :(&-/)$ <&(0&$/3"@,$-./3)3Y 3/'(/-&(, 72-.42,

"P)6&3&02* 3,$-./3)3= 7&3-"-(2$3*2-)&$=5/3)'1*2( 3-&(2+/= 2$% /9&',-&3)3

.*$8*$/%- ;&%3&#07 /%0 606$*(07 /#( 6%&$0*#7[":&3-/()&( 7)-1)-2(, +*2$% Q$/1(&.,7&7.,3)3R":&3-/()&( 7)-1)-2(, +*2$%N3 $/1(2* -)331/ 29&$3 2(/'&$$/'-/% -& $/1(&$2* '/** 6&%)/3 )$ -./.,7&-.2*2013

@02** :/7-)%/3 7(&%1'/% 6, .,7&-.2*2013Y";9,-&')$" 1-/()$/ '&$-(2'-)&$ 2- 6)(-. 2$%0)*O /]/'-)&$">$-)%)1(/-)' .&(0&$/ Q>^<= 523&7(/33)$R"2$-)%)1(/3)3 23 2 -&$)' /EE/'- QfS (/'/7-&(3R=2$% 523&'&$3-()'-)&$ Qf[ (/'/7-&(3R 2-.)+./( '&$'/$-(2-)&$3 %1()$+ .,7&5&*/0)2

@,$-./3)3 &E f23&7(/33)$ 2$% ;9,-&')$"@)-/ &E 3,$-./3)3Y $/1(&3/'(/-&(, $/1(&$3 )$ -./.,7&-.2*2013K":(&.&(0&$/ 7(&'/33)$+Y 6&-. .&(0&$/3 2(/ 72(- &E

7(/'1(3&( -.2- )3 '*/25/% 6, 37/')E)' 7(&-/23/3

S">$-/()&( 7)-1)-2(, +*2$% Q2%/$&.,7&7.,3)3RQ+*2$%1*2( -)331/R@02** :/7-)%/3Y

">%(/$&'&(-)'&-(&7)' .&(0&$/ Q>C8<R?*,'&7(&-/)$3Y

"8.,(&)% 3-)01*2-)$+ .&(0&$/ Q8@<R"?&$2%&-(&7)$3Y J1-/)$)L)$+ .&(0&$/ QJ<R=Z&**)'*/"3-)01*2-)$+ .&(0&$/ QZ@<R

:(&-/)$3Y"?(&4-. .&(0&$/Y ?(&4-.= 0/-26&*)' /EE/'-3":(&*2'-)$Y J2'-2-)&$

@,$-./3)3 &E >C8< 2$% F@< QF/*2$&',-/ 3-)01*2-)$+R"@,$-./3)L/% E(&0 7(&"&7)&0/*2$&'&(-)$ Q:;FCR

Page 4: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 4/40

:&%3&#0 =-#$;07*7 ./,0 >

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

UB$31*)$ 3,$-./3)3

"Q:(/R7(&)$31*)$ )3 3,$-./3)L/% 2- -./ (&1+. #P"@)+$2* 3/b1/$'/ )3 (/0&5/% %1()$+ ()6&3&02*3,$-./3)3"8/(-)2(, 3-(1'-1(/ E&(03 37&$-2$/&13*,

"^)31*E)%/ 6&$%3 E&(0 )$ #P"#$%&7/7-)%23/ Q7(&.&(0&$/ '&$5/(-23/R '1-3 &1-C":/7-)%/"'R8*3&+/% /3&8#$7 &< *#78+*# /#( JA606$*(0 /%0%0+0/70("C"7/7-)%/ .23 $& O$&4$ .&(0&$2* /EE/'-3

UC*)$)'2**,! 8/3- E&( C"7/7-)%/ )$ 72-)/$-3 3& -./, %&$&- .25/ -& +/- &EE )$31*)$ 0/%)'2-)&$ -& +/- (/2*0/231(/0/$- &E 3/*E"7(&%1'-)&$ &E )$31*)$

UF/)3/$6/(+ -2*O/% 26&1- P/$)$">$+)&-/$3)$ @,3-/0"f/(, 3-(2)+.-E&(42(%K P/5)/4 P/$2* 6*&'O )E 2$,-.)$+">C# )$.)6)-&(3 2(/ 13/% E&( 2$-).,7/(-/$3)5/ %(1+3=61- (/0/06/( -.2- 6(/2O%&4$ &E 6(2%,O)$)$ )3)$.)6)-/% ! 523&%)*2-)&$

Page 5: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 5/40

.%&7$/,+/#(*# Q*&);03*7$%-

:(&3-2+*2$%)$3"c&- .&(0&$/3 ! E&(0/% E(&0 *)7)%3 )$ 2** -)331/3 X2'- 23 3.&(-"*)5/% 72(2'()$/ 2$% 21-&'()$/0/33/$+/(3

@163-(2-/3 E&( :(&3-2+*2$%)$ @,$-./3)3 QSg C Z>3R" O%/);*(&#*) /)*( Q0&3- )07&(-2$- 3)$'/ 261$%2$-R

! ;0/+2"h Z2--, 2')%"#)'&32-()/$&)% 2')% ! ;0/+2"h Z2--, 2')%"#)'&327/$-2/$&)' 2')%3 ! ;0/+2"` Z2--, 2')%

.;&76;&+*6/70 O> *)6/(2-/3 2(2'.)%&$)' 2')% E(&00/06(2$/ *)7)%3

C,'*&&9,+/$23/ (/2'-)&$ 7(&%1'/3 :?<S

UP/0/06/( -.2- 7(&3-2+*2$%)$3 .25/ Sg '2(6&$3='2(6&9,* +(&17= 2$% 2 ()$+U@163'()7- )$%)'2-/3 -./ $106/( &E %&16*/ 6&$%3&1-3)%/ -./ ()$+ 2$% C27)-2* */--/( )$%)'2-/3 -./ -,7/&E 7(&3-2+*2$%)$P.K"> S .%&7$/)-)+*#J-)+&&H-,0#/70 &))8%7 *# > *7&<&%37C;i"[ ! 0&3- -)331/3= 7(/3/$- 2** -./ -)0/C;i"S ! B$%1')6*/= 02)$*, )$ */1'&',-/3 2$% 3&0/&-./( -)331/3 ! )$E*2002-)&$ 0/%)2-&(

` E&(03 &E :?#Y["#)'&32-()/$&)' 2')% ! :?#[>AO%/);*(&#*) /)*( .K'>`"#)'&327/$-2/$&)' 2')% ! :?#`

.%&7$/,+/#(*# /)$*&#7T "36&%$/#$ &#07 $& I#&N[":*2-/*/- 2++(/+2-)&$ Q8i>SRS"f23&%)*2-)&$ Q:?#S= :?BSR! (2)3/ '>F: */5/*`"j-/()$/ '&$-(2'-)&$ Q:?#S= :?ZS2*7.2R

! @)0)*2( -& &9,-&')$= 61- &9,-&')$ (/'/7-&(32(/ &$*, 7(/3/$- 2- /$% &E +/3-2-)&$ E&( *26&(K

:(&3-2+*2$%)$ (/'/7-&(3 2(/ 2*42,3 7(/3/$- 2$% '2$E2')*)-2-/ 26&(-)&$ &( ./*7 4)-. 1-/()$/ 6*//%)$+T"B$E*2002-)&$ Q:?#S= 8i>SR ! 523&%)*2-)&$ e WGC(/37&$3/ -& 0/%)2-/ 72)$ 2- $/(5/ /$%)$+3 2$%34/**)$+a"Z/5/( Q:?#SR ! 2'-3 )$ 7(/&7-)' 2(/2 E&(-./(0&(/+1*2-)&$h"P/%1'/% +23-()' 2')% 3/'(/-)&$= /$.2$'/% 01'13E&(02-)&$ Q:?#SR ! P/0/06/( -.2- c@>B^ 13/ '2$%202+/ +23-()' 01'&32U:?# ! 8.)$O ^)*2-)&$= :?Z ! 8.)$O C&$3-()'-)&$

.%&7$/,+/#(*#7 4*#( U KA6%&$0*# %0)06$&%7

":(&3-2',*)$ )3 2 -.(&06&92$/ 2$-2+&$)3- -.2-%/'(/23/3 C2Se

"B$ '*&--)$+= 7*2-/*/- )3 )$ %202+/% /7)-./*)10 4\&7(&3-2','*)$ ! 8.(&06&92$/ )3 6/--/( 2- )$'(/23)$+C2Se )$ -./ 7*2-/*/-

#EE/'-3 &E 7(&3-2+*2$%)$3 23 %(1+3["P27)% 0/-26&*)30 &E $2-1(2* 7(&3-2+*2$%)$3 2$%3&0/ 3,$-./-)' 2$2*&+3 2(/ 0/-26&*)'2**, 0&(/ 3-26*/S"F1*-)7*/ /EE/'-3 &$ 02$, &(+2$ 3,3-/03= 3& )$]/'-/%7(&3-2+*2$%)$ D 3,3-/0)' /EE/'-3

J)7&9,+/$23/ 72-.42,"@/5/(2* *)7&9,+/$23/3 02O/ 6)&*&+)'2**, 2'-)5/7&*,1$32-1(2-/% E2--, 2')%3 ! 3&7$ *36&%$/#$ *7VA+*6&H-,0#/70

":(&%1'/3 Sg"'2(6&$ 2')%3 4)-.&1- 2 ()$+ 3-(1'-1(/"J/1'&-()/$/3 2(/ E2)(*, 3-26*/ X *&$+ *)5)$+UUUJ/1'&-()/$/3 '&$-(2'- 6(&$'.)2* 30&&-. 013'*/2$% '&$-()61-/ -& 23-.02 ! '&((/*2-/ 4)-.7(/%$)3&$/ -(/2-0/$- E&( 23-.02VVV

#)'&32$&)%3Y :.2(02'&*&+,">$-))$E*2002-&(, 3-/(&)%3 Q+*1'&'&(-)'&)%3R )$.)6)--./ 7.&37.&*)723/ >S ! E&(02-)&$ &E 7(&3-2+*2$%)$32$% */1'&-()/$/3 Q2EE/'- )001$/ 3,3-/0R )3 (/%1'/%"c@>B^3" )$.)6)- C;i [\S\6&-. 2$% E&(02-)&$ &E7(&3-2+*2$%)$3= 61- c;8 */1'&-()/$/3

"P/%1'/ )$E*2002-)&$= 72)$= E/5/(= 7*2-/*/-2++(/+2-)&$= 2$% -.(&0613 E&(02-)&$UC213/ +23-()-)3 2$% 7/7-)' 1*'/( 2$% 2(/'&$-(2)$%)'2-/% )$ 23-.02 ! :?3 2(/ +&&%=*/1O&-()/$/3 2(/ 62% )$ 23-.02

Page 6: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 6/40

50+/$*&#7;*6AJ0#$0%0( J/%0T"36/)$ &# W8$)&307

PW4G0)$*D07 $;/$ =0+<%*(,0 0H/,,0%/$0(TA90<*#0 / X#0/% 3*77YAC*7$ $;0 Z&8% :/4*$7 &< :*,;+- '<<0)$*D0 .;-7*)*/#7A"(0#$*<- $;0 <&++&N*#, *# / )+*#*)/+ D*,#0$$0

A'+*)*$*#, $;0 6/$*0#$@7 60%760)$*D0A903&#7$%/$*#, 036/$;-

c/2( F)33"B$ 0/%)')$/= 2 $/2( 0)33 )3 2$, /5/$- 4./$ 2$ /((&('&1*% .25/ (/31*-/% )$ .2(0 &( %/2-.= 61- %)%$N- %1/-& 2 '&((/'-)&$ -& -./ /((&( &( -./ /((&( $&- '213)$+.2(0

F2*7(2'-)'/D /((&( 2$% -./ 62% &1-'&0/ -.2- (/31*-3)$ )$]1(,= %202+/= &( *&33 Q)07(&7/( &( $/+*)+/$--(/2-0/$-R

` C&(/ C&07&$/$-3 &E PCC["F)$%E1* :(2'-)'/Y 50R8*%07 [ :/4*$7

[">--/$-)5/ &63/(52-)&$S"C()-)'2* '1()&3)-, 2$% '&1(2+/ -& 3//-.(&1+. &4$ 4/2O$/33/3`"> E(/3. /,/\0)$%T":(/3/$'/ ! 1$%)3-(2'-/% '&07233)&$2-/2--/$-)&$ -& -./ 7/(3&$ 2$% -./ -23O 2- .2$%

S"Z&(02-)&$["C.2(2'-/( ! H-.(/2% ,&1 E&**&4dIS"<26)-3"

UT <26)-3 &E .)+.*, #EE/'-)5/ :.,3)')2$3 7*2, 2 (&*/ )$-./ E&(02-)&$ &E 2 7.,3)')2$= 61- -./, /33/$-)2**, 2(/-./ '&(/ '&07&$/$- &E '&001$)'2-)&$ 3O)**3

A[ :/4*$7 &< :*,;+- '<<0)$*D0 .;-7*)*/#7

`"P/*2-)&$3.)73H8./ -.(/2%I ./*73 7(/5/$- 61($&1-"C&07233)&$ 2$% /072-., 2(/ -4& E)(3- b12*)-)/3 -&%)0)$)3. 4./$ 2 7.,3)')2$ 31EE/(3 61($&1-

`"C&001$)'2-)&$ 3O)**3

:/4*$ 1T "#D07$ *# $;0 40,*##*#,"S 3)07*/= $&- /23,= 3O)**3["#*)')- 2** &E -./ 72-)/$-N3 '&$'/($3 )$ -./ 6/+)$$)$+&E 5)3)-S"^&$N- )$-/((17-

:/4*$ >T '+*)*$ $;0 ./$*0#$@7 .0%760)$*D0"G23)3 &E 7.,3)')2$"72-)/$- '&**26&(2-)&$

">3O -./ 72-)/$-N3 )%/23"B%/$-)E, -./ 72-)/$-N3 +&2*3 E&( -./ 5)3)-"#97*&(/ -./ )072'- &$ -./ 72-)/$-

:/4*$ \T 903&#7$%/$0 '36/$;-"#072-., )3 -./ 2'- &E '&((/'-*, 2'O$&4*/%+)$+ -.//0&-)&$2* 3-2-/ &E 2$&-./( 4)-.&1- /97/()/$')$+ -.2-3-2-/ &$/3/*E"@/*E()%+/ 0/$-)&$/% -.2- 4/ '2$$&- */- /072-., -1($)$-& 3,072-.,K W/ 3.&1*% $/5/( .25/ -& -2O/ '2(/ &E&1(3/*5/3 4.)*/ -2O)$+ '2(/ &E 2 72-)/$-= 2$% -./72-)/$- 3.&1*% '/(-2)$*, $/5/( .25/ -& '2(/ E&( 13 23

%&'-&(3 )$ 2 0/%)'2* 3/--)$+\5)3)-K"#072-., 13/% -& 6/ *&&O/% %&4$ 17&$ )$ -./ *23-+/$/(2-)&$ ! H(/02)$ %/-2'./% 2$% .25/ $/1-(2*/072-., E&( 2''1(2-/ %)2+$&3)3" >()$+ 2$% G*10+2(-I"#5)%/$'/ 32,3 &-./(4)3/ 26&1- /072-., 2$% )- ./*73(/31*- )$ 0&(/ -.&(&1+. %)2+$&3/3= 72-)/$-2%./(/$'/= 72-)/$- 32-)3E2'-)&$ 2$% -(13-= 2$%)07(&5/% 72-)/$- 7.,3)&*&+, 2$% %)3/23/ &1-'&0/3

W.& %& ,&1 E)$% 0&3- %)EE)'1*- -& %/2* 4)-.d @1(5/,:2-)/$-3 -.2- 2(/\'2$$&-"<&3-)*/ &( 2$+(,"c&- E&**&4)$+ )$3-(1'-)&$3"8&& %/02$%)$+ &( $//%,"^/3'()6/ .)3\./( 3,07-&03">3O)$+ -&& 02$, b1/3-)&$3

@1++/3-)&$3 &E '1*-)52-)$+ /072-., )$ */2($/(3["8/** 3-&()/3 )$ +(&173S"@-2(- 242(/$/33 +(&173`"G/+)$ /2(*, )$ -(2)$)$+T"Z2'1*-, %/5/*&70/$- 2$% 0&%/*)$+a"J)-/(2-1(/ 2$% 2(-3h":(2'-)'/ -./ 3O)**3 $//%/% 2$% )$5&*5/% 2$% Ac;W<;W 8; ̂ BZZ#P#c8B>8# #F:>8<k >c^@kF:>8<k

Page 7: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 7/40

.*$8*$/%- K+/#( ] :-6&$;/+/387:*7$&+&,- ./,0 1

907)%*40 $;0 +&)/$*&# /#( 034%-&#*) &%*,*#7 &<6*$8*$/%- ,+/#( B;-6&6;-7*7F":)-1)-2(, +*2$% )3 *&'2-/% )$ @/**2 81(')'2 &E @7./$&)%6&$/ )$ -./ '(2$)10">--2'./% -& .,7&-.2*2013 6, )$E1$%)61*10S *&6/3[">%/$&.,7&7.,3)3 )3 %/()5/% E(&0 &(2* /'-&%/(0

! Z&(0/% 6, P2-.O/N3 7&1'.S"c/1(&.,7&7.,3)3 )3 %/()5/% E(&0 $/1(2* /'-&%/(0

! #9-/$3)&$ &E .,7&-.2*2013 Q%)/$'/7.2*&$R^/30 $;0 (*D*7*&#7 &< $;0 6*$8*$/%- ,+/#([">%/$&

":2(3 %)3-2*)3 Q2$-/()&( 7)-1)-2(,R":2(3 -16/(2*)3":2(3 )$-/(0/%)2

S"c/1(&":2(3 $/(5&32 Q7&3-/()&( 7)-1)-2(,R"B$E1$%)61*2( 3-/0"F/%)2$ /0)$/$'/

^/30 $;0 )0++ $-607 *# 0/); 6*$8*$/%- (*D*7*&# /#(*#(*)/$0 /#- );/%/)$0%*7$*) 7$/*#*#, 6%&60%$*07M*338#&)-$&);03*7$%-M /#( '_2_ 6*)$8%07

PP=$/*#*#, %0<0%7 $& ,%/#8+07 #&$ )-$&6+/73:2(3 ^)3-2*)3 Q>$-/()&( :)-1)-2(,R["C.(&0&7.)*3ZCO` .*K Z=:M C:M OJ`:M `=:M .%&+/)$"#M K:

">')%&7.)*3 2$% @/'(/-)&$3[R @&02-&-(&7.3! ?< Q3&02-&-(&7)$RSR F200&-(&7.3 ! :(&*2'-)$

"G23&7.)*3 2$% @/'(/-)&$3PQAZCO ̀ Q/7&6;*+7 Z=:M C:M OJ`:M `=:

[R 8.,(&-(&7.3 ! 8@<SR C&(-)'&-(&7.3 ! >C8<= J:<= F@<=/$%&(7.)$3 2$% /$O/7.2*)$3

Q>** 7(&%1'/% -.(&1+. 7&3-"-(2$3*2-)&$2*0&%3 &E :;FCR`R ?&$2%&-(&7.3 ! Z@< 2$% J<

S"C.(&0&7.&6/3 ! $& ',-&7*230)' 3-2)$)$+

`"Z&**)'1*&3-/**2-/ '/**3" .25/ *&$+ 7(&'/33/3 2$%7(&5)%/ 2 $/-4&(O &E )$-/('&001$)'2-)&$ 2$%3177&(- -& 72(/$'.,02B001$&.)3-&'./0)3-(,":(/')3/ )%/$-)E)'2-)&$ &E /$%&'()$/ '/**3 )$ -./2%/$&.,7&7.,3)3 6, 13)$+ 37/')E)' 2$-)6&%)/3 -&3.&4 .&(0&$/ '&$-/$-

:2(3 816/(2*)3"Q/7&6;*+*) '/**3 '&$-2)$ 3/'(/-&(, +(2$1*/3 &E Z=:

2$% C: ! c& 3/'(/-)&$ -.&1+.V:2(3 B$-/(0/%)2"P1%)0/$-2(, )$ .102$3"C&$-2)$3 '&**&)%"E)**/% E&**)'*/3 QP2-.O/N3 ',3-3R *)$/%6, 302** 4/7&6;*+*) '16&)%2* 3.27/% '/**3 -.2- '2$7(&%1'/ .W2J K :2(3 %)3-2*)3 3/'(/-/3 :;FC7()02()*,K

C*7$ $;0 6*$8*$/%- ;&%3&#07M *#(*)/$*#, <&% 0/);$;0 (*D*7*&# /#( )0++ $-60 &< &%*,*#M /#( $;0 $/%,0$&< $;0 ;&%3&#0

907)%*40 $;0 %&+0 &< $;0 ;-6&$;/+/387 *#)&#$%&++*#, 6*$8*$/%- ,+/#( <8#)$*&#["8P< ! 8@< ! 8T e 8`S" CP< ! >C8< ! ?*1'&'&(-)'&)%3`"?$P< ! Z@<! #3-(&+/$ Q&52(,R

Z@<! @/(-&*) '/**3 Q-/3-)3RJ< ! 02-1(2-)&$= &51*2-)&$= 2$% '&(713*1-/10 E&(02-)&$J< ! J/,%)+ '/**3 &E -/3-)3 Q-/3-&3-/(&$/R

T"?P<Q@P<R! ?< ! @&02-&'/%)$ C QB?Z[R

a" @&02-&3-2-)$ ! %/'(/23/3 ?<h" ̂ &720)$/ ! %/'(/23/3 7(&*2'-)$

907)%*40 $;0 4+&&( 7866+- $& $;0 6*$8*$/%- ,+/#(/#( *$7 %&+0 *# 6*$8*$/%- <8#)$*&#

@-)01*2-)&$ &E 2$-/()&( 7)-1)-2(, +*2$%Y

["<,7&-.2*2013 3/'(/-/3 (/*/23)$+ .&(0&$/3 )$-&7()02(, '27)**2(, 7*/913 2- 0/%)2$ /0)$/$'/S"B$-/($2* '2(&-)% 2(-/(, ! 317/()&( .,7&7.,3/2*2(-/(, ! 7()02(, '27)**2(, 7*/913 ! .,7&7.,3/2*7&(-2* 5/)$3 ! 3/'&$%2(, '27)**2(, 7*/913 &E 72(3%)3-2*)3 QE/$/3-(2-/% '27)**2()/3R"<&(0&$/3 +& E(&0 3/'&$%2(, '27)**2(, 7*/913 -&)$E*1/$'/ '/**3 &E 72(3 %)3-2*)3":2(3 %)3-2*)3 3/'(/-/3 )$-& 2$-/()&( .,7&7.,3/2*5/)$3"G*&&% E(&0 7)-1)-2(, %(2)$3 )$-& '25/($&13 3)$13

'H6+/*# $;0 %&+0 &< $;0 #0,/$*D0 <00(4/)I *#6*$8*$/%- ,+/#( <8#)$*&#

@// $/+2-)5/ E//%62'O 72-.42, E&( ?< )$ :.,3)&*&+,$&-/3c/+2-)5/ Z//%62'O :2-.42, E&( .,7&-.2*2013 2$%-.,(&)% +*2$%"8` 2$% 8T (/+1*2-/ .,7&-.2*2013 2$% 7)-1)-2(,+*2$% )$ *&$+"*&&7 E//%62'O

c/1(&3/'(/-&(,c/1(&$3 E&(:2(3 %)3-2*)3

<,7&-.2*20&"<,7&7.,3/2* -(2'- E(&072(25/$-()'1*2(>$% 317(2&7-)' $1'*/)

Page 8: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 8/40

.*$8*$/%- K+/#( ] :-6&$;/+/387:*7$&+&,- ./,0 >

9*7$*#,8*7; 40$N00# $;0 #08%&;-6&6;-7*7 /#($;0 /(0#&;-6&6;-7*7 /#( *(0#$*<- $;0*%784(*D*7*&#7M 7*#87&*(7M /#( )0++ $-607 *# /3*)%&,%/6; &< $;0 6*$8*$/%- ,+/#(

:2(3 c/(5&32 Q:&3-/()&( 7)-1)-2(,R"c& 3/'(/-&(, '/**3"<23 ."`a"Jb`'= 2$% 02$, 1$0,/*)$2-/% 29&$3 &E$/1(&3/'(/-&(, $/1(&$3 -.2- '&0/ E(&0.,7&-.2*2013 2$% -/(0)$2-/ $/2( '27)**2()/3":)-1)',-/3 2(/ +*)2* '/**3 4)-. -./ 7(&-/)$ +*)2*E)6()**2(, 2')%)' 7(&-/)$ 2$% 3.&4 '.2(2'-/()3-)'3 &E23-(&',-/3K 8./, 31((&1$% 29&$3 &E -./$/1(&3/'(/-&(, '/**3 2$% '&$-2'- -./ 6232* *20)$2 &E-./ E/$/3-(2-/% '27)**2()/3":0%%*#, 4&(*07 '&$-2)$ .&(0&$/3 Q;8 X >^<R02%/ 6, -./ .,7&-.2*2013 2$% -./)( '2(()/( 7(&-/)$"$/1(&7.,3)$K </(()$+ 6&%)/3 2(/ 13/% E&( 3-&(2+/ )$-./ 72(3 $/(5&32 2$% 2(/ '&$-2)$/% )$ %)*2-)&$3 &E -./1$0,/*)$2-/% 29&$3"<,7&-.2*2013 3/'(/-/3 )$-& -./ .,7&-.2*20&".,7&7.,3)2* -(2'- -& +/- .&(0&$/3 -& 72(3 $/(5&32":2(25/$-()'1*2( $1'*/13 ! 7()02()*, ;8"@17(2&7-)' $1'*/13 ! 7()02()*, >^<

B001$&.)3-&'./0)3-(, @*)%/

C/**3 &E :2(3 %)3-2*)3

Page 9: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 9/40

.;-7*&+&,- &< $;0:-6&$;/+/3*)A.*$8*$/%- OH*7 ./,0 1

"C*40%*#D (/*/23)$+ .&(0&$/ Q)K/K" 8P<R"=$/$*#D )$.)6)-)$+ .&(0&$/ Q)K/K"%&720)$/R"`%&6*) ;&%3&#07 " 2'- &$ 2$&-./( /$%&'()$/ +*2$%"^&#A$%&6*) ;&%3&#07A%)(/'-*, 2'- &$ -2(+/- '/**

U^&720)$/ )3 $&- 2 7/7-)%/ ! C2-/'.&*20)$/VU>C8< )3 (/31*- &E 7&3-"-(2$3*2-)&$2* 7(&'/33)$+ &E

:;FC ! >*3& 7(&%1'/3 0/*2$&',-/ 3-)01*2-)$+.&(0&$/3 Q2*7.2= 6/-2= +2002RK @&= CP< 3-)01*2-/3-./ 7(&%1'-)&$ &E :;FC 2$% (/*/23/ &E :;FC %/()5/%7/7-)%/3C.2(2'-/()3-)'3 &E <,7&-.2*20)' <&(0&$/3[K @/'(/-/% )$ 71*3/3SK G)$% -& 0/06(2$/ 6&1$% (/'/7-&(3 23 [ 3- 0/33/$+/(3`K @-)01*2-/ (/*/23/ &E 3-&(/% 2$-/()&( 7)-1)-2(,.&(0&$/TK @-)01*2-/ 3,$-./3)3 &E 2$-/()&( 7)-1)-2(, .&(0&$/aK F2, (/+1*2-/ 7&3-"-(2$3*2-)&$2* 7(&'/33)$+ &E

2$-/()&( 7)-1)-2(, .&(0&$/3hK F2, (/+1*2-/ &4$ (/'/7-&(3lK B$%1'/ ;-60%6+/7*/ 2$% ;-60%$%&6;- &E -2(+/-'/**3KK%&N$; S ;-60%6+/7*/ /#(c&% ;-60%$%&6;-

Z00(4/)I C&&67

a+$%/7;&%$ +&&6" .,7&-.2*20)' (/*/23)$+ E2'-&( )33/'(/-/% 2$% E//%3 62'O &$ )-3/*E -& (/+1*2-/ )-3 &4$7(&%1'-)&$ ! C2$ 6/ 7&3)-)5/ &( $/+2-)5/

"F2]&()-, &E 1*-(23.&(- *&&7 E//%62'O *&&732(/ 3//$ )$ 26$&(02*\./)+.-/$/%7.,3)&*&+)'2* 3-2-/3BK#! Z)+.- &( Z*)+.-= CP< .23 7&3)-)5/ /EE/'-

&$ 1*-(23.&(- E//%62'O *&&7 -& .,7&-.2*2013"j*-(23.&(- *&&73 -/$% -& 6/ 3.&(- *)5/% &(72-.&*&+)'2* 2$% %&/3 $&- /9)3- )$ C<P;cBC3-2-/3

=;&%$ C&&6" :)-1)-2(, .&(0&$/3 (/+1*2-/ -./ (/*/23/&E -./ .,7&-.2*20)'"(/*/23)$+ .&(0&$/! :(/%&0)$2$-*, $/+2-)5/ (/+1*2-&(3U#iC#:8B;c":(&*2'-)$ )3 -./ /9'/7-)&$ 3)$'/ )- )3 1$%/( -&$)')$.)6)-&(, '&$-(&* &E %&720)$/":(&*2'-)$ 2$% ^&720)$/ .25/ )$5/(3/ (/*2-)&$3.)7

:-6&6%&+/)$*#03*/a78/++- 70)&#(/%- $& 6*$8*$/%-

"H:(&*2'-)$ ^/E)')/$',I"@/912* ^,3E1$'-)&$ )$ F/$ 2$% W&0/$F#cN@ @,07-&03Y

"J&33 &E *)6)%&

"B$E/(-)*)-, %1/ -& (/%1'/% 37/(0 '&1$- 2$%(/%1'/% -/3-&3-/(&$/

W;F#cN@ @,07-&03Y"^/*2,/% 716/(-,"F/$3-(12* %)3&(%/("B$E/(-)*)-,"@16E/(-)*)-,">*2'-&+/$/3)3 &( )$2%/b12-/ *2'-2-)&$

:-60%6%&+/)$*#03*/ B50(8)0( 9&6/3*#0dddF ">6&5/ Sg$+\0*"@177(/33/3 -./ (/*/23/ &E ?$P<"J&4 -& *&4"$&(02* */5/*3 &E Z@< 2$% J<

F#cN@ @,07-&03Y"J&33 &E *)6)%&"#(/'-)*/ %,3E1$'-)&$"f)312* 7(&6*/03"</2%2'./

W;F#cN@ @,07-&03Y";*)+&0/$&((./2">0/$&((./2"B$E/(-)*)-,

C&#, +&&6" <&(0&$/ (/*/23/% E(&0 /$%&'()$/ +*2$%(/+1*2-/3 -./ (/*/23/ &E .,7&-.2*20)' (/*/23)$+

E2'-&(3 2$%\&( 7)-1)-2(, .&(0&$/3"F&3- &E -./ -)0/ )3 2 $/+2-)5/ *&&7"9*%0)$ ! 2'-3 &$ 7)-1)-2(, +*2$%""#(*%0)$ ! 2'-3 &$ .,7&-.2*2013

UB$%)(/'- J&$+ *&&7 E//%62'O (/b1)(/3 -./ 0&*/'1*/3-& '(&33 -./ GGG= 3& )- )3 3/72(2-/% )$-& )$%)(/'- 2$%%)(/'- ! ̂ )(/'-"B$%)(/'- E//%62'O .23 -./ .&(0&$/'(&33)$+ -./ GGG Q)K/K"3-/(&)%3\Z>3R= 2$% B$%)(/'-"B$%)(/'- E//%62'O .23 -./ .&(0&$/ 2'-)$+ 23 2 [ 3- 0/33/$+/(= &( -.(&1+. '2(()/("0/%)2-/%-(2$37&(-Q-.,(&9)$R= &( /-'K

j$%/(3-2$%)$+ >6$&(02* @/'(/-)&$ ! C*)$)'2**,

Page 10: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 10/40

.;-7*&+&,- &< $;0:-6&$;/+/3*)A.*$8*$/%- OH*7 ./,0 >

J&$+ .&7*$*D0 Z//%62'O *&&73 D #iC#:8B;cUj312**, c#?>8Bf#["F/$3-(12* ','*/

"Z@< X J< 3-)01*2-/ #3-(2%)&* 7(&%1'-)&$ 6,%&0)$2$- E&**)'*/ )$ &52(,= 4.)'. 3-)01*2-/3?$P< -& '213/ J< 31(+/ ! ;51*2-)&$";51*2-)&$ 4)** $&- &''1( 4)-.&1- *&$+ *&&7

S";9,-&')$ (/E*/9 2('3";9,-&')$ 6)$%3 -& &9,-&')$ (/'/7-&(3

"F,&0/-()10 1-/(13 ! Z0%,87&#%0<+0H "F,&/7)-./*)2* '/**3 *)$)$+ -./02002(, 2*5/&*) ! =8)I+*#, %0<+0H

";9,-&')$ 2'-)&$ 3-)01*2-/3 -./ (/*/23/ &E0&(/ &9,-&')$ E(&0 -./ 7&3-/()&( 7)-1)-2(,%1()$+ 6/%$8%*$*&# /#( 4%0/7$<00(*#,

:&3-/()&( :)-1)-2(, )3 '&$3)%/(/% /9-/$3)&$ &E.,7&-.2*2013":&3-/()&( .&(0&$/3

";9,-&')$ Q;8R"f23&7(/33)$ Q>^<R

"W` 2$% O9: 2(/ 3,$-./3)L/% )$ -./ .,7&-.2*20132$% -(2$37&(-/% 5)2 -./ .,7&-.2*20&".,7&7.,3/2*-(2'- -& 6/ 7$&%0( 2$% 70)%0$0( E(&0 -./ 7&3-/()&(7)-1)-2(,

+,$-.,$/' Y

"@17(2&7-)' $1'*/13 Q@;cR!

>^<":2(25/$-()'1*2( $1'*/13 Q:fcR ! ;8UG&-. 3/'(/-/% 6, 02+$&'/**1*2( $/1(&$3

U@-&(/% )$:0%%*#, 4&(*07 -.2- 2(/ %)3-()61-/% 2*&$+29&$3;8 2$% >^< -(2$30)33)&$ X 3/'(/-)&$Y"@;c 2$% :fc 7(&%1'/ ;8 2$% >^< 2$% -./, 2(/-(2$37&(-/% )$ 37/')E)'"'2(()/( 7(&-/)$3= '2**/%$/1(&7.,3)$3= 2*&$+ 29&$3 -& $/(5/ -/(0)$2*3 2-7&3-/()&( 7)-1)-2(, *&6/"@;c 2$% :fc 3/$% $/(5/ )071*3/3 -& '213/ C2Se%/7/$%/$- /9&',-&3)3 &E ;8 2$% >^< E(&0 -./7&3-/()&( 7)-1)-2(,

;8 2$% >^< 2(/ 5/(, 3)0)*2( 2$% .25/ %)EE/(/$-20)$& 2')% '&07&3)-)&$3 2- m` 2$% mnK">(+ 2- n &E >^< )3 )07&(-2$- E&( 2$-)%)1(/3)3"J/1')$/ 2- n &E ;8 %&/3 c;8 (/0&5/ >JJ &E -./2$-)%)1(/-)' '2726)*)-)/3 ! 2- .)+. */5/*3 &E ;8! >$-)%)1(/3)3VVV

U:.2(02'&*&+)'2* '&((/*2-)&$ ! ^/30&7(/33)$

2034%/#0A4&8#( WH-$&)*# 50)06$&% BW`5F"? 7(&-/)$ '&17*/% (/'/7-&( ! B:`\^>?"=3&&$; 387)+0 )&#$%/)$*&# BI0- );/%/)$0%*7$*)F

Q%0/7$ &% 8$0%*#0 )&#$%/)$*&#":.&37.&*)723/ C Q:JCR"@-)01*2-/3 C2Se 0&6)*)L2-)&$

e/7&6%077*# 50)06$&%7 KA6%&$0*# )&86+0(f[ P/'/7-&(A=3&&$; 387)+0 )&#$%/)$*&# BI0- );/%/)$0%*7$*)F

eO=WJW^=`5"J`"W^":.&37.&*)723/ C Q:JCR

"@-)01*2-/3 C2Se 0&6)*)L2-)&$"B:`\^>? 3)+$2*)$+

fS P/'/7-&(Af/$0% Q/+/#)0 BI0- );/%/)$0%*7$*)F"@-)01*2-/3 2%/$,*2-/ ','*23/"@-)01*2-/3 '>F:

9*/40$07 "#7*6*(87! #9'/33 7(&%1'-)&$ &E 1()$/[R C/$-(2*

"B$26)*)-, &E -./ 6&%, -& 7(&%1'/ &( (/*/23/>^<"810&(3= -(2102= 31(+/(,= /-'K

SR c/7.(&+/$)'"B$26)*)-, &E -./ O)%$/,3 -& (/37&$% -& >^<"P/$2* %)3/23/= >^<"1$(/37&$3)5/$/33=^(1+3 *)O/ *)-.)10= /-'K

@,$%(&0/ &E B$277(&7()2-/ >^< @/'(/-)&$ Q ="O9: R"#9'/33 >^< ! #9'/33 W2-/( P/-/$-)&$"#9'/33 (/*/23/% 6, 7&3-/()&( 7)-1)-2(, &( E(&02$&-./( 3&1('/ *)O/ 2 302** '/** '2(')$&02"P/3-()'- 42-/( )$-2O/ E&( )00/%)2-/ -(/2-0/$-

@-)01*2-/3:(&*2'-)$= -&&= -&(/7*/$)3. 0)*O

j-/(13 -& %/*)5/(, 2$% -&523&'&$3()'- 5/33/*3

Page 11: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 11/40

.;-7*&+&,- &< K%&N$; :&%3&#0 ./,0 1

?(&4-. <&(0&$/ Q?<R"P/+1*2-/3 ?(&4-. ! ;65)&13"W&(O3 4)-. )$31*)$"*)O/ +(&4-. E2'-&(3QB?Z3R -& 02)$-2)$ 2$% 3-)01*2-/ +(&4-.

K: =0)%0$*&#

=5"ZSK:":S=&3/$&7$/$*#"?< (/+1*2-/3 ?<P< 2$% @PBZ )$ 3.&(-"*&&7 E//%62'OX ?< (/+1*2-/3 2$-/()&( 7)-1)-2(, )$ 21-&'()$/02$$/( 23 2$ 1*-(23.&(- E//%62'O *&&7"?< 3-)01*2-/3 (/*/23/ &E B?Z3 E(&0 *)5/( X B?Z3 '2$(/+1*2-/ ?<P< 2$% @PBZ

?< )3 3/'(/-/% )$ $&(02* ')('2%)2$ (.,-.0 Q71*32-)*/02$$/(R 2$% )$ (/37&$3/ -& 3-(/$1&13/9/(')3/\E23-)$+ Q/7)3&%)'R

":1*32-)*/ 3/'(/-)&$ 72--/($"B$'(/23/% )$ %//7 3*//7VVVV! )07&(-2$- E&('.)*%(/$VVVV"?< &77&3/3 )$31*)$ )$ 2'1-/ /EE/'-3 &$ +*D0%M387)+0M /#( /(*6&70 $*7780 "?< 7(&%1')$+ -10&(3 ! )$31*)$ (/3)3-2$'/=+*1'&3/ )$-&*/(2$'/= 2$% 02, 6/ %)26/-)'"ago 6&1$% -& ?<"6)$%)$+ 7(&-/)$ Q?<G:R

"?< 7(&0&-/3 -./ 0&6)*)L2-)&$ &E E1/* 3-&(/3 -&)$'(/23/ 7*2302 +*1'&3/ E&( -)331/3 )$ $//%"?< 7/2O3 )$ 716/(-,"?< 2$% B?Z[ )$'(/23/ -&+/-./( )$ 716/(-,= 2$% 6&-.(/+1*2-/ 2$% 02)$-2)$ 6&%, 0233 )$ 2%1*-.&&% 23 4/**23 E1*E)**)&360#7/$&%- ,%&N$; B*_0_A $/I0 &#0I*(#0- &8$ /#( $;0 &$;0% ,%&N7 $& 3/$); <&%30%3/77 &< 4&$; I*(#0-7FP50,8+/$07 ;-6&$;/+/387 70)%0$*&# &< K:5:

P/'/7-&("233&')2-/% -,(&3)$/ O)$23/3 3-)01*2-/ -./p>A 2$% @8>8\F>:A 72-.42,3 -.(&1+.7.&37.&(,*2-)&$

"?< 6)$%3 4)-. ?< (/'/7-&( &$ ./72-&',-/3-& 3-)01*2-/ 3/'(/-)&$ &E BZ?3

P.%0(&3*#/#$+- 4*#(7 $& +*D0%M /(*6&70M ] 387)+0F/06(2$/"6&1$% ?< (/'/7-&( '2$ 6/0/-2**&7(&-/&*,-)'2**, '*/25/% -& E&(0 ?<G:

"?< (/'/7-&( .23 )$-(2'/**1*2( 2$%/9-(2'/**1*2( %&02)$3

"@/(10 */5/*3 &E ?<G: (/E*/'- (/*2-)5/ ?<(/'/7-&( %/$3)-, ! %&/3 $&- '&((/*2-/-& ?< 3/(10 */5/*VVV"?<G: D 3&*16*/ ?< (/'/7-&(">%)7&3/ -)331/ )3 7()02(, 3&1('/ &E ?<G:"?<G: /9-/$%3 ?< .2*E"*)E/= 02(O/%*,

"G)$%3 Tg"ago ')('1*2-)$+ ?<"?< 2$% B?Z 2(/ 1$)b1/= 3)$'/ -./, .25/ G:3

U:(&-/)$ .&(0&$/3 -,7)'2**, %& $&- .25/ 6)$%)$+7(&-/)$

?< 2'-)&$3

"B$'(/23/3 *)7&*,3)3 )$ 2%)7&3/ -)331/"P/%1'/3 ?*1'&3/ 17-2O/ )$ 013'*/"B$'(/23/3 ./72-)' +*1'&$/&+/$/3)3"?B -(2'- .&(0&$/ ! ?.(/*)$ )3 (/*/23/% 7()&( -& 0/2*2$% )$'(/23/3 ?< (/*/23/U?< 2$% B?Z3 2$% B$31*)$ 1-)*)L/ +*1'&3/

B?Z3 0/%)2-/ -./ /EE/'-3 &E ?<"B?Z[ 2$% B?ZS 2(/ (/*/23/% E(&0 *)5/( -&(/+1*2-/ 02)$-/$2$'/ 2$% +(&4-. &E -)331/-.(&1+.&1- 6&%,

B?Z[Y

"B?Z[D@&02-&0/%)$ C"P/+1*2-/3 E/-2* %/5/*&70/$- &E 72$'(/232$% 02]&( &(+2$3"B?Z["$1** O$&'O&1- )3 */-.2* E&( 02]&()-, &E0)'/

B?ZSY"B?ZSD@&02-&0/%)$ >":(/%&0)$2$- ')('1*2-)$+ B?Z )$ 2%1*-3"B?ZS */5/*3 %/5)2-/ )$ %)3/23/3"B?ZS"$1** O$&'O&1- 0)'/ (/2'. 02-1()-,"B?ZS"$1** O$&'O&1- 0)'/ 2(/ +(&4-.)072)(/% 61- +(&4-. (2-/ )3 $&(02*

B?ZG:3 2(/ %,$20)'Y -(2$37&(- B?Z 2$% .25//$%&'()$/ X 72(2'()$/ E1$'-)&$3= 1$)b1/ 3)$'/7(&-/)$3 %&$N- -/$% -& .25/ G:N3 2$% %&/3 $&- $//% -&%)33&')2-/ -& .25/ 2 E1$'-)&$K

#$%&'()$/ E1$'-)&$3 &E B?ZG:3"KZQ.A\ ! 02]&( '2(()/( )$ ')('1*2-)&$B?ZG:"` ! 3-)01*2-/3 /$%&'()$/ E1$'-)&$"KZQ.A[ ! )$.)6)-3 B?Z X 3/(10 '&$'/$-(2-)&$ )3 *&4

"KZQ.Ag ! ;$*, 6&$%3 B?ZS X )$.)6)-3 B?ZS 2'-)&$

:2(2'()$/ E1$'-)&$3 &E B?ZG:3 ! K%&N$; Z/)$&%7VB?ZG:"[ ! 20$)&-)' E*1)%B?ZG:"S 2$% "h ! C@ZB?ZG:"` ! Z&**)'1*2( E*1)% QE*1)% 31((&1$%)$+ &510RB?ZG:"T! -)331/ 37/')E)' 2$% (/+1*2-/3 B?ZB?ZG:"a ! 6&$/ 02-()9

\ 50)06$&%7 4*#( "KZ7

8,7/ [ B?Z P/'/7-&(Y

"</-/(&-/-(20/("G)$%3 B?Z[ X B?ZS 4)-. .)+. 2EE)$)-,"@-(1'-1(2**, )%/$-)'2* -& )$31*)$ (/'/7-&(":(/3/$- )$ 2** -)331/3 /9'/7- *)5/(">C8Bf# 3/'&$% 0/33/$+/( 3)+$2*)$+"P/'/7-&( 3)+$2*)$+Y

"B$-()$3)' -,(&3)$/ O)$23/ (/'/7-&("F1*-)7*/ 72-.42,3

8,7/ S B?Z P/'/7-&(Y"G)$%3 B?ZS 4)-. .)+. 2EE)$)-,"G)$%3 B?Z[ 4)-. *&4 2EE)$)-,

"F&3-*, Bc>C8Bf# 2$% >'-3 23 '*/2(2$'/ (/'/7-&( E&(B?ZS

B$31*)$ P/'/7-&(Y"G)$%3 B?Z[ 4)-. FjC< *&4/( 2EE)$)-, -.2$ )$31*)$"B?Z[ 013- 6/ 2- 5/(, .)+. */5/* -& 6)$% -& )$31*)$(/'/7-&(3

B?Z"B$31*)$ P/'/7-&( <,6()%"C/** /EE/'-3 1$O$&4$":&-/$-)2* E2'-&( &( 3&1('/ )$ (/'/7-&("

0/%)2-/% )$31*)$ (/3)3-2$'/"^&$N- (/2**, 6)$% 2$,-.)$+ Q)$31*)$ &( B?ZR

Page 12: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 12/40

.;-7*&+&,- &< K%&N$; :&%3&#0 ./,0 >

?<"B?Z 29)3 (/+1*2-)&$"?< 7()02()*, %&/3 3.&(-"*&&7 E//%62'O"B?Z3 /9/(- *&$+"*&&7 E//%62'O"?<P< /9/(-3 1*-(23.&(- *&&7 E//%62'O

K:@7 $*7780A760)*<*) 0<<0)$7=$*38+/$*&# "#;*4*$*&#

O(*6&70 "J)7&*,3)3 "?*1'&3/ 17-2O/

C*D0%

":(&-/)$ 3,$-./3)3"?*1'&$/&+/$/3)3"?*,'&+/$&*,3)3"B?Z3

"?*,'&+/$/3)3

287)+0

":(&-/)$ 3,$-./3)3">0)$& 2')% 17-2O/"?*,'&+/$&*,3)3

AK+8)&7086$/I0

AW66&7*$0<%&3 "KZ

UB?Z -,7)'2**, &77&3/3 ?<N3 0/-26&*)' /EE/'-3"KZ7 $*7780A760)*<*) 0<<0)$7

=*38+/$*&# "#;*4*$*&#

J;&#(%&)-$07

"p13- O$&4 -.2-)- '213/3 6&$/+(&4-.= 3& 2 *&-&E 3,$-./3)3 2$%+(&4-. 23 4/**23 .,7/(7*23)22$%.,7/(-(&7.,

C*D0%

c&- 2 *&- &E B?Z(/'/7-&(3 61-%&/3 )$.)6)-Y

"?*1'&$/&+/$/3)3"?*,'&+/$&*,3)3

287)+0

":(&-/)$3,$-./3)3">0)$& 2')%17-2O/"K+8)&7086$/I0

AW66&7*$0<%&3 K:

j$%/(3-2$% -./ (/*2-)&$3.)7 6/-4//$ B?Z 2$% ?<"?< '213/3 B?Z 3/'(/-)&$"?< .277/$3 E)(3- -& )$'(/23/ 7*2302 +*1'&3/-./$ B?Z 1-)*)L/3 -./ +*1'&3/ -& (/+1*2-/02)$-/$2$'/ 2$% +(&4-.K">*-.&1+. -./, &77&3/ )$ +*1'&3/ 17-2O/ &E013'*/= B?Z[ 2$% ?< )$'(/23/ 7(&-/)$3,$-./3)3 )$ 013'*/":(&0&-/ .,7/(7*23)2 2$% .,7/(-(&7.,

P5030340% $;0%0 /%0 1 K:Q. /#( g "KZQ.7

C*)$)'2* C&((/*2-/3"?)+2$-)30

":)-1)-2(, +)+2$-)30 ! 7(/"'*&31(/ &E/7)7.,3/3"#92++/(2-/% *)$/2( +(&4-. -.2- )3 02)$*,)$ '.)*%(/$

">'(&0/+2*,"#9'/33)5/ 3/'(/-)&$ &E ?< %1()$+ 2%1*-.&&%"#$*2(+/0/$- &E E2')2* 3-(1'-1(/3= .2$%3= 2$%E//-

"@&E- -)331/ 34/**)$+ &E &(+2$3"^//7/$/%= 3*&4 5&)'/ E(&0 5&'2* '&(%34/**)$+

":)-1)-2(, ^42(E)30":(/"'*&31(/ &E /7)7.,3/3"F2)$*, )$ '.)*%(/$

":2$.,7&7)-1)-2()30 ! &''1(()$+ )$ 2%1*-.&&%"<,7&-.,(&)%)30"^/7(/33/% 7(&%1'-)&$ &E +*1'&'&(-)'&)%3 )$2%(/$2* +*2$%"C.(&$)' .,7&+*,'/0)2"Z2- )$'(/23/":(&-/)$ %/'(/23/3"F13'*/ 4/2O$/33"#2(*, /9.213-)&$

U:)'-1(/ -.2- &E 2 */-.2(+)' 7/(3&$ QE(&0 *2'O &E

-.,(&)% .&(0&$/3R 4.& )3 +2)$)$+ 4/)+.- Q6/'213/ &E*2'O &E E2- 0&6)*)L2-)&$ 6, ?<= 2%(/$&'&(-)'&-(&7)'=2%(/$&'&(-)'2*= 2$% -.,(&)% .&(0&$/3R 2$% .23)072)(/% 3/912* E1$'-)&$3K

Page 13: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 13/40

.*#0/+ K+/#( :*7$&+&,-

907)%*40 $;0 7$%8)$8%0M <8#)$*&#M /#( +&)/$*&# &<$;0 6*#0/+ ,+/#(907)%*40 $;0 034%-&#*) &%*,*# &< $;0 6*#0/+ ,+/#(8./ 7)$/2* +*2$% %/5/*&73 E(&0 -./ (&&E &E -./%)/$'/7.2*&$ 2$% )3 '&$3)%/(/% 2 %&(32* %)5/(-)'1*10q06*6;-7*7 )0%04%*_8./ 7)$/2* (/'/33 '&001$)'2-/3 4)-. -./ ̀ (% 5/$-()'*/

^/30 $;0 ;&%3&#0B7F 6%&(8)0( 4- $;06*#0/+&)-$07

"J)+.- 3-)01*2-/3 -./ (/*/23/ &E $&(/7)$/7.()$/=4.)'. )$ -1($ )$'(/23/3 3/(&-&$)$K"J)+.- %/'(/23/3 c"2'/-,*-(2$3E/(23/ Q@>FR= 4.)'.'&$5/(-3 3/(&-&$)$ -& 2$ )$-/(0/%)2-/ )$ -./3,$-./3)3 &E 0/*2-&$)$">- $)+.-= a".,%(&9, )$%&* ;"0/-.,*-(2$3E/(23/)$'(/23/3 Q&$*, E&1$% )$ 7)$/2* +*2$%R 2$% '&$5/(-33/(&-&$)$ -& 0/*2-&$)$K

20+/$&#*#" O#$* ,&#/(&$%&6*) 0<<0)$ *# 3/33/+7

"F/*2-&$)$ %/'(/23/3 +&$2%2* 3-/(&)% */5/*3 6,)$.)6)-)$+ ?$P< )$ $/1(&3/'(/-&(, $/1(&$3

! C2$ '213/ 3/23&$2* 3/912* 2'-)5)-,">*3&= 0/*2-&$)$ '2$ 3-)01*2-/ ?< (/*/23/ 6,)$.)6)-)$+ 3&02-&3-2-)$ (/*/23/

J+*#*)/+ J&%%0+/$07@/23&$2* 2EE/'-/% %)3&(%/( Q@>^RY"^/7(/33)&$ -.2- )3 '&((/'-/% 6, 6()+.- *)+.-

p/- *2+Y

"F/*2-&$)$ '2$ 6/ 13/% -& ./*7 '&1$-/(2'- 3,07-&03&E %(&43)$/33 2$% %)3&()/$-2-)&$

! :)$/2* +*2$% 2%]13- -& 31%%/$ '.2$+/3 )$%2, */$+-.

:)$/2* +*2$% -10&(Y".%0)&)*&87 6840%$- Q/2(*, &$3/-R )E -10&(%/3-(&,3 7)$/2*&',-/3 &% 716/(-, '2$ 6/%/*2,/% )E -10&( )3 02%/ &E 7)$/2*&',-/3

"(0#$*<- 6*#0/+&)-$07M /7$%&,+*/+ )0++7M /#( 4%/*#7/#( B)&%6&%/ /%0#/)0/F *# / 3*)%&,%/6; &< $;06*#0/+ ,+/#(

:)$/2* +*2$% )3 '&07&3/% &E -4& '/** -,7/3[":)$/2*&',-/3";(+2$)L/% )$-& '&(%3 2$% '*13-/(3"@/'(/-/ 0/*2-&$)$ -.2- )3 '&$5/(-/% E(&0 3/(&-&$)$Q-(,7-&7.2$ )3 -./ 7(/'1(3&(R"F/*2-&$)$ )3 .)+./3- 2- $)+.-

"J)+.- %/'(/23/3 0/*2-&$)$ 3,$-./3)3"P/37&$3)5/ -& %)1($2* Q%2)*,R *)+.- 2$% %2(O 7/()&%3":)$/2*&',-/3 .25/ &$/ &( -4& *&$+ ',-&7*230)'7(&'/33/3 4)-. 61*6&13 /972$3)&$3 -.2- -/(0)$2-/$/2( E/$/3-(2-/% '27)**2()/3

P5*44&#7 /%0 (0#70 $848+/% 7$%8)$8%07 $;/$</)*+*$/$0 0H&)-$&7*7 /#( 0#(&)-$&7*7 &< D07*)+07/#( J/>h );/##0+ 6&7*$*&#*#, *# %076&#70 $&,%/(0( 6&$0#$*/+7_ Z/7$ /#( 787$/*#0(#08%&$%/#73*77*&#d

S" c/1(&+*)2* C/**3">'- *)O/ )$-/(3-)-)2* '/**3

"8./ 7)$/2* +*2$% .23 4%/*# 7/#( = 2*3& (/E/((/% -& 23)&%6&%/ /%0#/)0/

AJ&#$/*# J/.W[ /#( J/JW\ 6%0)*6*$/#$7">77/2( )$ '.)*%.&&% 2$% )$'(/23/ 4)-. 2+/Aa70( /7 / %/(*&+&,*)/+ 3*(+*#0 3/%I0%

Page 14: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 14/40

`;-%&*( K+/#( :*7$&+&,-

907)%*40 $;0 7$%8)$8%0M <8#)$*&#M /#( +&)/$*&# &<$;0 $;-%&*( ,+/#(

P.$ 3/- ;/D0 / 6-%/3*(/+ +&40"8./ -.,(&)% +*2$% )3 '&07&3/% &E -.,(&)% E&**)'*/32$% 72(2E&**)'1*2( QC '/**3R '/**3

8.,(&)% Z&**)'*/ C/**3"Z&**)'1*2( '/**3 '(/2-/ 2 *10/$ '2**/% 2 E&**)'*/ -.2- )3E1** &E '&**&)% Q+/*2-)$&13 02-/()2*R

! @-&(/3 .&(0&$/3"Z&**)'*/3 2(/ *)$/% 6, 3)07*/ /7)-./*)10

"C16&)%2*! c&(02*"@b120&13 ! B$2'-)5/"C&*10$2( ! @-)01*2-/%

:2(2E&**)'1*2( '/**3 QC '/**3 6/'213/ -./, 2(/ '*/2(R"^/()5/% E(&0 c/1(2* '(/3- '/**3 -.2- 0)+(2-/% -&1*-)0&6(2'.)2* 6&%, )$ -./ T -. 7.2(,$+/2* 7&1'.= -./$-& -./ -.,(&)% +*2$% Q317/()&( 72(2-.,(&)% )3 T -. 7&1'. %/()52-)5/R"@/'(/-/ '2*')-&$)$ -.2- 2'-3 &$ &3-/&'*23-3

"B$.)6)-3 6&$/ (/263&(7-)&$"B$'(/23/3 C2Se (/-/$-)&$ 6, 6&$/3"^/'(/23/3 C2Se 2$% :;T" 6*&&% */5/*3"B$'(/23/% C2Se */5/* )$ 3/(10 '213/3)$'(/23/% '2*')-&$)$ 2$% %/'(/23/% :8<

907)%*40 $;0 034%-&#*) &%*,*# &< $;0 $;-%&*(,+/#("Z&(03 2- -./ E&(20/$ '/'10 &$ -./ %/5/*&7)$+-&$+1/ &E '/7.2*)' ?B -(2'-K Q#$%&%/(0R"^/3'/$%3 )$ -./ 0)%*)$/ 23 2 6)*&6/% %)5/(-)'1*102$% )3 '&$$/'-/% -& -.,(&+*&332* %1'- %1()$+0)+(2-)&$"8.,(&+*&332* %1'- '2$ 7/(3)3- 23 2 ',3- &( 2 3)$13 -.2-'&001$)'2-/3 4)-. -./ 31(E2'/ &E $/'OK

! F2)$*, E&1$% '*&3/ -& 0)%*)$/^/30 $;0 ;&%3&#07 6%&(8)0( 4- $;0 $;-%&*( /#(6/%/<&++*)8+/% )0++i Z&% 0/); ;&%3&#0M *(0#$*<- $;0)0++ $-60 %076&#7*4+0 <&% *$7 70)%0$*&# /#(%0,8+/$*#, </)$&%7

8.,(&)% Z&**)'*/3 @/'(/-/Y"8())&%&-.,(&$)$/ Q8`R"8/-(2)&%&-.,(&$)$/ Q8TR

C C/**3 @/'(/-/Y

"C2*')-&$)$

P/+1*2-)&$YJ/5/* &E )&%)$/! .)$%/(3 3,$-./3)3

! <,7&-.,(&)%)30! 8.,(&)% .,7/(-(&7., E(&0 8@< )$'(/23/)$ $/+2-)5/ E//%62'O *&&7K 8@< 6)$%)$+ -&8@< (/'/7-&(3 '2$ 3&*/*, '213/ -.,(&)%.,7/(-(&7.,! C2**/% B&%)$/ %/E)')/$', ?&)-/( &( #$%/0)'?&)-/(

^)3&(%/(3Y"C(/-)$)30" .,7&3/'(/-)&$ &E -.,(&)% .&(0&$/3%1()$+ E/-2* *)E/ &( )$E2$',

! ̂ 42(E)30 3)$'/ 8T 2$% ?< 4&(O3,$/(+)3-)'2**, )$ 6&$/ E&(02-)&$! F/$-2* (/-2(%2-)&$

"?(25/3 ^)3/23/" -.,(&)% .,7/(E1$'-)&$ E(&0)001$&*&+)'2* %,3E1$'-)&$K >1-&2$-)6&%)/3 6)$% -&8@< (/'/7-&(3 '213)$+ /*/52-/% -.,(&9)$/ */5/*3

! #9&7.-.2*0&3 Q61*+)$+ /,/R! #$*2(+/% -.,(&)% +*2$%

`%/)0 $;0 7$067 *# $;0 7-#$;07*7M 7$&%/,0M /#(70)%0$*&# &< ;&%3&#07 4- $;0 $;-%&*(@7 <&++*)8+/%)0++7 O<$0% `=: 4*#(7 $& `=: %0)06$&% &# 4/7/+ 7*(0T["8.,(&+*&61*)$ Q8?GR )3 3,$-./3)L/% )$ -.,(&)%E&**)'1*2( '/**N3 P#P 2$% +&*+) 3,3-/0 4)-. -,(&3)$/S"B&%)%/ )3 -(2$37&(-/% )$-& E&**)'1*2( '/** 6, 2 c2e\B">8:23/"%/7/$%/$- 3,07&(-/(K B&%)%/ )3 &9)%)L/% -&)&%)$/ 6, 60%&H*(/70 )$ -./ 27)'2* 0/06(2$/ 2$%3.1--*/% &1- 5)2 60#(%*# `"B&%)$2-)&$ 2$% '&17*)$+ &E FB8 2$% ^B8 E&(0 8`2$% 8T )$ -./ '&**&)%K ̂ B8 eFB8D 8`= ̂ B8e^B8D 8T^B8D ^)")&%&-,(&3)$/= FB8DF&$&")&%&-,(&3)$/T" 8@< 3-)01*2-/3 3/'(/-)&$

a"B&%)$/"'&$]1+2-/% 8?G )3 7)$&',-&3/% 5)2 (/'/7-&(0/%)2-)&$K S %)EE/(/$- )$-(2'/**1*2( 72-.42,3 -&623)*2( 0/06(2$/ 3)%/

["J,3&3&02* 72-.42," 8?G )3 %/+(2%/% )$-&20)$& 2')%3= '2(63= E(// FB8= E(// ^B8= 8`=2$% 8T 2$% (/*/23/% )$-& ',-&3&*K FB8 2$%^B8 2(/ (/13/% 4.)*/ 8` 2$% 8T 2(//9&',3-&3/% &$ 623)*2( 3)%/ )$-& '27)**2()/3Q02]&( 72-.42,RS" 8(2$3/7)-./*)2* 72-.42," '&$]1+2-/% 8?G

)3 -(2$37&(-/% %)(/'-*, -& 623)*2( 3)%/ 2E-/(6)$%)$+ -&30,/+*# = 4.)'. )3 2-(2$30/06(2$/ 7(&-/)$K! .)+. 8@< '213/3 0/+2*)$ -& 6)$% -& *2(+/20&1$-3 &E 8?G '213)$+ 8` 2$% 8T (/%1'-)&$

"(0#$*<- $;0 <&++*)+07M <&++*)8+/% )0++7M 4/7030#$

3034%/#0M )&++&*(M )/6*++/%*07M /#( 6/%/<&++*)8+/%)0++7 *# / 3*)%&,%/6; &< $;0 $;-%&*( ,+/#(

Page 15: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 15/40

`;-%&*( Q*&);03*7$%-

=-#$;07*7 &< `;-%&*( ;&%3&#07"8` 2$% 8T 2(/ 3,$-./3)L/% E(&0 7(&-/)$"6&1$%-,(&3)$/ 2$% )&%)$/"S ^B83 D 8T X ^B8 e FB8 D 8`

^B8D ^)")&%&-,(&3)$/FB8DF&$&")&%&-,(&3)$/

U8.,(&+*&61*)$ )3 3-&(/% )$ -./ -.,(&)% +*2$% )$ -./'&**&)% 2$% .23 2 3177*, 31EE)')/$- E&( ` 0&$-.3

! ^&/3 $&- 3-&(/ 8` &( 8TVVVV

`%/#76&%$ &< $;-%&*( ;&%3&#078.,(&)% .&(0&$/3 2(/ 6&1$% $&$"'&52*/$-*, -&7*2302 7(&-/)$3

"8.,(&9)$/"6)$%)$+ +*&61*)$ Q8G?R! F2]&()-,

"8(2$3-.,(/-)$ ! G)$%3 5)-20)$ > -&&">*610)$

@-/(&)% .&(0&$/3 2(/ 7(&-/)$"6&1$% -&&"8(2$3'&(-)$ ! ?*1'&'&(-)'&)%3"@/9 .&(0&$/ 6)$%)$+ +*&61*)$ ! /3-(&+/$2$% 2$%(&+/$

UG)&*&+)'2* 2'-)5)-, &E .&(0&$/ )3 7(&7&(-)&$2* -&*/5/* &E 1$6&1$% .&(0&$/= c;8 -&-2* .&(0&$/8G? %/E)')/$', ! $& '*)$)'2* 3)+$3

`/%,0$ $*7780 30$/4&+*73 &< `\ /#( `["8.,(&)% 7(&%1'/3 0&(/ 8T -.2$ 8`= 61- 8` )3 0&(/6)&*&+)'2**, 2'-)5/K F&3- 8` 7(&%1'/% 6, &-./( -)331/3"8` )3 0&(/ 7&-/$- -.2$ 8T 3)$'/ 8` .23 .)+./(2EE)$)-, E&( (/'/7-&(3"8T )3 6&1$% 0&(/ -)+.-*, )$ 6*&&% -.2$ 8`

"F&3- &E -.,(&9)$/ )3 7(&-/)$ 6&1$% )$ 6*&&%"8T )3 2'-)52-/% 2- -2(+/- -)331/ -& 8` &( )$2'-)52-/% -&(/5/(3/ 8`

"8T )3 '&$5/(-/% -& 8` &( (/5/(3/ 8` Q(8`R )$ -2(+/--)331/3 2$% %/7/$%3 &$ -./ )&%)$23/ )$ -2(+/- -)331/

8.,(&)% 2'-)&$ &$ -2(+/- -)331/Y["^)33&')2-/3 E(&0 6)$%)$+ 7(&-/)$S"C2(()/( 6()$+3 .&(0&$/ )$-& '/**

`"P/'/7-&( )3 L)$'"E)$+/( 7(&-/)$ -.2- 1312**,3177(/33/3 -(2$3'()7-)&$ 4)-.&1- .&(0&$/ 61-/$.2$'/3 )- 4./$ .&(0&$/ )3 7(/3/$-T"C&$5/(3)&$ &''1(3 )$ '/** ! 8`a"8` 4)** 6)$% -& $1'*/2( (/'/7-&(

"<)+./( 2EE)$)-, -.2$ 8TV

.*$8*$/%-A$;-%&*( <00(4/)I B+&#,A+&&6F

O)$*&#7 /#( <8#)$*&#7 &< $;-%&*( ;&%3&#07"F2)$ /EE/'- )3 )$'(/23/% 0/-26&*)' (2-/

! )$'(/23/% >8:23/ 2'-)5)-,

" ↑ >77/-)-/A =&(*83A6&$/77*83 O`./70A J/+)*83 O`./70" ↑ :(&-/)$ 3,$-./3)3 2$% %/+(2%2-)&$" ↑ J)7&+/$/3)3 2$% *)7&*,3)3" ↑ :*2302 E(// E2--, 2')%3" ↑ Z1-)*/ ','*)$+ )$ '2(6&.,%(2-/ 0/-26&*)30" ↑ j$'&17*)$+ 7(&-/)$3 ! </2- +/$/(2-)&$

;-./( #EE/'-3Y" G(2)$ 02-1(2-)&$" @-)01*2-)&$ &E 6&$/ +(&4-. Q3,$/(+)3-)'2**, 4\?<R"↑ </2(- (2-/"↑ c; 7(&%1'-)&$ ! ↓ :/()7./(2* 523'1*2( (/3)3-2$'/"↑ F/$-2* 2*/(-$/33" @/$3)-)L2-)&$ -& 02$, r"2%(/$/(+)' /EE/'-3K

"</2(-= O)%$/,3= 2$% 2%)7&3/ -)331/

8` (/+1*2-)&$"8` )3 (/+1*2-/% 0&3-*, 4)-. (/5/(3/ 8` )$ -./ -2(+/--)331/3"8` )3 %/'(/23/% 2$% 8`Y8T (2-)&3 %/'(/23/3 )$7(&*&$+/% E23-)$+"C&*% /97&31(/ )$'(/23/3 8@< 3/'(/-)&$ )$ )$E2$-3&$*, 2$% )$'(/23/3 8` E&(02-)&$ )$ 013'*/ 2$%2%)7&3/ -)331/ )$ 2** 2+/3

"36&%$/#)0 &< (*0$/%- *&(*#0"c2e\B" >8:23/"%/7/$%/$- 3,07&(-/( '2$ 6/)$.)6)-/% 6, -.)&',2$2-/ -.2- )3 )$ '2662+/ 2$% &-./()$&(+2$)' 2$)&$3

<,7&-.,(&)%)30@/5/(/ .,7&-.,(&)%)30 D F,9/%/02 )$ 2%1*-3

"P/%1'/% 0/-26&*)' (2-/"@16'1-2$/&13 /%/02

UF2)$*, '213/% 6, 21-&)001$/ -.,(&)%)-)3 Q-.,(&)%+*2$% )3 -./ 7()02(, 3&1('/ &E .,7&-.,(&)%)30 )$0&3- '23/3 -&&RK C2$ 6/ '213/% 6, )&%)$/ %/E)')/$',=-.,(&)% 31(+/(,= /97&31(/ -& (2%)&2'-)5/ )&%)$/

Page 16: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 16/40

.;-7*&+&,- &< `;-%&*( K+/#( ./,0 1

8@< 3-)01*2-/3Y"B&%)%/ 7107"B&%)$2-)&$ &E -,(&3)$/ 3163-(2-/ )$ 8?G":(&-/&*,3)3 &E 8?G"<,7/(-(&7., &E -.,(&)% '/**3":(&%1'-)&$ &E 8` 2$% 8T

8T )3 '&$5/(-/% -& 8` 6, ` %)EE/(/$- -,7/3 &E -)331/"

37/')E)' %/)&%)$23/3 Q8T )3 2 7(&.&(0&$/ E&( 8`R

8,7/ [ ̂ /)&%)$23/AC*D0% /#( E*(#0-":()02()*, (/37&$3)6*/ E&( 8T -& 8` '&$5/(3)&$A.8$7 *$ 4/)I *#$& 7-7$03*) )*%)8+/$*&# /7 `\

8,7/ S ̂ /)&%)$23/AQ%/*#M 6*$8*$/%-M 4%&N# /(*6&70 $*7780"C&$5/(-3 8T -& 8` )$-(2'/**1*2(*,Aa70( N*$;*# $*77807

8,7/ ̀ ̂ /)&%)$23/AQ%/*#M 7I*#M 6+/)0#$/ B6+/)0#$/ +*3*$7 ;&%3&#0 *#6%0,#/#)-F"F2]&( 3)-/3 &E )$2'-)52-)&$A"#$%/)0++8+/% )&#D0%7*&# &< `[ $& 50D0%70 `\

P/5/(3/ 8` D )$2'-)5/ 8`

8G? 6&1$% ! 1$252)*26*/8(2$3-.,(/-)$ ! 252)*26*/ X (/3/(5&)(>*610)$ ! /23)*, %)33&')2-/3 X 6)&252)*26*/

UF&3- -.,(&9)$/ )3 6&1$%

8G? ^/E)')/$',":2-)/$-3 /9.)6)- /1-.,(&)% '&$%)-)&$3 ! $&(02*-.,(&)% E1$'-)&$"C2$ 6/ 2'b1)(/% )$ 72-)/$-3 -(/2-/% E&(.,7/(-.,(&)%)30"J/5/*3 &E E(// -.,(&)% .&(0&$/ )$)-)2**, ()3/ '213)$+2 %/'(/23/ )$ 8@< */5/*3

"P/7(/3/$-3 316'*)$)'2* .,7/(-.,(&)%)30 2-[ 3-

"Z(// -.,(&)% .&(0&$/ */5/*3 3-26)*)L/ )$ E//%62'O

*&&7 "B$ -./ /$%= 0&(/ .&(0&$/3 2(/ 6&1$% -&-(2$3-.,(/-)$ 2$% 2*610)$

U.&(0&$/ 6&1$% -& 2*610)$ )3 '&$3)%/(/%6)&252)*26*/["F&3- 0&*/'1*/3 6)$% 4)-. 4/2O 2EE)$)-, -& 2*610)$S"G)&252)*26*/ 20&1$- D m E(// e m 6&1$% -& 2*610)$UG)$%)$+ +*&61*)$3 2**&4 b1)'O 2$% /EE)')/$-(/+1*2-)&$<&(0&$/"37/')E)' +*&61*)$3 23 /$%&'()$/ 61EE/(3"B$'(/23/ ! */33 .&(0&$/ 6&1$% -& 2*610)$

! */33 6)&252)*26)*)-,"^/'(/23/ ! 0&(/ .&(0&$/ 6&1$% -& 2*610)$

! 0&(/ 6)&252)*26)*)-,

c&(02* -.,(&)% E1$'-)&$Y"J&+"*)$/2( (/*2-)&$3.)7 6/-4//$ 3/(10 8@< 2$% E(//8T"@02** '.2$+/ )$ E(// 8T '213/3 *2(+/ )$5/(3/ '.2$+/)$ 8@<

<)/(2('., &E >33/33)$+ 8.,(&)% E1$'-)&$

["8@< '&$'/$-(2-)&$ ! 0&3- '&00&$ 02(O/(S" 8&-2* 8T '&$'/$-(2-)&$`"8&-2* 8` '&$'/$-(2-)&$T"Z(// 8T Q&( 8`R '&$'/$-(2-)&$

"8.,(&)% .&(0&$/3 2(/ H3.1--*/%I 2'(&33 -./ '/**0/06(2$/ 6, '.27/(&$/ 7(&-/)$3

! C2(()/("0/%)2-/% -(2$37&(-"9*%0)$+- (/+1*2-/ +/$/ -(2$3'()7-)&$"F/06(2$/ (/'/7-&( -.2- 3.1--*/3 8T 02, .25/ &-./(2EE/'-3 ! C2Se >8:23/= 2%/$,*2-/ ','*23/= ?Jj83= 2$%8,7/ S %/)&%)$23/U8T '&$5/(-/% -& 8` )$-(2'/**1*2(*, 2$% 8` 2'-12**,.23 2 $1'*/2( (/'/7-&( 23 02]&( )3&E&(0 1$*)O/ &-./(3-/(&)%3

8.,(&)% <&(0&$/Y ?/$/(2* #EE/'-3:()02(, #EE/'-3 ! G232* F#8>G;JB@F";9,+/$ '&$3107-)&$":(&-/)$ 0/-26&*)30"C2(6&.,%(2-/ 0/-26&*)30"J)7)% 0/-26&*)30"f)-20)$ 0/-26&*)30

8.,(&)% .&(0&$/3 2(/ 2*3& 7/(0)33)5/ .&(0&$/3":/(0)33)5/ .&(0&$/3" 21+0/$- -./ 2'-)&$ &E &-./(.&(0&$/3

"> S $% .&(0&$/ '2$ 2'- &$ 2 '/** -& )$'(/23/-./ (/37&$3)5/$/33 -& -./ [ 3- .&(0&$/":/(0)33)5/ .&(0&$/ 2**&43 7()02(,.&(0&$/ -& 02)$-2)$ .&0/&3-23)3">6$&(02* 7/(0)33)5/ .&(0&$/ '213/326$&(02* 7()02(, .&(0&$/ E1$'-)&$

U8.,(&)% .&(0&$/3 )$'(/23/ m &E 2%(/$/(+)'(/'/7-&(3 )$ '2(%)&0,&',-/3 E&( '2-/'.&*20)$/3U?*1'&'&(-)'&)%3 /$.2$'/ ?< /EE/'-3 )$ .,7&+*,'/0)'3-2-/3 &( )$31*)$ &$ 3O/*/-2* 013'*/ )$ .,7/(+*,'/0)'33-2-/3 )$ 0,&',-/3 E&( (/+1*2-)&$ &E +*1'&3/0/-26&*)30

Uc&(02* */5/*3 &E -.,(&)% .&(0&$/ 7(&0&-/ 6&$/+(&4-. )$ %/5/*&70/$- 2$% ./*7 C2Se .&0/&3-23)3-.(&1+. )$'(/23)$+ :8< (/'/7-&(3

Page 17: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 17/40

.;-7*&+&,- &< `;-%&*( K+/#( ./,0 >

8.,(&)% (/+1*2-)&$ &E '2(%)2' &1-71- 2$% 523'1*2((/3)3-2$'/Y^)(/'- #EE/'-3 ! (/+1*2-/ <P 2$% C2(%)2' ;1-71- "B$'(/23/3 C2(%)2' 013'*/ %1/ -& !

"P/+1*2-/3 '2(%)2' 0,&3)$ ./25, '.2)$ +/$/-(2$3'()7-)&$ Q'213/3 2*7.2 s 6/-2 ./25,'.2)$R"B$'(/23/% c2e\Ae >8:23/

"@-)01*2-/3 G/-2"2%(/$/(+)' 3)+$2*)$+ 2$%(/37&$3)5/$/33"B$'(/23/% (2-)& &E 3-)01*2-&(, '&17*)$+ ?"

7(&-/)$ -& )$.)6)-&(, '&17*)$+ ?"7(&-/)$3"B$'(/23/3 '2(%)2' &1-71- ! ;S -& -)331/3 )$'(/23/%

":&3)-)5/ '.(&$&-(&7)' Q37//%R":&3)-)5/ )&$&-(&7)' QE&('/R

"^/'(/23/% 8:P

B$%)(/'- #EE/'-3"B$'(/23/% ./2- 7(&%1'-)&$"B$'(/23/ -)331/ C;S

"^/'(/23/ 8:P"P/+1*2-/3 32('&7*230)' (/-)'1*10 C2Se">8:23/2'-)5)-, ! (2-/ &E %)23-&*)' (/*292-)&$ )3 (/+1*2-/%"@,3-&*)' )$'(/23/% Q3-(&O/ 5&*10/ %/7/$%/$-R 2$%%)23-&*)' %/'(/23/% Q8:P %/7/$%/$-R -& 4)%/$ 71*3/7(/331(/

"^/'(/23/% %)23-&*)' G: X %/'(/23/%2%(/$/(+)' 3-)01*2-)&$ ! G*&&% 5&*10/)$'(/23/% E(&0 2'-)52-)$+ (/$)$"2$+)&-/$3)$q2*%&3-/(&$/ 3,3-/0! (/+1*2-/3 ./2(- (2-/ 2$% '2(%)2' &1-71-

U8` -(/2-0/$- '2$ ./*7 7&3- '2(%)2' 31(+/(, 72-)/$-3

"8.,(&)% .&(0&$/3 .25/ %)(/'- /EE/'-3 &$ 4.)-/ 2$%6(&4$ 2%)7&3/ -)331/! @-)01*2-/3 $;0%3&,0#07*7 )$ 6(&4$ 2%)7&3/ -)331/

"@-)01*2-/3 2%)7&3/ %)EE/(/$-)2-)&$"P/+1*2-/3 *)7&*,3)3 2$% *)7&+/$/3)3"B$'(/23/3 G/-2"2%(/$/(+)' (/'/7-&((/37&$3)5/$/33"P/+1*2-/3 */7-)$ 7(&%1'-)&$\(/*/23/

8` E1$'-)&$3 )$ $1-3./** QZ)(3- >)%RYT GN3[" G(2)$ 02-1(2-)&$S"G&$/ +(&4-.`" G/-2"2%(/$/(+)' /EE/'-3T"B$'(/23/% GFP

"G(&4$ 2%)7&3/ -)331/ .23 a"0&$&)&%&-.,(&$)$%/)&%)$23/ E&( 8T -& 8` '&$5/(3)&$"C&(% '1--)$+= $/&$2-2* '&&*)$+= '2-/'.&*20)$/3-)01*2-)&$= 2$% 8T -& 8` 21+0/$-2-)&$ '213/3-./(0&+/$/3)3 )$ $/&$2-/3"8T 2$% c# (/+1*2-/ '&$'/$-(2-)&$ &E ./2-

G>8 )3 /$/(+, %)33)72-)$+= W>8 )3 /$/(+, 3-&()$+

UG>8 )3 7()02()*, 2(&1$% O)%$/,3= 2%(/$2* +*2$%3=2$% 6*&&% 5/33/*3 &E -./ 0/%)23-)$10 2$% $/'OK

8.,(&)% .&(0&$/ 2$% *)5/(\./72-)' E1$'-)&$Y"@-)01*2-/3 02*)' /$L,0/= ?h: ^<= 2$% Z> 3,$-.23/-& (/+1*2-/ *)7&+/$/3)3\*)7&*,3)3"@-)01*2-/3\(/+1*2-/3 02$, /$L,0/3 (/b1)(/% E&('.&*/3-/(&* 0/-26&*)30

"P/+1*2-/3 7(&*)E/(2-)&$\27&7-&3)3 &E ./72-&',-/3

8.,(&)% 2$% 6&$/ +(&4-.= &3-/&'*23-3= 2$%'.&$%(&',-/3

<>@ :#PFB@@Bf# Z#>8jP# Bc >^jJ8@ >c^ G;c#

"8.,(&)% .&(0&$/3 2(/ '()-)'2* E&( $/1(2*%/5/*&70/$- 61- 0/'.2$)303 2(/ 1$O$&4$

"C/(/6(2* '&(-/9= 5)312* 2$% 21%)-&(, '&(-)'/3=.)77&'20713= 2$% '/(/6/**10

@1002(, &E :.,3)&*&+)'2* /EE/'-3 &E -.,(&9)$/

>6$&(02* #$%&'()$/ +*2$% E1$'-)&$ 2$% .&(0&$/*/5/*3 .25/ %)EE/(/$- '*233)E)'2-)&$3.%*3/%- ! >6$&(02* E1$'-)&$ &E +*2$% 2$% +*2$%%&/3 $&- (/37&$% '&((/'-*, -& -(&7)' .&(0&$/=84)+*#*)/+ ! :()02(, .&(0&$/ */5/* )3 $&(02* 61-7)-1)-2(, .&(0&$/ )3 26$&(02*K ^)EE)'1*- -& %)2+$&3/=0)&#(/%- ! >6$&(02* */5/*3 &E -(&7)' .&(0&$/ 2$%/$%&'()$/ +*2$% .&(0&$/3K :(&6*/0 )3 $&- E(&0/$%&'()$/ +*2$%= 61- %1/ -& )$31EE)')/$- -(&7)'.&(0&$/ 3/'(/-)&$ 6, 7)-1)-2(,

<,7&-.,(&)%)30.%*3/%- ! .)+. 8@< 2$% *&4 8T=84)+*#*)/+ ! .)+. 8@< 2$% $&(02* 8T

=0)&#(/%- !

*&4 8T 2$% $&(02* 8@< 3)$'/ 7)-1)-2(,)3 $&- (/37&$%)$+ -& *&4 8TUF&(/ '&00&$ )$ 4&0/$

Page 18: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 18/40

.;-7*&+&,- &< `;-%&*( K+/#( ./,0 \

.%*3/%- :-6&$;-%&*(*73

:/7;*3&$&@7 `;-%&*(*$*7">1-&)001$/ %)3/23/ 4./$ 21-&2$-)6&%)/32--2'O -.,(&+*&61*)$ Q8?GR 2$% 7/(&9)%23/K8./3/ 2(/ 2$-)"8:; 2$-)6&%)/3 '213)$+-.,(&)% -)331/ %/3-(1'-)&$

<,7/(-.,(&)%)30:()02(, ! *&4 8@< 2$% )$'(/23/% 8T 2$%\&( 8`

"8@< 6/*&4 gKga )$%)'2-/3 .,7/(-.,(&)%)30UF13- /52*12-/ 8@< -&&V

@16'*)$)'2* ! *&4 8@< 2$% $&(02* 8` 2$% 8T

U>+2)$= 0&(/ '&00&$ )$ 4&0/$ -.2$ 0/$

?(25/3 %)3/23/"F&3- '&00&$ '213/ &E .,7/(-.,(&)%)30">$-)"8@< 21-&2$-)6&%)/3 6)$% -& 8@< (/'/7-&(3

"@-)01*2-/3 -.,(&)% .&(0&$/3"C&00&$ 3,07-&03

"#9&7.-.2*0&3 Q61*+)$+ /,/3R"?&)-/("</2- )$-&*/(2$'/"B$'(/23/% 277/-)-/"P/3-*/33$/33\ )(()-26)*)-,"W/)+.- *&33"B$'(/23/% ./2(- (2-/

UP2(/ 61- c&$"2'-)52-)$+ 2$-)"8@< 21-&2$-)6&%)/3 '2$6/ 7(&%1'/% '213)$+t<k:;-.,(&)%)30

?/$/(2**,Y

<,7/(-.,(&)%)30"BcCP#>@#^ 0/-26&*)30"B(()-26)*)-,"@,07-&03 233&')2-/% 4)-. -&& 01'. /$/(+,

<,7&-.,(&)%)30"^#CP#>@#^ 0/-26&*)30

"Z2-)+1/"@,07-&03 233&')2-/% 4)-. *&4 /$/(+,

W&*EE"C.2)O&EE #EE/'-" -(2$3)/$- %/'(/23/ )$ 8`\8T*/5/*3 %1/ -& /9'/33 )$+/3-)&$ &E )&%)%/= 4.)'. )$.)6)-3)&%)%/ 7107 2'-)5)-,

Page 19: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 19/40

2*)%&#8$%*0#$7 1 "#$%& ./,0 1

=&(*83 ! F&3- )07&(-2$- /9-(2'/**1*2(*,

C213/3 &E .,7&$2-(/0)2"A)%$/, E2)*1(/ 2$% %/E/'- )$ 2%(/$2* '&(-/9"f&0)-)$+ 2$% %)2((./2

C213/3 &E .,7/($2-(/0)2"<,7/(2'-)5)-, &E 2%(/$2* '&(-/9 4./$ 42-/( *&33

/9'//%3 c2e *&33 Q%/.,%(2-)&$R"@,07-&03Y .)+. 6*&&% 7(/331(/= E*1)% (/-/$-)&$= 2$%34/**)$+

.&$/77*83 ! F&3- )07&(-2$- )$-(2'/**1*2(*,"#33/$-)2* )$-(2'/**1*2(*, E&( /$L,0/"0/%)2-/%(/2'-)&$3 Q7,(152-/ O)$23/= +*,'&+/$ 3,$-./3)3=7(&-/)$ 3,$-./3)3= X /-'KR"B07&(-2$- /9-(2'/**1*2(*, E&( '2(%)2' 013'*/

<,7&O2*/0)2 2$% <,7/(O2*/0)2 2(/ 02)$*, '213/% 6,(/$2* E1$'-)&$

J;+&%*(0"F2)$-2)$3 /*/'-(&*,-/ 62*2$'/ 2$% &30&-)' 7(/331(/

<,7&'.*&(/0)2 ! 0/-26&*)' 2*O2*&3)3

<,7/('.*&(/0)2 ! 0/-26&*)' 2')%&3)3= %/.,%(2-)&$=%/'(/23/% (/$2* 6*&&% E*&4= 0/%)'2-)&$3= 200&$)10'.*&()%/= 2$% .,7/(72(2-.,(&)%)30

c2e= Ae= 2$% C*""F2)$-/$2$'/ &E E*1)% 5&*10/3 2$% &30&-)' 7(/331(/"Z&(02-)&$ &E 61EE/(3"c/(5/ )071*3/ -(2$30)33)&$"F13'*/ '&$-(2'-)&$"C*" 2'-)52-/3 20,*23/ /$L,0/"C*" )3 )07&(-2$- E&( E&(02-)&$ &E +23-()' <C*

J&660%A 0H*7$7 *# h1 &% h> 7$/$0"C&07&$/$- &E 0/-2**&/$L,0/3"F2)$*, 6&1$% -& '/(1*&7*230)$ 3/(10= 61- 2*3&2*610)$ &( .)3-)%)$/ '&07*/9UA/, Z1$'-)&$"C,-&'.(&0/ &9)%23/ )$ /" -(2$37&(-'.2)$

C&77/( %/E)')/$',N3 %)3-)$+1)3./% 3,07-&03Y"J&4 '/(1*&7*230)$ */5/*3"F)'(&',-)' .,7&'.(&0)' 2$/0)2 E(&0 %/'(/23/%E/((&9)%23/ 2'-)5)-,"^/7)+0/$-2-)&$

C&77/( -&9)')-,N3 >FGB?j;j@ 3,07-&03Y"?23-()' 72)$"c213/2"f&0)-)$+

"^)2((./2"C&02";*)+1()2"</72-)' $/'(&3)3"f23'1*2( '&**273/"^#>8<

W)*3&$N3 %)3/23/ &( </72-&*/$-)'1*2( ̂ /+/$/(2-)&$">1-&3&02* (/'/33)5/ %)3/23/ 4)-. C1Se>8:23/"^)3-)$+1)3./% 3,07-&03Y

"Z2-2* %)3/23/"A2,3/("Z*/)3'./( ()$+3 )$ 6&-. /,/3

"J/$-)'1*2( $1'*/) Q%/0/$-)2= 0&5/0/$-%)3&(%/(R"J&4 '/(1*&7*230)$ )$ 3/(10 QE/((&9)%23/R"<)+. '&77/( */5/* )$ 6*&&% 2$% 1()$/

C1Se ^/E)')/$',Y .,7&'.(&0)' 0)'(&',-)' 2$/0)28(/2-0/$-Y '&77/( './*2-&(= ^"7/$)')**20)$/

F/$O/3 @,$%(&0/ &( A)$O,".2)( %)3/23/"i"*)$O/% (/'/33)5/= %/E/'-)5/ C1Se>8:23/-(2$37&(-/("C&77/( )3 $&- 252)*26*/ E&( $&(02* E1$'-)&$3 2$%2''101*2-/3 )$ -./ )$-/3-)$/= 37*//$= 013'*/= 2$%

O)%$/,"@,07-&03 (/3/06*/ '&77/( -&9)')-, 2$% %/E)')/$',C*)$)'2* :(/3/$-2-)&$"?(&4-. (/-2(%2-)&$ $&-)'/% )$ )$E2$',"C&$$/'-)5/ -)331/ %)3&(%/("<,7&7)+0/$-2-)&$ )$ 3O)$ 2$% .2)( ! '&2(3/= +(/,= XO)$O,"F/$-2* %/E)')/$', X @/)L1(/3"Z2)*1(/ -& -.()5/"^#>8< Gk ̀ k#>P@C2$ -(/2- 4)-. '&77/(".)3-)%)$/ '&07*/9= 61- %/2-. )3)$/5)-26*/

A2,3/("Z*/)3./( ()$+3

<,7&7)+0/$-2-)&$ &E .2)( )$ F/$O/3

j*#) Bj#>hF &#+- 0H*7$7 *# h> 7$/$0"Z1$'-)&$3 )$ u$"%/7/$%/$- /$L,0/3= $&(02* +(&4-.=%/5/*&70/$-= 2$% (/7(&%1'-)&$">63&(7-)&$ /$.2$'/% 6, <)3 2$% C,3

u)$' ^/E)')/$',

O)%&(0%3/$*$*7 0#$0%&6/$;*)/ )3 2$ 21-&3&02*(/'/33)5/ %)3/23/ %1/ -& 2 72(-)2* %)3&(%/( &E)$-/3-)$2* L)$' 17-2O/K @)+$3 1312**, 277/2( 4)-.)$ -./

E)(3- 0&$-.3 &E *)E/= 4)-. 2 '.2(2'-/()3-)' '1-2$/&13(23. -.2- )3 3,00/-()'2*= *&'2-/% 2(&1$% -./ 6&%,&()E)'/3= 6/.)$% -./ /2(3= 2$% &$ .2$%3= E//-= 2$% ./2%K^)3&(%/(3 &E -./ 01'&13 0/06(2$/3 )$'*1%/+)$+)5)-)3= 3-&02-)-)3 2$% +*&33)-)3K`%0/$30#$ '&$3)3-3 )$ L)$' 31*E2-/ 2%0)$)3-(2-)&$= E&(4.)'. -./ %&3/3 2(/ (/+1*2(*, )$'(/23/% -.(&1+.&1--./ +(&4-. 7/()&%= 23 4/** 23 %1()$+ 7(/+$2$', 2$%$1(3)$+K J&$+"-/(0 7(&+$&3)3 )3 +&&% 61- -(/2-0/$-013- $/5/( 6/ %)3'&$-)$1/%K

"`&H*)*$-Y c& 3.&(- -/(0 -&9)' /EE/'-3 17 -& Sgg 0+\%=

61- *&$+ -/(0 /EE/'-3 2(/ 1$O$&4$K f/(, .)+. %&3/3 &Eu$Se */2% -& E/5/(= 5&0)-)$+= %)2((./2= )001$/3177(/33)&$= Z/ *&33 E(&0 *)5/(= C1Se

Page 20: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 20/40

2*)%&#8$%*0#$7 1 "#$%& ./,0 >

>'(&%/(02-)-)3 /$-/(&72-.)'2

2/#,/#070 B2#F ^W` `'=`'9">'-3 23 2 '&E2'-&( &( 2$ 2'-)52-&( E&( 3/5/(2* /$L,0/3"8&9)')-,D 73,'.&3)3 2$% 72(O)$3&$)30

2&+-4(0#83 B2&F"J/+10/3= 0/2-= 2$% 4.&*/ +(2)$"C&E2'-&( )$ 0/-26&*)30 &E C= c= 2$% @"C2$ '2-2*,L/ -./ -(2$3E/( &E 3)$+*/ /*/'-(&$3 2$% &E/*/'-(&$3 72)(3 )$ (/2'-)&$3 4)-. H/#$;*#0 &H*(/70 2$% 2*%/.,%/ &9)%23/

F& ^/E)')/$',"J&4 277/-)-/"@*&4 +(&4-."P/%1'/% E/(-)*)-,"<)+. 0&(-2*)-, &E )$E2$- 2$% 0&-./("F/$-2* %)3-1(62$'/3= '&02= X %/2-.

F& 8&9)')-,"^)2((./2">$/0)2"@*&4 +(&4-."Z2)*1(/ &E (/% '/** 02-1(2-)&$"?&1-":(/5/$-3 C1Se 1-)*)L2-)&$

=0+0#*83 B=0F">$-)&9)%2$-":2(- &E ,+8$/$;*&#0 60%&H*(/70 )$ 7(&-/'-)&$ &E <6=7&*,1$32-1(2-/% E2--, 2')%3= 2$% '/** 0/06(2$/3 E(&0&9)%2-)&$"C&07*/0/$-3 5)-20)$ #

Z+8&%*(0"B3&0&(7.&13 (/7*2'/0/$- &E ;<" )$ .,%(&9,272-)-/)$ 6&$/ 2$% -//-."Z" '213/3 )$'(/23/% .2(%$/33 2$% (/3)3-2$'/ 2')%3

Z" ^/E)')/$',"8&&-., %/'2,";3-/&7&(&3)3

Z" 8&9)')-,"Z*1&(&3)3 4)-. '.2*O, 2$% 6(&4$)3. 3-2)$3 &$/$20/*":)--)$+ 23 /$20/* E&(02-)&$ )3 )$.)6)-/%">'1-/ -&9)')-, ! )$.)6)-3 /$&*23/ Q+*,'&*,3)3R

Z" )$ :.2(02'&*&+,"8&&-. 723-/"^()$O)$+ 42-/( E*1&()%2-)&$"?(/, 3-&77/( 7.*/6&-&0, -16/3 -& 3-&7 0/-26&*)30)$ 6*&&% 3207*/3

`%/)0 0+030#$7T"C.(&0)10" '&E2'-&( E&( )$31*)$K :&-/$-)2-/3 -./2'-)&$ &E /$%&+/$&13 2$% /9&+/$&13 )$31*)$K >'-3 23-./ 0/-2* 7&(-)&$ &E +*1'&3/ -&*/(2$'/ E2'-&( Q?8ZRK?8Z 2EE/'-3 0/-26&*)30 4)-. )$31*)$= +*1'&3/='.&*/3-/(&*= 2$% -()2',*+*,'/()%/3

"C&62*-" B$ '&62*20)$/ Qf)-20)$ G[SR

Page 21: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 21/40

Page 22: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 22/40

2*)%&#8$%*0#$ /#( 2*#0%/+ :&30&7$/7*7J&34*#0( .;-7*&+&,- /#( Q*&);03*7$%-

./,0 1

J/+)*83T8;8>J G;^k '&$-/$- &E C2SeD [ggg +(203

"vao )$ 6&$/ )$ E&(0 &E .,%(&9,272-)-/C2*')10 )&$ )3 )$ 3&E- -)331/3 *)O/ -./ E&**&4)$+Y"[\S ')('1*2-)$+ C2Se )3 E(//= (/3- )3 7(&-/)$ 6&1$% &('&07*/9/% 4)-. :;T"= <C;`"= 2$% C)-(2-/"B07&(-2$- E&( 6&$/ 2$% 0&3- 6)& 7(&'/33/3"W2(0 0)*O 2$% .&$/, "s $2-1(2* -(2$b1)*)L/%= 61-0)*O .23 -(,7-&7.2$ ! 3/(&-&$)$ ! 0/*2-&$)$

2/,#07*83TU@0&*2$&EE 0/$-)&$/% $1-3 23 2 7()02(, 3&1('/3/5/(2* -)0/3"F+Se )3 )$ 013'*/= $/(5/= ./2(- Q@>R= *)+2$%"(/'/7-&(6)$%)$+= 2$% .&0/&3-23)3 E&( 6*&&% 7(/331(/= 6*&&%31+2(= /$/(+, 0/-26&*)30= 2$% 7(&-/)$ 3,$-./3)3"C.*&(&7.,** .23 F+Se Q^2(O */2E, +(//$3R">63&(6/% 6, 302** )$-/3-)$/ 2$% /9'(/-/% 6, O)%$/,)$ -)+.- (/+1*2-)&$

UF+Se 2$% C2Se .&0/&3-23-)3 ! S 0/'.2$)303["C2Se )3 %/7/$%/$- &$ F+SeK B$'(/23/% )$-(2'/**1*2(F+SeQE&(03 4)-. <S;R ! )$.)6)-)&$ &E C2Se-(2$37&(- )$-& '/** 2$% E(&0 32('&7*230)' (/-)'1*10! F+Se %/E)')/$', D )$'(/23/% C2Se )$-(2'/**1*2(*,S"F+Se )3 $//%/% E&( (/*/23/ &E :8<K @& '2*')103177*/0/$-2-)&$ 02, $&- ./*7 )E :8< )3 $&- )$ /EE/'--& ./*7 263&(6 C2Se E(&0 -./ +1-U:2-)/$-3 &$ 7(&-&$ 7107 )$.)6)-&(3 2(/ 313'/7-)6*/-& F+Se %/E)')/$', 23 4/** 23 72-)/$-3 -.2- 5&0)- 2$%.25/ %)2((./2K J&3/ *)--*/ F+Se )$ 34/2-K

.;&76;/$0T:;T" )3 )$ 3&E- -)331/3"#$/(+,= 7.&37.&*)7)%3= 0/-26&*)30= X 7<^/E)')/$',D E2-)+1/ 2$% *&33 &E 277/-)-/"Z(// :;T" Q0&3-R D )&$)L/% 2$% %)EE13)6*/":(&-/)$ 6&1$%D$&$"%)EE1326*/"4\ /9-(2'/**1*2( '2-)&$3" $&$")&$)L/%X%)EE1326*/

"P/0/06/( C2Se 2$% :.&37.&(13 263&(6/% -&+/-./(

q>')%)-, )$'(/23/3 3&*16)*)-,= 2*O2*)$)-, &77&3/3

F)*O"2*O2*) 3,$%(&0/Y 8(/2-0/$- &E 7/7-)' 1*'/(%)3/23/C2Se e <C;`" D .,7/('2*'/0)2 2$% 2*O2*/0)2UG23)'2**, '213/3 3/'&$%2(, .,7/(72(2-.,(&)%)30"C2$ '213/ %)26/-/3 )$3)7)%13"8(/2- 4)-. $&(02* 32*)$/ -& (/3-&(/ 5&*10/"Z&**&4 4)-. *&&7 %)1(/-)' -& ()% C2SeU</ 0/$-)&$/% ;8C 6)'2(6&$2-/ 2$%'2*')10Q2$-2')%3R *)O/ )$ -103 '2$ '213/.,7/('2*'/0)2

e*$/3*# 9T"@&1('/3 0/$-)&$/%Y Z)3.= (/)$%//(= X 3.)-2O/013.(&&03"C&% *)5/( )3 ()'. )$ 5)-20)$ ^ 61- .23 5)-20)$ >= 3&-&& 01'. '2$ '213/ f)-20)$ > -&9)')-,

Uf)-20)$ ^ 2$% /EE/'-3 &$ C2Se X :;T" .&0/&3-23)3Y"@-)01*2-/3 263&(7-)&$ &E C2Se 2$% 7.&37.&(13 )$ +1-"P/+1*2-/3 (/263&(7-)&$ &E C2Se 2$% :.&37.&(13 )$O)%$/,"P/+1*2-/3 0&6)*)L2-)&$ &E C2Se 2$% 7.&37.&(13K

A)%$/, 2$% 6&$/ '2$ '.2$+/ -& (/37&$% -& 72-.&*&+,-.2- %/5)2-/% E(&0 .&0/&3-23)3U:(/+$2$- 2$% *2'-2-)$+ 4&0/$ $//% f)- ̂ V

907)%*40 e*$/3*# 9 30$/4&+*73

UUUf)-20)$ ^S 5/(313 f)-20)$ ^`

>*3&= &$/ 02)$ 7&)$- 0/$-)&$/% 6, @0&*2$&EE )3 -.2-^S '2$ 6/ 7(/02-1(/*, 2*7.2".,%(&9,*2-/% 2- ST7&3)-)&$ %1/ -& 2**,*)' .,%(&+/$ 2$% )$ -.2- E&(0 .23*&4/( 2EE)$)-, -& ^ 6)$%)$+ 7(&-/)$ E&( -(2$37&(- -&*)5/( 2$% O)%$/,3 ! +/-3 %/+(2%/% 2$% '*/2(/% E23-/(

"@-)** '2$ 6)$% -& f^P

>'-)52-/% f)-20)$ ^ Q[=Sa"%).,%(&9,5)-20)$ ^R 6)$%3-& f)-20)$ ̂ (/'/7-&(3 -.2- 2(/ 7(2'-)'2**,/5/(,4./(/ )$ -./ 6&%,K F&3- &E -./3/ -)331/3 .25/

6//$ 3.&4$ -& .25/ ["2*7.2 .,%(&9,*23/ 23 4/**

^` Z1$'-)&$3 Qc&- 2**= ]13- 02)$R"B001$/ E1$'-)&$ ! )$'(/23/3 2$-)0)'(&6/ 2'-)5)-,2$% %/'(/23/% 21-&)001$)-,"P/%1'/3= (/$2* )331/3= )$31*)$ (/3)3-2$'/= 523'1*2(3-)EE$/33= 6*&&% 7(/331(/= 2$% )$E*2002-)&$ E(&0(/%1')$+ ',-&O)$/ */5/*3"j7"(/+1*2-/3 J/$;0+*)*(*# QJJ"`lR= 4.)'. )3 2 6(&2%"37/'-(10 2$-)0)'(&6)2* 2$% 7(/5/$-2-)5/ E&()$E*1/$L2

A)%$/, Q02)$R &( :2(2'()$/ '/**3

BJ/+)*(*&+F

BJ/+)*$%*&+F

9>S'%,&)/+)*<0%&+9\SJ;&+0)/+)*<0%&+

'H)077 )/# 40 *#/)$*D/$0( /#( 6%&(8)07 J/+)*$%&*) /)*(

a70( (*/,#&7$*)/++- $& /))077e*$/3*# 9 /)$*D*$-

Page 23: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 23/40

2*)%&#8$%*0#$ /#( 2*#0%/+ :&30&7$/7*7J&34*#0( .;-7*&+&,- /#( Q*&);03*7$%-

./,0 >

"c/- 6&$/ %/7&3)-)&$ 1$-)* `g"c/- 6&$/ %/7*/-)&$ 2E-/(42(%3"^/'(/23/3 -/3-&3-/(&$/ 2$% /3-(&+/$ %/'(/23/ 6&$/%/$3)-, Q-/3-&3-/(&$/ 6/'&0/3 /3-(&+/$)$-(2'/**1*2(*,RT :()02(, .&(0&$/3 -.2- (/+1*2-/ 0)$/(2*.&0/&3-23)3[":2(2-.,(&)% .&(0&$/ Q:8<RS"C2*')-&$)$ QC8R`"Z)6(&6*23- +(&4-. .&(0&$/ S` QZ?ZS`RT"f)-20)$ ^ Qf)-^R

U:8<(:"(/*2-/% -& :8< 2$% 2'-3 *)O/ )-K c&- 72(- &E/$%&'()$/ C2Se .&0/&3-23)3 2$% )3 3&0/-)0/3 72(- &E'2$'/( 2$% -./ 233&')2-/% C2Se %,3(/+1*2-)&$ -.2-2''&072$)/3 '2$'/(

[":8<"P/*/23/% E(&0 '.)/E '/**3 &E 72(2-.,(&)%"G)$%3 -& ?"7(&-/)$ '&17*/% (/'/7-&( ! '>F: "@/(10 C2Se )3 7()02(, E//%62'O (/+1*2-&(

! B$5/(3/ (/*2-)&$3.)7 E&( :8< 2$% C2Se":2(2-.,(&)% .23 C2Se"3/$3)$+ (/'/7-&( QC2@PR

"P/+1*2-/% 6, f)-20)$ ^ QZ?ZS` (/%1'/3f)- ^R UUUUUUUUU"^/-/'-3 -./ '.2$+/3 &E 3/(10 C2Se

:8<N3 #EE/'-3 &$ G&$/Y"<)+. w:8<x ! 6&$/ F>8PBi (/3&(7-)&$ )$'(/23/%"J&4 2$% )$-/(0)--/$- w:8<x ! )$'(/23/% 6&$/E&(02-)&$ 2$% '&$3)3-/$- 6&$/ (/0&%/*)$+ &''1(3 -&0&6)*)L/ C2Se )$-& 6*&&% E(&0 -./ /9-(2'/**1*2( E*1)%&E -./ 6&$/= c;8 -./ 02-()9

:8<N3 #EE/'-3 &$ A)%$/,Y"^/'(/23/3 C2Se /9'(/-)&$"B$'(/23/3 7.&37.&(13 /9'(/-)&$"@-)01*2-/3 '2*')-()&* 7(&%1'-)&$ Qf)- ^ >'-)52-)&$R

:8<N3 #EE/'- )$ 6*&&%"B$'(/23/ C2Se"^/'(/23/3 7.&37.&(13 Q%1/ -& O)%$/, /9'(/-)&$R

:8<N3 #EE/'-3 &$ ?B -(2'-"B$'(/23/3 C2Se 2$% 7.&37.&(13 263&(7-)&$

UUU8.)3 )3 2 7/(0)33)5/ /EE/'- %1/ -&)$'(/23/% '2*')-()&* 7(&%1'-)&$ )$ O)%$/,

":8< (/'/7-&(3 2(/ 7(/%&0)$2$-*, &$ 6&$/ 2$%O)%$/, -& .25/ -)+.- (/+1*2-)&$ &E C2Se '&$'/$-(2-)&$

U:8<(:"G)$%3 -& :8< (/'/7-&(

":(&%1'/3 +(&4-. 2$% 7(&*)E/(2-)&$ 2$% '2$ .25/3&0/ &E :8<N3 /EE/'-3"8,7)'2**, 0&(/ 72(2'()$/ 2$% */33 3,3-/0)':(&%1'/% 6, 3&0/ 02*)+$2$- -10&(3"@b120&13 '/**"G(/23- 2$% 7(&3-2-/ '2$'/("#9/(-3 3,3-/0)' /EE/'-3 2$% 3-)01*2-/3 &3-/&'*23-2'-)5)-, E&( (/3&(7-)&$ ! .,7/('2*'/(0)2VV

S"C2*')-&$)$"@,$-./3)L/% 2$% 3/'(/-/% 6, 72(2E&**)'1*2( '/**3 )$-.,(&)%

"@-)01*2-/% 6, +23-()$ 2$% /*/52-/% C2Se -& ./*7(/-2)$ %)/-2(, C2Se"8.,(&)% .23 C2@P3 -&& 2$% -./(/ )3 2 %)(/'-"7(&7&(-)&$2* (/*2-)&$3.)7 6/-4//$ C2Se 2$%C2*')-&$)$ QC8R"<23 ?"7(&-/)$ '&17*/% (/'/7-&(3 ! '>F:":(&0&-/3 6&$/ 0)$/(2*)L2-)&$\%/7&3)-)&$"B$'(/23/3 (/$2* /9'(/-)&$ &E 7.&37.&(13 %1/ -&)$.)6)-)&$ &E 7.&37.&(13 (/263&(7-)&$

`"Z?ZS`":(&-/)$ 7(&%1'/% 6, &3-/&'*23-3 2$% &3-/&6*23-3

PA:*,; .W[A h :*,; e*$ 9 ZKZ>\ 86%0,8+/$*&#"B$.)6)-3 (/$2* (/263&(7-)&$ &E 7.&37.2-/

"B$%)(/'-*, )$'(/23/3 $/- /9'(/-)&$

:.&37.2-/ .&0/&3-23)3

a#(0%7$/#( $;0 %&+0 &< e*$/3*# 9 &# )/+)*83 /#(6;&76;/$0 ;&30&7$/7*7"f)-20)$ ̂ )3 -(2$37&(-/% 6&1$% -& 3/(10 7(&-/)$3

"^ 6)$%)$+ 7(&-/)$ &( 2*610)$"^G: )3 $&- 32-1(2-/%= 5/(, *)--*/ E(//'2*')%)&*\'2*')-()&*

"f)-20)$ ^ (/'/7-&( ! ',-&3&*)' 3-/(&)% (/'/7-&("B$-(2'/**1*2(

"P#?jJ>8#@ ?#c# 8P>c@CPB:8B;c"P/+1*2-/ -./(0&+/$/3)3 -.(&1+. )$.)6)-)&$&E '&$5/(3)&$ &E 4.)-/ E2- -& 6(&4$ E2-

f)-20)$ ̂ 2$% F)$/(2* .&0/&3-23)3YB$ -./ +1-Y QE1*E)**3 7/(0)33)5/ /EE/'- &E :8<R"B$'(/23/3 C2Se X :.&37.&(13 17-2O/"B$'(/23/3 0/06(2$/ E*1)%)-, &E )$-/3-)$2* /7)-./*)2"B$'(/23/3 )$-(2'/**1*2( -(2$37&(- &E C2Se E(&0 27)'2*0)'(&5)**)"@-)01*2-/3 -(2$3'()7-)&$ 2$% -(2$3*2-)&$ &E)/+4*#(*# = 4.)'. )3 7()02(, C2Se 6)$%)$+ 7(&-/)$ )$

',-&3&*

B$ -./ O)%$/,Y"f^P3 2(/ &$ /7)-./*)2* '/**3 ! f)- ^ (/+1*2-/3 )-3/*E":/(0)33)5/ /EE/'- &$ O)%$/, (/263&(7-)&$ 2$%/9'(/-)&$

f)-20)$ ̂ 2$% G&$/"f^P3 2(/ &$ &3-/&6*23-3";3-/&6*23-3 3-)01*2-/ P>cAJ 7(&%1'-)&$= 4.)'.6)$%3 -& P>cA &3-/&'*23- 7(/'1(3&( */2%)$+ -&&3-/&'*23- (/'(1)-0/$-

"B$'(/23/3 -./ (2-/ &E (/3&(7-)&$ %1()$+.,7&'2*'/0)2= 8./(/E&(/ :8< 2$% C2*')-()&* 2(//*/52-/% -&+/-./(

kll3,

\ll 3,

gll 3,

'H$%/)0++8+/% .W[A )&307Z%&3 7&<$ $*7780 7$&%/,0M(*0$M &% 4&#0 %03&(0+*#,

Page 24: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 24/40

2*)%&#8$%*0#$ /#( 2*#0%/+ :&30&7$/7*7J&34*#0( .;-7*&+&,- /#( Q*&);03*7$%-

./,0 \

C2*')10 <&0/&3-23)3

UA)%$/,3 2(/ 7.,3)&*&+)'2**, 6/--/( 2- (/263&(6)$+C2Se -.2$ 7.&37.2-/

Uj$%/(3-2$% -.2- )$ 2'1-/ (/37&$3/3 -& .,7&'2*'/0)2=:8< 0&6)*)L/3 C2Se E(&0 #i8P>C#JJjJ>P E*1)% &EG;c# -& )$'(/23/ 3/(10 C2Se 2$% 2*3& 3-)01*2-/3O)%$/, (/263&(7-)&$ &E C2Se 2$% '&$5/(3)&$ &E'2*')%)&* -& '2*')-()&* )$ -./ O)%$/,UA)%$/, 4)** $&- '&$5/(- '2*')%)&* -& '2*')-()&* E&( $&(/23&$KUC2*')%)&* )3 0/231(/% E&( 5)-20)$ ^ %/E)')/$',

:(&*&$+/% <,7&'2*'/0)2 P/37&$3/Y":(&*&$+/% .)+. :8< E&( 6&$/ (/3&(7-)&$ 2$% f)-20)$

^ E&( +1- 263&(7-)&$ -& 3177*, C2Se"A)%$/, 013- /9'(/-/ 7.&37.2-/ -& 25&)%.,7/(7.&37.2-/0)2VV

907)%*40 $;0 (*70/707 /#( (*7&%(0%7 /77&)*/$0(N*$; /4#&%3/+ 6+/73/ )&#)0#$%/$*&#7 &< 0/);4*&3&+0)8+0

;3-/&7&(&3)3"^/'(/23/ )$ 6&$/ %/$3)-, &5/( -)0/"^/'(/23/ )$ /3-(&+/$ E&( 4&0/$"^/'(/23/ )$ -/3-&3-/(&$/ E&( 0/$ Q-/3-&3-/(&$/6/'&0/ /3-(&+/$ 3& /33/$-)2**, -./ 320/R! ^)/-2(, 5)-20)$ ̂ 2$% C2Se 3177*/0/$-2-)&$

:()02(, .,7/(72(2-.,(&)%)30Y C.(&$)'.,7/('2*'/0)2@,07-&03Y"@-&$/3= -.(&$/3= 6&$/3= 26%&0)$2* +(&2$3= 2$%73,'.)2-()' 0&2$3"@-&$/3" O)%$/, 3-&$/3= $/7.(&'2*')$&3)3= 2$%%)26/-/3 )$3)7)%13 QE(&0 7&*,1()2R"8.(&$/3" :&*,1()2"G&$/3"6&$/ %)3/23/ qZ)6(&%,37*23)2 &33)E)'2$7(&+(/33)52= &3-/&7&(&3)3= &3-/&02*2')2= 2$% 2(-.()-)3">6%&0)$2* +(&2$3" 7/7-)' 1*'/(3= 72'(/2-)-)3=

'&$3-)72-)&$= )$%)+/3-)&$= $213/2 2$% 5&0)-)$+":3,'.)2-()' 0&2$3" */-.2(+,= E2-)+1/= %/7(/33)&$=0/0&(, *&33= 73,'.&3)3= 2-29)2= %/*)()10= 2$% '&02

@/5/(/ <,7/('2*'/0)2Y Z)6(&%,37*23)2 &33)E)'2$37(&+(/33)52 ! P>P#V"F13'*/ 2$% '&$$/'-)5/ -)331/ 2(/ +(2%12**, &33)E)/%"#9-(2"3O/*/-2* 6&$/ 3/5/(/*, '&$3-(2)$3 0&5/0/$-"B$]1(, -& 3&E- -)331/ '213/3 &33)E)'2-)&$ )$ 2EE/'-/%2(/2">EE/'-/% '.)*%(/$ 6&($ 4)-. 6)+ -&/3

C.(&$)' O)%$/, %)3/23/Y <,7/(7.&37.2-/0)2! @/'&$%2(, <,7/(72(2-.,(&)%)30 .277/$3 -&&VV"Z?ZS` )3 )$'(/23/% -& 3-)01*2-/ 7.&37.2-/ /9'(/-)&$23 0/$-)&$/% 26&5/"<B?< Z?ZS` (/%1'/3 f)-20)$ ^K :2(2-.,(&)%6/'&0/3 (/3)3-2$- -& $/+2-)5/ (/+1*2-)&$ &E Z?ZS`

"^& $&- '&$E13/ 4)-. .&4 Z?ZS` )317(/+1*2-/% 4)-. )$'(/23/% f)-20)$ ^ 2$%7.&37.&(13 ! -.)3 '&$'/7- )3 ]13- 72(- &EZ?ZN3 7&3)-)5/ E//%62'O *&&7

"#*/52-/% :8< 0/33/3 4)-. .&0/&3-23)3 )$ O)%$/,%)3/23/ 2$% -./ $/- 0&6)*)L2-)&$ &E 7.&37.2-/ '213/3

.,7/(7.&37.2-/0)2"B$'(/23/% :8< 2''&072$)/3 72(2-.,(&)% .,7/(7*23)22$% /$*2(+/0/$- 23 4/** 23 (/3)3-2$'/ -& (/+1*2-)&$

"Z?ZS` )3 3177&3/% -& 3177(/33 :8< 3/'(/-)&$= 61--./(/ )3 %&4$"(/+1*2-)&$ &E A*&-.&"Z?ZP[' '&07*/9E&( (/'/7-)&$ &E '2*')-()&*= Z?ZS`= C2Se QC2@PR= f^P=2$% :8<

G&-'./% 8.,(&)%/'-&0, 2$% <,7&'2*'/0)2">'')%/$-2* (/0&52* &E 72(2-.,(&)% +*2$%3

! <,7&72(2-.,(&)%)30"C2(%)2' 2((.,-.0)23"^/7(/33)&$

"C&$51*3)&$3"@O/*/-2* 013'*/3"@72303"F13'*/ '(2073"C.5&3-/ON3 3)+$! E*)'O E2')2* $/(5/ 2$% E2')2*-4)-'./3 &''1("8(&133/21N3 3)+$! '2(72* 372303 %1/ -& G:'1EE

":2)$E1* 2$% E(2+)*/ 6&$/3

f)-20)$ ^ %/E)')/$',"<,7&'2*'/0)2

C213/3Y"B$31EE)')/$- %)/- &E f)- ^"B$2%/b12-/ /97&31(/ -& 31$*)+.- QA/2-&( 0/$-)&$/%31$3'(//$ 2$% '*&-.)$+ 2(/ -& 6*20/ -&&R"P/$2* 2$% *)5/( %)3/23/":3/1%&5)-20)$ ^ %/E)')/$',

"Hf)-20)$ ^"%/7/$%/$- ()'O/-3 8,7/"[I"?/$/-)' %/E/'-"C2$$&- '&$5/(- '2*')%)&* -& '2*-()&*

"8,7/"S f)-20)$ ̂ %/7/$%/$- ()'O/-3 )3 %1/ -& f^P%/E/'-<2**02(O 7(&6*/03 )$ 5)-20)$ ^ %/E)')/$', )3

1$%/(0)$/(2*)L/% 6&$/! P)'O/-3 )$ '.)*%(/$! ;3-/&02*2')2 )$ 2%1*-3

f)-^` -&9)')-, )3 5/(, .2(% -& 2''&07*)3.sTg=ggg Bj3\%2,"^&/3 $&- 7(&%1'/ .,7/('2*'/0)2

'H$%/)0++8+/% J/>h 4/7*)/++-&#+- )&307 <%&3 (*0$ /#(7$&%0( J/>h *# 4&#

1lll 3,

Vl 3, 8#/47&%40(Vl 3, 0H)%0$0(

>ll 3,

Page 25: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 25/40

8<kP;B^ ̂ B@#>@##:B^#FB;J;?k

8.,(&)% %)3/23/3 2(/Y" 5/(, '&00&$" 0&3-*, 21-&)001$/" 0&3- '&00&$ )$ 4&0/$

?(25/3 %)3/23/Y ;5/(3-)01*2-)&$ &E

-.,(&)% +*2$% 6, 2$ B+? 2$-)6&%," :(/52*/$'/Y [o -& So )$ 4&0/$gK[o -& gKSo )$ 0/$

" c2-1(2* '&1(3/Y f2()26*/= [\` %/5/*&7.,7&-.,(&)%)30 2E-/( Sg ,/2(3 &E'&$3/(52-)5/ -(/2-0/$-K

<23.)0&-& %)3/23/Y >1-&)001$/-.,(&)%)-)3= */2%3 -& %/3-(1'-)&$ &E-.,(&)% +*2$%" :(/52*/$'/Y So -& ao )$ 4&0/$

gKTo -& [o )$ 0/$

" c2-1(2* '&1(3/Y P/'1((/$- 2--2'O3 4)-..,7&" &( .,7/(-.,(&)%)30= /5/$-12**,*23-)$+ .,7&-.,(&)%)30K

?;B8#P#$*2(+/0/$- &E -./ -.,(&)% +*2$% )3 '2**/% +&)-/(KF&3- E&(03 2(/ '213/% 6, &5/(3-)01*2-)&$ &E -./-.,(&)% +*2$% -.(&1+. -./ 8@< 3,3-/0Y" B&%)$/ %/E)')/$', (2)3/3 -./ 8@< */5/*K" B$ ?(25/% %)3/23/= 2$ 26$&(02* 2$-)6&%, 3-)01*2-/3-./ 8@< (/'/7-&(K

8<kP;8;iBC;@B@@B?c@ X @kF:8;F@

F/-26&*)'Y↑ F/-26&*)' (2-/↑ >77/-)-/ Q0&3- 72-)/$-3R↑ B&$ 71073 Qc2e"Ae= C2SeR↑ :(&-/)$ 3,$-./3)3 X %/+(2%2-)&$↑ J)7&+/$/3)3 X *)7&*,3)3↑ :*2302 E(// E2--, 2')%3

↑ Z1-)*/ ','*)$+ )$ '2(6&.,%(2-/ 0/-26&*)30↑ j$'&17*)$+ 7(&-/)$3↓ J^J '.&*/3-/(&*

c/1(&*&+)'2*Y" P/3-*/33$/33" c/(5&13$/33" @*//7*/33$/33" Z2-)+1/

C2(%)&523'1*2(Y↑ c; 7(&%1'-)&$↓ :/()7./(2* 523'1*2( (/3)3-2$'/↑ </2(- (2-/↑ @/$3)-)5)-, -& β "2+&$)3-3

>-()2* E)6()**2-)&$ QS"SgoR;'1*2(Y#9&7.-.2*013 Q3&0/ 72-)/$-3R

P/7(&%1'-)5/YF/$3-(12* 3177(/33)&$↓ Z/02*/ E/(-)*)-,

:(/+$2$',Y↑ P)3O &E '&07*)'2-)&$3

c/46&($ .23 3)+$3 &E -.,(&-&9)'&3)3

^BZZ#P#c8B>J ̂ B>?c;@B@

F&3- '23/3 &E -.,(&-&9)'&3)3 2(/ '213/% 6, ?(25/3%)3/23/K

;-./( 7&33)6)*)-)/3Y[K 8.,(&)% 2%/$&02SK :)-1)-2(, 2%/$&02`K :&3-"72(-10 .,7/(" Q&( .,7&"R-.,(&)%)30

^)2+$&3-)' 7(&'/%1(/3Y[K :.,3)'2* %)2+$&3)3Y 8.,(&)% /$*2(+/0/$-SK 8&-2* 2$% E(// 8` 2$% 8T`K 8@<TK F/231(/0/$ - &E -.,(&)%"3-)01*2- )$+2$-)6&%,aK P2%)&)&%)$/ 3'2$

PB@A Z>C8;P@ Z;P ?P>f#@ ^B@#>@#

[K ?/$/-)'3Y ?(25/3 %)3/23/ )3 2 01*-)E2'-&()2*-(2)- -.2- )3 0&(/ '&00&$ )$ '*&3/ (/*2-)5/3 &E 272-)/$-KSK ?/$%/(Y P)3O )3 l"[g -)0/3 .)+./( E&( E/02*/3

-.2$ 02*/3K ?(25/3 %)3/23/ )3 (2(/ 6/E&(/ 716/(-, 61-'&$-)$1/3 1$262-/% 2E-/( 0/$&7213/K`K :(/+$2$',Y B07(&5/0/$- %1()$+ 7(/+$2$',=/92'/(62-)&$ 2 E/4 4//O3 2E-/( 6)(-.K

TK f)(2* )$E/'-)&$3Y j$'/(-2)$K

8P#>8F#c8 ;Z8<kP;8;iBC;@B@

[K >$-)-.,(&)% %(1+3Y 8.)&'2(620)%/3)$.)6)- -.,(&7/(&9)%23/K" :(&7,*-.)&1(2')*" F/-.)02L&*/" C2(6)02L&*/

SK W&*EE"C.2)O&EE /EE/'-Y #9'/33 )&%)%/)$.)6)-3 .&(0&$/ (/*/23/ 2'1-/*,= 2*3&)$.)6)-)&$ &E -.,(&7/(&9)%23/K

`K r"6*&'O/(3Y Z&( '2(%)2' 3,07-&03KTK @1(+/(,Y #EE/'-)5/= 61- ()3O3 &E (/0&5)$+

72(2-.,(&)%3 2$% %202+)$+ (/'1((/$-*2(,$+/2* $/(5/K

aK P2%)&)&%)$/Y >''101*2-/3 )$ -.,(&)% +*2$%=%/3-(&,3 -./ +*2$%K

hK >$, %)/-2(, )$-/(5/$-)&$3d

$ $ $ $ $

Page 26: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 26/40

./#)%0/7

1_907)%*40 $;0 034%-&#*) &%*,*# &< $;0 *7+0$7 &<+/#,0%;/#7 /#( 0H&)%*#0 /)*#*_":2$'(/23 )3 %/()5/% E(&0 S 61%3 &()+)$2-)$+ E(&0 -.//$%&%/(02* *)$)$+ &E -./ %1&%/$10

"f/$-(2* 61%" '*&3/ -& 6)*/ %1'- 2$% E&(03 -./1$')$2-/ 7(&'/33 2$% )$E/()&( 72(- &E ./2%"^&(32* 61%" )$ %&(32* 0/3/$-/(, 2$% E&(03(/3- &E -./ 72$'(/23

"2/*# 6/#)%0/$*) (8)$ )3 E&(0/% 6, /$-)(/ 5/$-(2*72$'(/2-)' %1'- 2$% %)3-2* %1'- &E %&(32* 7&(-)&$":(&9)02* 7&(-)&$ &E %&(32* 61% '2$ 6/'&0//))077&%- 6/#)%0/$*) (8)$ )E )- 7/(3)3-3"S 61%3 (&-2-/ 2$% E13/ )$ C"3.27/% 72(- &E %1&%/$10

J+*#*)/+ J&%%0+/$0T">$$1*2( 72$'(/23" */E- 72(- &E 5/$-(2* 61% (&-2-/3$&(02**,= 2$% ()+.- 72(- (&-2-/3 )$ &77&3)-/ %)(/'-)&$-& '&$3-()'- %1&%/$10 2$% '213/ &63-(1'-)&$

>_907)%*40 $;0 7$%8)$8%0 /#( <8#)$*&# &< $;00H&)%*#0 6&%$*&# &< $;0 6/#)%0/7K"#9&'()$/ 7&(-)&$ )3 2 '&07&1$% $848+&/)*#/%70%&87 ,+/#(A@/'(/-/3 6)'2(6&$2-/ 2$% %)+/3-)5/ /$L,0/3":2$'(/2-)' %1'- Q&E W)(31$+R /9-/$%3 -./ /$-)(/+*2$% 2$% /07-)/3 )$-& ./72-&72$'(/2-)' 2071**2 Q&Ef2-/(R 2E-/( '&00&$ 6)*/ %1'- ]&)$3">''/33&(, 72$'(/2-)' %1'- Q&E @2$-&()$)R 02, &( 02,$&- 6/ 7(/3/$-"J&&3/ CK8K E&(03 2 '2731*/ 4)-. 3/7-2 -.2- 3/72(2-/-./ +*2$% )$-& *&61*/3

"#2'. 2')$2( '/** )3 7,(20)%2* 3.27/% 2$% .23 2 (&1$%$1'*/13 31((&1$%/% 6, 4/7&6;*+*) )-$&6+/73 ">')$2( '/** 27/9 )3 E1** &E 3/'(/-&(, +(2$1*/3 -.2-.25/ /$L,0/3"P/'/7-&(3 2(/ *&'2-/% &$ -./ 6232* 3)%/ &E 2')$2( '/**0/06(2$/3 E&( 6)$%)$+ &E CCA 2$% 2'/-,*'.&*)$/"^1'- 3,3-/0 6/+)$3 4)-. '/$-/( &E 2')$13 2- '/**3'2**/% '/$-(&2')$2( '/**3= 4.)'. 2(/ 3b120&13 -& *&4'16&)%2* 2$% 2$ /9-/$3)&$ &E -./ )$-/('2*2-/% %1'-K"G&-. '/$-(&2')$2( 2$% )$-/('2*2-/% '/**3 .25/(/'/7-&(3 E&( 3/'(/-)$ 2$% >'. E&( 3-)01*2-)&$ &E6)'2(6&$2-/ 3/'(/-)&$ -& 61EE/( 2')% '.,0/ )$%1&%/$10 '&0)$+ E(&0 3-&02'.

"^1'-3 ]&)$ -& 02O/ )$-(2*&61*2( %1'-3= -./$)$-/(*&61*2( %1'-3= 2$% -./$ %107 )$-& -./ 02)$72$'(/2-)' %1'-

">')$2( '/**3 (/*/23/ 20,*23/= *)723/= ()6&$1'*/23/=^c>3/= 2$% 7(&/$L,0/3 4\ -(,73)$ )$.)6)-&( -&

7(/5/$- 7(/02-1(/ 2'-)52-)&$ &E -(,73)$= 4.)'. '2$'213/ 72$'(/2-)' %202+/"CCA 2$% >'. 3-)01*2-/ (/*/23/ E(&0 2')$2( '/**3\_907)%*40 $;0 7$%8)$8%0M <8#)$*&#M /#( +&)/$*&# &<$;0 *7+0$7 &< +/#,0%;/#7 *# $;0 6/#)%0/7_

"C&07&3/% &E B3*/-3 &E J2$+/(.2$3 -.2- 2(/31((&1$%/% 6, (/-)'1*2( E)6/(3 2$% 2 $/-4&(O &EE/$/3-(2-/% '27)**2()/3"C2$$&- %)3-)$+1)3. '/** -,7/3 &$ -(2%)-)&$ <X# 3-2)$"C2** -,7/3 277/2( &$ F2**&(,">L2$ 3-2)$ 2E-/( u/$O&*"E&(02* E)92-)&$AV J0++ $-607

[" OB/+6;/FA +*1'2+&$ 3/'(/-)$+= *&'2-/%7/()7./(2**, 2$% 3&0/ '/$-(2**,S"QBQ0$/FA )$31*)$ 3/'(/-)$+= *&'2-/%'/$-(2**,

`" 9B90+$/FA 3&02-&3-2-)$ 3/'(/-)$+Q)$.)6)-&(, &$ > 2$% GR= 3'2--/(/% -.(&1+.&1-B3*/-3K F2)$*, 72(2'()$/ /EE/'-3 &$ > 2$% G'/**3K <23 /$%&'()$/ /EE/'-3 &$ (/*29)$+30&&-. 013'*/ )$ ?B -(2'- -& (/%1'/ 0&-)*)-,

T"91 )0++7 " @/'&$% -,7/ &E %/*-2 '/** -.2-3/'(/-/3 523&2'-)5/ )$-/3-)$2* 7/7-)%/ QfB:R-& )$%1'/ +*,'&+/$&*,3)3= .,7/(+*,'/0)2= 2$%(/+1*2-/ 30&&-. 013'*/ 0&-)*)-, )$ -./ +1-Ka" Z )0++ $-60" .&(0&$/ )$.)6)-3 /9&'()$/72$'(/23K B- 3-)01*2-/3 +23-()$ (/*/23/ E(&0'.)/E '/**3 4.)*/ )$.)6)-)$+ <C* 3/'(/-)&$ E(&072()/-2* '/**3

98/+ 4+&&( 7866+-

[_"(0#$*<- $;0 *7+0$7 &< C/#,0%;/#7 *# 3*)%&,%/6;7

O3-+&*(&7*7 &))8%7 *# "7+0$7 *# $-60 > (*/40$07=&+84+0 6%&$0*# 40)&30 *#7&+84+0 O3-+&*( *7 3/(0 &< /3-+*# <*40%7 *# 40$/ )0++7 O660/%7 0&7*#&6;*+*) *# $;0 *7+0$

"fB

Page 27: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 27/40

.;-7*&+&,- &< '#(&)%*#0 ./#)%0/7./,0 1

"B$31*)$ E&**&43 -./ '*233)'2* 7(&.&(0&$/ 72-.42,":(&)$31*)$ )3 $&- 3/'(/-/% E(&0 72$'(/23= )$31*)$ )33/'(/-/%":(/7(&)$31*)$ '*/25/% )$ #P":(&)$31*)$ '*/25/% )$ ?&*+)"F2-1(/ )$31*)$ 2$% C"7/7-)%/ 3-&(/ )$ *2(+/ 5/3)'*/3"^)31*E)%/ 6&$%3 *)$O )$31*)$ '.2)$3

"C"7/7-)%/ )3 '*/25/% E(&0 7(&.&(0&$/ 2$% .23 2*&$+ .2*E"*)E/ -.2- )3 13/E1* E&( %)2+$&3-)' 71(7&3/3

?*1'&3/N3 -()++/( &E )$31*)$ (/*/23/ )3 2 l"3-/7 7(&'/33Y["?*1'&3/ /$-/(3 G/-2 '/** 5)2 KCa`A> -(2$37&(-/(S"?*,'&*,3)3 -()++/(3 ()3/ )$ >8:`"Ae>8: '.2$$/*3 '*&3/T"G/-2 '/** %/7&*2()L/3a"C2Se '.2$$/*3 &7/$h"C2Se )$E*19 */2%3 -& )$-(2'/**1*2( C2Se (/*/23/QE(&0 30&&-. #PdRl"B$-(2'/**1*2( C2Se )$'(/23/ -()++/(3 )$31*)$

0&6)*)L2-)&$ 2$% (/*/23/

"?*1'&3/ )3 -./ 7()02(, E2'-&( '&$-(&**)$+ )$31*)$(/*/23/"@/'&$%2(, -,7/3 &E 3-)01*) E&( )$31*)$ (/*/23/'&$3)3-3 &E >'.= ?*2$)$= ?*1'2+&$"*)O/ :/7-)%/ [Q?J:"[R= 2$% /7)$/7.()$/

"B$31*)$ (/'/7-&( )3 '&07&3/% &E S 2*7.2 3161$)-3 )$/9-(2'/**1*2( %&02)$ 2$% S 6/-2 3161$)-3 )$)$-(2'/**1*2( %&02)$K >*7.2"6/-2 %)0/()L2-)&$ &''1(34./$ )$31*)$ 6)$%3 ! (/'/7-&( )3 )$ 320/ E20)*, 23B?Z"[ (/'/7-&("8kPA 7.&37.&(,*2-)&$ )$ )$31*)$ 6)$%)$+ -& )$31*)$(/'/7-&( 2'-)52-/3 ?Jj8T -(2$37&(-/( E&( +*1'&3/17-2O/ )$ 013'*/ 2$% 2%)7&3/"B$31*)$ (/'/7-&( )3 2$ )$-()$3)' 8kPA 7.&3 (/'/7-&(B$31*)$ (/37&$3/ -& 2 0/2*"G23/*)$/ 3/'(/-)&$ )3 71*32-)*/ 2$% E&**&43 ')('2%)2$(.,-.0"P/37&$3/ -& 2 0/2* '213/3 2 G)7.23)' (/37&$3/

["B$)-)2* )$'(/23/S"8(2$3)/$- ()3/

"c&-/ -.2- -.)3 )3 -()++/(/% 23 2$ #7)3&%)' (/*/23/ %1/-& -./ 0/2* -.2- 423 )$+/3-/%

?Jj8 -(2$37&(-/(3 E2')*)-2-/ +*1'&3/ -(2$37&(- 2'(&33'/** 0/06(2$/3 ! T C*233 [ ?Jj83

?Jj8[ ! G(2)$ 2$% PGC3?Jj8S ! Bc@jJBc Bc^#:#c^#c8= GB^BP#C8B;c>J=6/-2 )3*/- '/**3= *)5/(= O)%$/,= 2$% 302** )$-/3-)$/?Jj8` ! G(2)$= $/1(&$3= 2$% 7*2'/$-2?Jj8T ! Bc@jJBc ̂ #:#c^#c8= </2(-= 3O/*/-2*013'*/= 2$% 2%)7&3/

"G(2)$ -&&"F/%)2-/3 7&3-7(2$%)2* +*1'&3/ 17-2O/

B$31*)$N3 @-)01*2-&(, 2$% B$.)6)-&(, /EE/'-3"@-)01*2-/3 +*1'&3/ E&(02-)&$ 2$% 3-&(2+/

"B$.)6)-3 6(/2O%&4$ &E +*1'&3/ 3-&(/3 2$% +*,'&+/$"B$31*)$ )3 '&$3)%/(/% '2-26&*)'"B$.)6)-3 +*1'&$/&+/$/3)3 6, )$'(/23)$+ ES=h"6)37.&37.2-/ ! )$'(/23/3 7D:ZA )$ +*,'&*,3)3

?*1'2+&$"?*1'2+&$ )3 3-&(/% )$ %/$3/ +(2$1*/3 )$ 2*7.2"'/**3 &E)3*/-3 )$ 72$'(/23"@/'(/-/% )$ C2Se %/7/$%/$- 72-.42,3 *)O/ )$31*)$

"<,7&+*,'/0)2 3-)01*2-/3 +*1'2+&$ (/*/23/"J&4 */5/*3"@1%%/$ %(&73 &E +*1'&3/= -&&

"<,7/(+*,'/0)2 )$.)6)-3 +*1'2+&$ (/*/23/

"B$31*)$ (/+1*2-/3 +*1'2+&$ (/*/23/ -& 2$ /9-/$-"A/,Y +*1'&3/= E2--, 2')%3= 2$% O/-&$/ 6&%)/3 2(/7()02(, (/+1*2-&(3 &E +*1'2+&$ (/*/23/;-./(3 -.2- '2$ 3-)01*2-/Y"#7)$/7.()$/"?23-()$"CCA

"fB:"?B:;-./(3 -.2- '2$ )$.)6)-Y"B$31*)$"@&02-&3-2-)$"G/-2"2%(/$/(+)' (/'/7-&( 72-.42,

U<,7/(-.,(&)%)30 2$% <,7/('&(-)3&*/0)2 )$'(/23/?*1'2+&$ 3/'(/-)&$

?*1'2+&$ (/'/7-&(";$ *)5/( 2$% 2%)7&3/ -)331/

@&02-&3-2-)$ Q@PBZ\?<B<R"@.&(- .2*E"*)E/"J&4 '&$'/$-(2-)&$ 3,3-/0)'2**,= /9/(-3 72(2'()$//EE/'-3"S E&(01*2-)&$3" [T 2$% Sn= %& 320/ -.)$+">61$%2$- )$ <k:;8<>J>Fj@= 6(2)$3-/0= 37)$2*'&(%= $/(5/3 )$ ./2(-= -.,(&)%= 3O)$= 2$% /,/"B$.)6)-3 ?< (/*/23/ E(&0 .,7&-.2*2013 6,&5/(()%)$+ ?<P<

"B$.)6)-3 (/*/23/ &E )$31*)$ 2$% +*1'2+&$ E(&072$'(/23"B$.)6)-3 '/** ','*/ +(&4-."B$.)6)-3 2$+)&+/$/3)3"B$.)6)-3 +(&4-. E2'-&( 3/'(/-)&$= 3-)01*2-/327&7-&3)3"a (/'/7-&( 316-,7/3

7*& & & '#(&)%*#0 /#)%0/7 ?*1'&3/ G2*2$'/ 23 2 '&$3 2$ 2$% '&$ )$1&13 "?< 2$% B?Z3 3 )01*2 / %)EE/(/$ 2$% 52()&13 +(&4

Page 28: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 28/40

.;-7*&+&,- &< '#(&)%*#0 ./#)%0/7./,0 >

B$'(/-)$3"?1-"6(2)$ 7/7-)%/3 -.2- (/+1*2-/ 72$'(/23 E1$'-)&$":(&%1'/% )$ 302** )$-/3-)$/"?*1'&3/"%/7/$%/$- )$31*)$&-(&7)' 7&*,7/7-)%/ Q?B:R

":(&%1'/% 6, A"'/**3"?*1'2+&$"*)O/ 7/7-)%/ Q?J:"[R

":(&%1'/% 6, J"'/**3UUUUB$'(/-)$ #EE/'-

"B$31*)$ 3/'(/-)&$ )$'(/23/ 3163-2$-)2**, 4./$.&(0&$/3 2(/ (/*/23/% 6, -./ ?B -(2'- 2$% %1()$+.,7/(+*,'/0)2"C&072(/ Bf +*1'&3/ 5/(313 &(2* +*1'&3/

"U</ 3-(/33/% -.)3 %1()$+ */'-1(/

:(&+*1'2+&$ )3 '*/25/% %)EE/(/$-*, %/7/$%)$+ &$4./(/ )- )3":2$'(/23 ! +*1'2+&$"?1-\G(2)$ ! ?J:"[ X S= ?P::= ?*)'/$-)$= )$-/(5/$)$+7/7-)%/ [ X S= 2$% ;9,$-&0&%1*)$

?J:"[ 3-)01*2-/3 )$31*)$ (/*/23/ %)(/'-*, 2$% )$.)6)-3+*1'2+&$ (/*/23/ )$%)(/'-*, 6, 3-)01*2-)$+ ?J:(/'/7-&(3 Q?"7(&-/)$R )$ 6/-2 '/**3

?B: )3 %/()5/% E(&0 :(&?B:= c;8 7(&+*1'2+&$"fB:"@/'(/-)$"+*1'2+&$ E20)*,"?B: 3-)01*2-/3 (/*/23/ &E )$31*)$ *)O/ ?J:"[2$% %)(/'-*, 3-)01*2-/3 +*1'2+&$ 3/'(/-)&$

"?B: (/'/7-&(3 2(/ &$ 2*7.2 2$% 6/-2 '/**3

"?B: 2$% ?J:"[ 2(/ %/+(2%/% 6, ̂ ::Bf

?*1'&3/ <&0/&3-23)3

UB$'(/-)$ 7*2302 '&$'/$-(2-)&$ &''1(3 3*)+.-*, 6/E&(/-./ ()3/ &E )$31*)$= 7&3-7(2$%)2*

?*1'&3/ G2*2$'/ .23 2 '&$3-2$- 2$% '&$-)$1&130/-26&*)' 3.)E-">63&(7-)5/ 3-2-/Y `g"hg 0)$ 2E-/( 2 0/2*

"B$31*)$ 7(&0&-/3 2$26&*)30"Z1/* )3 263&(6/% )$-& '/**3

":&3-"263&(7-)5/ 3-2-/Y S .( 2E-/( 0/2*"?*1'2+&$ 7(&0&-/3 '2-26&*)30"Z1/* )3 1-)*)L/%

<1$+/("<1$+/( '213/3 -./ 3-&02'. -& 3/'(/-/ ?.(/*)$ -.2-3-)01*2-/3 >('12-/ $/1(&$3 &E -./ .,7&-.2*2013

"c/1(&7/7-)%/ k 3-)01*2-/3 277/-)-/ 2$% /2-)$+"?< )3 (/*/23/% 6/E&(/ 2 0/2*"?< .23 %)5/(+/$- 2'-)5)-,

"B$5&*5/% )$ 02)$-/$2$'/ 2$% +(&4-.7()02()*, 2- $)+.-"B$5&*5/% 4)-. 0/-26&*)30 Q+*,'&+/$&*,3)32$% *)7&*,3)3R *)O/ )$ .1$+/(= 4.)'. )3 )-32$-))$31*)$ /EE/'-K ?< 3/'(/-/% 6/E&(/

+*1'2+&$ )$ E23-)$+U?< (/*/23/% )$ 3-(/$1&13 2'-)5)-, -&&@-2(52-)&$ 2$% E23-)$+ 2(/ %)EE/(/$- 3)$'/ E23-)$+ )3 2'.&)'/"Z23-)$+ )$'(/23/3 ?< ! )$'(/23/% +*1'2+&$ -&0&6)*)L/ +*1'&3/ 3-&(/3 E(&0 *)5/( Q+*1'&$/&+/$/3)3 X+*,'&+/$&*,3)3R 2$% 2%)7&3/ Q*)7&*,3)3R

"<)+. +*1'&3/ 2$% )$31*)$ )$.)6)- c:k= ?<P<= 2$% ?<3/'(/-)&$ 6, 3-)01*2-)$+ .,7&-.2*20)' @PBZ

P/*2-)&$3.)7 6/-4//$ ?<= +*1'&3/= 2$% )$31*)$"?< */5/*3 3*&4*, ()3/ 2E-/( )$31*)$ .23 '213/3 17-2O/&E +*1'&3/ 2$% %/'(/23/% )$ '&$'/$-(2-)&$ )-3/*E

"?< 2$% B?Z3 3-)01*2-/ %)EE/(/$- 2$% 52()&13 +(&4-.E2'-&(3y[S .&1(3 2E-/( 2 0/2*

J/7-)$ )3 72(- &E 32-)/-,K B- )$.)6)-3 c:k= ?< *)O/+*1'&3/ 2$% )$31*)$ 2E-/( 2 0/2*K @PBZ )3 2*3&3-)01*2-/%

>'1-/ 3-2(52-)&$"@)0)*2( -& E23-)$+ /9'/7- 0&(/ +*,'&+/$&*,3)3 )$013'*/= 4.)'. )3 3-)** *)--*/ E&( E1/* 3)$'/ 013'*/ 2(/+(//%, 2$% O//7 )- -& )-3/*E"> *&- &E 0&6)*)L2-)&$ &E -()+*,'/()%/3 */2%)$+ -& -./13/ &E E2--, 2')%3 E&( /$/(+,"^/E)$/% 23 E)(3- a %2,3 2E-/( -./ ST .( 7/()&%7&3-7(2$%)2*

C.(&$)' @-2(52-)&$"C.(&$)' 3-2(52-)&$ 3-2(-3 26&1- a -& l %2,3 2$% 2--.2- 7&)$- ?<P< 4)** 3-2(- -& %/'(/23/ %1/ -&1*-(23.&(- E//%62'O 2$% ?< %/'*)$/3 -./$"?JjC;@# J#f#J@ >P# C;c8BcjBc? 8; ^#CJBc#"J)5/( &9)%)L/3 E(// Z23"A/-&$/ 6&%, 7(&%1'-)&$"F13'*/ 2$% 6(2)$ '2$ 13/ O/-&$/ 6&%)/3"C.27/(&$/"0/%)2-/ 21-&7.2+, &''1(3 )$ -)331/3&-./( -.2$ 6(2)$ 2$% 013'*/":(&*&$+/% 3-2(52-)&$ 4)** /5/$-12**, %/7*/-/

+*,'&+/$ 3-&(/3 )$ *)5/( 2$% -./$ -./ *)5/( ./72-&',-/34)** 1$%/(+& 21-&7.2+, -&&

7*& & &< '#(&)%*#0 /#)%0/7

Page 29: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 29/40

.;-7*&+&,- &< '#(&)%*#0 ./#)%0/7./,0 \

"<,7&+*,'/0)2 '2$ O)** ,&1 b1)'O*, 4.)*/.,7/(+*,'/0)2 '2$ -2O/ -)0/

>0/()'2$ ^)26/-/3 >33&')2-)&$ ?1)%/*)$/3

"^)26/-)' 72-)/$-3 .25/ )$31*)$ (/3)3-2$'/ '213)$+ 2.)+. '&$'/$-(2-)&$ &E 3/(10 +*1'&3/

<,7&+*,'/0)2 @,07-&038,7/ S ^)26/-/3 C&07*)'2-)&$3

^)2+$&3-)' 8/3-)$+

C":/7-)%/ E&( 6/-2 '/** E1$'-)&$"J&$+/( .2*E"*)E/ -.2$ )$31*)$ 2$% '2$$&- 3O/4 (/31*-3)$ 2 72-)/$- 2*(/2%, -2O)$+ 3177*/0/$-2(, )$31*)$

</0&+*&6)$ >[C"?*,'2-/% ./0&+*&6)$"PGC3 *)5/ E&( vg %2,3= 3& 2 (/7(/3/$-2-)&$ &E +*1'&3/*/5/*3 '2$ 6/ 3//$ E&( ̀ 0&$-.3Vc&(02*zaKlo:(/"%)26/-/3 aKl"hKao^)26/-/3 shKao

?& ;5/( c1 () )&$ J/' 1(/ G J206/(

Page 30: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 30/40

?& ;5/( c1-()-)&$ J/ -1(/ G, J206/(-

J/%4&; (%/$0 20$/4&+*73 / 0 1 `JO J )+0 50D*0NT UF13'*/ 23 /5/( )$+ /9'/7 +*1'&3/"h"

Page 31: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 31/40

J/%4&;-(%/$0 20$/4&+*73 ./,0 1

K+-)&+-7*7 50D*0NT

JO J-)+0 50D*0NT

K+8)&#0&,0#07*7T

"` /$L,0/3 4-6/77 )((/5/(3)6*/ +*,'&*,-)' (/2'-)&$"P/2'-)&$ )3 1$)b1/ -& *)5/( 3)$'/ )- .23?*1'&3/"h"7.&37.2-23/"B07&(-2$- E&( +*1'&3/ %/*)5/(, -& 6(2)$= -/3-/3= PGCN3=2$% O)%$/, 0/%1**2"` 3-2(-)$+ 7&)$-3

["J2'-)' 2')%

S">0)$& 2')%3" /$-/( 8C>Q2$27*/(&-)'R &(7,(152-/`"?*,'/(&*

UF13 */ .23 /5/(,-.)$+ /9 /7- +*1 &3/ h7.&37.2-23/ ! )- )3 +(//%, 2$,42,3 2$% O//73 2** -./+*1'&3/ E&( )-3 &4$ >8: 7(&%1'-)&$ 5)2 +*,'&*,3)3

W./(/ %&/3 J2'-2-/ 2$% >*2$)$/ '&0/ E(&0d

U>*2$)$/ ','*/ E//%3 200&$)2 )$-& 1(/2 ','*/ )$ *)5/(Uc&-/ -./ *2(+/ 20&1$- &E >8: 13/% -& 02O/ +*1'&3/

1 7$ Q-6/77.'. J/%4&H-I*#/70T>'-)52-/% 6,"?*1'2+&$"C&(-)3&*B$.)6)-/% 6,"B$31*)$

.-%8D/$0 J/%4&H-+/70T>'-)52-/% 6,">'/-,* C&> 2**&3-/()'2**," 3)$'/ >8: .23 -& 6/252)*26*/B$.)6)-/% 6,">^: 2**&3-/()'2**, 3)$'/ >8: .23 -& 6/ 252)*26*/V

Uc&-/ -.2- )$ 7,(152-/ O)$23/ (/2'-)&$ &E +*,'&*,3)3=2** &E -./ [3- 6,7233 (/+1*2-&(3 .25/ (/')7(&'2* 2'-)&$

J/%4&; (%/$0 20$/4&+*73 / 0 > "ZZ>3 7(&%1'/% 6 2%)7&3/ -)331/ *)7&* 3)3 6 Z(1'-&3/ 2$% ?2*2'-&3/

Page 32: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 32/40

J/%4&;-(%/$0 20$/4&+*73 ./,0 >

>#( Q-6/77Z%8)$&70 1Mg 4*76;&76;/$/70T>'-)52-/% 6,"?*1'2+&$"#7)$/7.()$/ 2$% c&(/7)$/7.()$/">8: 2**&3-/()'2**,"C)-(2-/ 2**&3-/()'2**,B$.)6)-/% 6,

"B$31*)$"Z(1'-&3/ S=h 6)37.&37.2-/" 3)$'/ -.2- 4&1*% 0/2$:ZA"[ )3 2**&3-/()'2**, 2'-)52-/%= 2$% +*,'&*,3)3 )3+&)$+ -./ &-./( 42,

Uc&-/ -.2- )$ :ZA"[ (/2'-)&$ &E +*,'&*,3)3= 2** &E -./S$% 6,7233 (/+1*2-&(3 .25/ (/')7(&'2* 2'-)&$

"Q?*1'2+&$\B$31*)$ 2% #7)\c&(/7)R

\ %( Q-6/77K+8)&70 gA6;&76;/$/70T>'-)52-/% 6,Y

"?*1'2+&$B$.)6)-/% 6,Y"B$31*)$"?*1'&3/" 2**&3-/()'2**,"C.*&(&+/$)'" 2**&3-/()'2**,= 3)$'/ )- )$.)6)-3-(2$3*&'23/

Q/7*) :&%3&#/+ J&#$%&+ &< Q+&&( K+8)&70

U?*1'&$/&+/$/3)3 4)-. -./ *)5/( 2$% 2%)7&3/ -)331/

ZZ>3 7(&%1 /% 6, 2%)7&3/ -)331/ )7& ,3)3 6,.&(0&$/ 3/$3)-)5/ *)723/ 2(/ &9)%)L/% )$ *)5/( E&(7(&%1'-)&$ &E 2'/-,*"C&> 2$% /$/(+,= -./(/E&(/7(&0&-)$+ 7,(152-/ '2(6&9,*23/ 2'-)5)-, &E [ 3- 6,7233K">%)7&3/ -)331/ E//%3 +*,'/(&* )$-& +*1'&$/&+/$/3)3"P/0/06/( -.2- +*,'/(&* )3 E/% )$-& -()+*,'/()%/3,$-./3)3 23 2 +*,'&*,-)' )$-/(0/%)2-/

! #97*2)$3 .&4 +*1'&3/ 6/'&0/3 E2-VVV

?(&+2$N3 %)2+(20 ! F2O/ $/4 &$/ )E -)0/

O(*6&I*#07J/7-)$":(&%1'/% 02)$*, 6, 4.)-/ 2%)7&3/ -)331/ 2$% */5/* &E')('1*2-)$+ */7-)$ )3 7(&7&(-)&$2* -& 20&1$- &E2%)7&3/ -)331/ )$ -./ 6&%,"B$E&(03 6(2)$ &E /$/(+, 3-&(/3 )$ 6&%,>%)7&$/'-)$"@-)01*2-/3 E2--, 2')% &9)%2-)&$ 2$% +*1'&3/ 17-2O/ )$3O/*/-2* 013'*/ -& 3177(/33 +*1'&3/ &1-71- E(&0 *)5/(

810&( $/'(&3)3 E2'-&( Q8cZ"2R"P/*/23/% 6, 02'(&7.2+/3 $/2( 2%)7&3/ -)331/"B$%1'/3 013'*/ 2$% ./72-)' '/** )$31*)$ (/3)3-2$'/

G2*2$')$+ &E Z> ')('1*2-)&$ 2$% &9)%2-)&$"J&4 +*1'&3/ ! +*1'2+&$ ! )$'(/23/ )$ .&(0&$/3/$3)-)5/ *)723/">%)7&O)$/ Q*/7-)$ 2$% 2%)7&$/'-)$R 2(/ /$%&'()$/(/+1*2-&(3 &E 277/-)-/"<B?< */7-)$ D J;W 277/-)-/"c; */7-)$ D <B?< 277/-)-/ ! -/$%/$', &E &6/3)-,

"J/7-)$ )$3/$3)-)5)-, )3 233&')2-/% 4)-./2-)$+ %)3&(%/(3 2$% 0/-26&*)' 3,$%(&0/

Z(1 -&3/ 2$% ?2 2 -&3/"G&-. 2(/ 0/-26&*)L/% )$ *)5/("Z(1'-&3/" 6&1$% -& +*1'&3/ )$ 31'(&3/

"<&$/, 2$% E(1)-3"<B?< ZPjC8;@# C;Pc @kPj:

"?2*2'-&3/" 6&1$% -& +*1'&3/ )$ *2'-&3/"?*,'&*)7)%"?*,'&7(&-/)$3"F)*O 31+2(

Z(1'-&3/ 2$% ?2*2'-&3/ F/-26&*)30

:(&6*/0 4)-. <)+. ^)/-2(, Z(1'-&3/["Z"[": '2$ 2''101*2-/ %1/ -& 3*&4 2'-)&$ &E>*%&*23/"G! *&4 /$/(+, E(&0 7.&37.2-/ -(277)$+S"Z(1'-&3/ 6,7233/3 :ZA"[ '&$-(&* )$ +*,'&*,3)3

! J2'-2-/ 2$% -()+*,'/()%/3 2''101*2-/! ?>: E//%3 )$-& +*,'&*,3)3 2$% -()+*,'/()%/3,$-./3)3VVVVV Q?*,'/(&*VVVVVR

K0#0$*) 9*7&%(0% N*$; Z%8)$&70 20$/4&+*73[K Z(1'-&O)$23/ %/E/'- ! #33/$-)2* Z(1'-&31()2

! G/$)+$

SK>*%&*23/ G %/E/'-!

</(/%)-2(, Z(1'-&3/B$-&*/(2$'/ Q<ZBR"B$'(/23/% Z"[": '.2$+/3 +*1'&3/ */5/*3":&&( E//%)$+= E2)*1(/ -& -.()5/= ./72-)' 2$%(/$2* )$31EE)')/$',= 2$% %/2-.">3,07-&02-)' )$ %)/- /9'*1%)$+ E(1'-&3/ 2$%31'(&3/"@,07-&03 (/3/06*/ E(1'-&3/ [=h"

6)37.&37.2-23/ %/E/'-

`%*&I*#/70

J/%4&; (%/$0 20$/4&+*73 / 0 1 K+-)& 0# =$&%/ 0 9*7&%(0%7

Page 33: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 33/40

J/%4&;-(%/$0 20$/4&+*73 ./,0 1

K0#0$*) 9*7&%(0% N*$; K/+/)$&70 20$/4&+*73C*233)'2* ?2*2'-&3/0)2 ! >1-&3&02* P/'/33)5/

"^/E)')/$', )$ +2*2'-&3/["7.&37.2-/ 1()%,*" -(2$3E/(23/ Q?2*"[": j^:? -(2$3E/(23/R

"c& '&$5/(3)&$ -& +*1'&3/">@8 X >J8 )$'(/23/% )$ $/46&($3"F/$-2* %/E)')/$', 2$% ')((.&3)3 &E *)5/("C2-2(2'-3 E(&0 +2*2'-)-&* 2''101*2-)&$ )$

*/$3"89Y P/%1'/ %)/-2(, +2*2'-&3/U> c/4 P/-2(%/% J)5/( 4)-. C2-2(2'-3

2*#&% ./$;N/-7 ":(&5)%/ 0/-26&*)-/3 E&(6)&3,$-./-)' 71(7&3/3[" ... Q&9)%2-)5/ 2$% $&$"&9)%2-)5/ 6(2$'./3R

":(&%1'/3 C;S= c>^:<= 2$% ()6&3/

c&$";9)%2-)5/"J)$O3 ()61*&3/ a"7.&37.2-/ Q/$% 7(&%1'- &E&9)%2-)5/ 6(2$'.R -& +*,'&*,3)3 2$% +*1'&$/&+/$/3)3)$ (/5/(3)6*/ (/2'-)&$3"p13- O$&4 -.2- 8(2$32*%&*23/ 2$% 8(2$3O/-&*23/ 2(/-./ 0&3- )07&(-2$- /$L,0/3U?*1'&3/"h"7.&37.2-/ ^< )$.)6)-/% 6, .)+.c>^:<\c>^:e (2-)&U:(&'/33 )07&(-2$- )$ 0)-&-)' '/**3 2$% (/%1'-)5/-)331/3 ! 5QJ7M +*D0%M /(*6&70M 3/33/%-M ]/(%0#/+ )&%$0H

J0++8+/% ^00(7 &< ^O9.: ... WH*(/$*D0 Q%/#);d"Z&( ()6&$1'*/&-)%/ (/%1'-23/ )$ (/%1'-)&$ &E %/&9,"$1'*/&3)%/ -()7.&37.2-/ Q%/&9,"c8:3R"Z> 2$% 3-/(&)% 6)&3,$-./3)3

"J)5/( ! Z> 3,$-.23/ X <F?"C&> (/%1'-23/";9)%2$- '&$-(&* )$ PGC3 5)2 +*1-2-.)&$/ (/%1'-23/

";9)%2$-3 %202+/ *)7)%3 2$% '/** 0/06(2$/"?h:^ %/E)')/$', ! 2''/*/(2-/% %202+/

>A.&+-&+ 6/$;N/- ! S /$L,0/3 -& 02O/ Z(1'-&3/"<)+. '&$'/$-(2-)&$ &E E(1'-&3/ )$ 3/0)$2*E*1)%! 703*#/+ D07*)+07 7(&%1'/

\AO3*#& 78,/% 7-#$;07*7 " +*1'&*)7)%3= +*,'&7(&-/)$3=?>?3 ! O/, E&( /9-(2'/**1*2( 02-()9[Aa%&#*) /)*( 6/$;N/-7 " ?>?3 Q>')%)' 31+2(6)&3,$-./3)3R ! O/, E&( /9-(2'/**1*2( 02-()9

K+-)&,0# 20$/4&+*73":&*,0/()L/% &$ 7(&-/)$ '2**/% +*,'&+/$)$ Q-()5)2*O$&4*/%+/R"2*7.2 [=T 2$% 2*7.2 [=h Q6(2$'./%R '&$$/'-)&$3

K+ )&,0# $&%/,0 9 7&%(0%71Ae&# K*0%I0@7 B1/ /#( 14F"#P +*1'&3/ h"7.&37.2-23/ &( +*1'&3/ -(2$37&(-%/E)')/$', ! J)5/("Z23-)$+ .,7&+*,'/0)2 3)$'/ *)5/( '2$$&- 7(&%1'/+*1'&3/ 2$%\&( 3.1--*/ )- &1- )$-& 6*&&% 3-(/20@,07-&03Y

"J2'-)' 2'2%/0)2"<,7/(1()'/0)2"A/-&3)3

89Y @-/2%, '2(6&.,%(2-/3 E(&0 %)/-

>A2)J/%(+0@7 BeF"F13'*/ 7.&37.&(,*23/ %/E)')/$',"F,&+*&6)$ 2$% CA 2(/ )$ 6*&&%@,07-&03Y

":2)$E1* 013'*/ '(2073 &$ /9/(')3/

\A.&360@7 B""F"J,3&3&02* 2')% 2*7.2"+*1'&3)%23/ %/E)')/$',">EE/'-3 ./2(- 2$% 013'*/3@,07-&03

"^/2-. )$ )$E2$', E(&0 ./2(- E2)*1(/

C0)$8%0 =833/%-">** '/**3 %& +*,'&*,3)3 3)$'/ -./, .25/ 2** &E -.//$L,0/3"?*1'&$/&+/$/3)3 )3 &$*, )$ *)5/("F13'*/ '2$ %& +*1'&$/&+/$/3)3 61- )3 0)33)$+ ? h"7.&37.2-23/ 2$% '2$ $&- E&(0 +*1'&3/ 2$% 3.1--*/ )-&1-"J2'-2-/= 20)$& 2')%3= 2$% +*,'/(&* 2(/ 3-2(-)$+ 7&)$-3E&( +*1'&$/&+/$/3)3"<&(0&$/3= )$31*)$ 2$% +*1'&3/= -.(&1+.

7.&37.&(,*2-)&$ E(&0 3/'&$% 0/33/$+/( 3)+$2*)$+=(/+1*2-/ +*1'&3/ 3-&(2+/"?*1'&3/ )3 $//%/% -& 7(&%1'/ ()6&3/ 2$% c>^:< )$6)&3,$-./3)3"?*1'&3/ )3 13/% E&( 37/')2* 31+2( 3,$-./3)3 2$% ./*734)-. -./ 6)&3,$-./3)3 &E /9-(2'/**1*2( 02-()9 ! ?>?3E&( /9207*/

^B>G#8#@ F#JJB8j@ ;Gp#C8Bf#@ " F2)$ 3&1('/ 2(/ E2--, 2')%3 E(&0 2%)7&3/

Page 34: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 34/40

B G#8#@ F#JJB8j@ ;Gp#C8Bf#@[K C*)$)'2* 7(/3/$-2-)&$SK 8,7/3 &E %)26/-/3`K F2$2+/0/$- &E )$31*)$"%/7/$%/$- %)26/-/3TK ^)/-2(, (/'&00/$%2-)&$3aK >'1-/ '&07*)'2-)&$3hK J2-/ '&07*)'2-)&$3

8k:#@ ;Z ̂ B>G#8#@8,7/ [ %)26/-/3Y ao " [go &E 2** %)26/-)'3K" ;$3/- 0&3- '&00&$ )$ '.)*%(/$ 2$%-//$2+/(3" >1-&)001$/ %/3-(1'-)&$ &E r"'/**3" >$-)")3*/- 2$-)6&%)/3 7(/3/$- QvgoR" B$31*)$ %/7/$%/$'/8,7/ S %)26/-/3Y svgo &E 2** %)26/-)'3K" ;$3/- 0&3- '&00&$ )$ 0)%%*/"2+/% 2$% &*%7/&7*/" (/%1'/% )$31*)$ 3/'(/-)&$= &( )$31*)$(/3)3-2$'/= &( 6&-." 8(/2-/% 4)-. %)/-= &(2* 2$-)%)26/-)'3= 2$%\&()$31*)$ )$]/'-)&$3

Bc@jJBc #ZZ#C8@ ;c ?JjC;@# :>8<W>k@

J)5/(Y ↑ ?*,'&*,3)3↑ ?*,'&+/$ 3,$-./3)3↓ ?*1'&$/&+/$/3)3↓ ?*,'&+/$ 6(/2O%&4$

F13'*/Y ↑ ?*1'&3/ 17-2O/ Q?Jj8TR↑ ?*,'&+/$ 3,$-./3)3

>%)7&3/ -KY↑ ?*1'&3/ 17-2O/ Q?Jj8TR

<k:#P?JkC#FB> Bc ̂ B>G#8#@

" #9'/33)5/ +*1'&$/&+/$/3)3= )$.)6)-/%+*,'&*,3)3 )$ -./ *)5/(" P/%1'/% +*1'&3/ '&$3107-)&$ )$ 013'*/ 2$%2%)7&3/ -)331/ 6/'213/ &E *&4 ?Jj8T -(2$37&(-/(" 8.(/3.&*% E&( (/$2* +*1'&3/ /9'(/-)&$ )326&1- [hg 0+\%J{1/3-)&$Y W., )3 +*1'&$/&+/$/3)3 0&(/ )07&(-2$--.2$ +*,'&+/$ 6(/2O%&4$ E&( .,7/(+*,'/0)2 )$%)26/-/3d

A#8;?#c#@B@" A/-&$/3 2(/ E&(0/% E(&0 2'/-,*"C&> )$ -./*)5/(

F2)$ 3&1( / 2(/ E2 , 2 )%3 E(&0 2%)7&3/-)331/" A/-&+/$/3)3 $&(02**, &''1(3 )$ 7(&*&$+/%E23-)$+= 61- )3 &1- &E '&$-(&* )$ %)26/-/3" A/-&$/3 2(/ )07&(-2$- 3&1('/3 &E /$/(+, E&(0&3- -)331/3 %1()$+ 3-2(52-)&$" B07&(-2$- '&$-(&* 3)-/3 2(/ *)7&*,3)3 )$2%)7&3/ -)331/ 2$% '2($)-)$/ 3.1--*/ )$ *)5/(" A/-&$/3 2(/ &9)%)L/% 6, 0&3- -)331/3= 61- $&--./ *)5/(

A#8;>CB^;@B@

A/-&2')%&3)3 )3 -./ 0&3- )07&(-2$- 2'1-/'&07*)'2-)&$ )$ -,7/ [ %)26/-/3K" A/-&+/$/3)3 )$ -./ *)5/( /9'//%3 O/-&$/ 6&%,&9)%2-)&$ )$ -./ -)331/3" P2072$- .,7/(+*,'/0)2 2''&072$)/3O/-&3)3" ^/.,%(2-)&$ %1/ -& &30&-)' %)1(/3)3 Q+*1'&3/)$ 1()$/R" C2$ 6/ -()++/(/% 6, 3-(/33 -.(&1+. )$31*)$"

2$-2+&$)3-)' 3-(/33 .&(0&$/3Y '&(-)3&*= /7)$/7.()$/" 8(/2-0/$-Y B$31*)$ )$]/'-)&$3= )5 E*1)%3^)26/-)' O/-&2')%&3)3 )3 2$ /0/(+/$', -.2- )3 E2-2*4)-.&1- )$-/(5/$-)&$V

<k:;?JkC#FB><&4 '2$ .,7&+*,'/0)2 6/ 7(/5/$-/%d<&4 %& ,&1 -(/2- .,7&+*,'/0)2dW.2- )3 4&(3/Y .,7&+*,'/0)2 &(.,7/(+*,'/0)2d<&4 2++(/33)5/*, 3.&1*% %)26/-/3 6/ -(/2-/%d

J>8# C;F:JBC>8B;c@ Bc ̂ B>G#8#@F&3- *2-/ '&07*)'2-)&$3 &()+)$2-/ )$26$&(02*)-)/3 &E 302** 6*&&% 5/33/*3K" #$%&-./*)2* '/** %,3E1$'-)&$" >6$&(02* 623/0/$- 0/06(2$/3" B$'(/23/% 523'1*2( 7/(0/26)*)-," ^/7&3)-)&$ &E /9'/33 02-()9 7(&-/)$3 2$%

7*2302 7(&-/)$3" c2((&4)$+ &E -./ *10/$ &E 302** 6*&&%5/33/*3F/'.2$)303 &E -./3/ '.2$+/3 2(/ )$'&07*/-/*,O$&4$K

J>8# C;F:JBC>8B;c@Y C>P^B;f>@CjJ>P^)26/-/3 2''/*/(2-/3 2-./(&3'*/(&3)3K B$'(/23/%()3O3 &EY" >'1-/ 0,&'2(%)2* )$E2('-)&$" @-(&O/" ?2$+(/$/>$, 31++/3-)&$3 E&( 7(/5/$-)&$ 2$% -(/2-0/$-d

J>8# C;F:JBC>8B;c@Y AB^c#k@B$ -./ j@= sago &E 72-)/$-3 &$ ./0&%)2*,3)3 .25/%)26/-/3K c/7.(&72-., 3-2(-3 4)-. +*&0/(1*2(%,3E1$'-)&$= 61- /5/$-12**, %202+/3 -./ -161*2(3,3-/0K

<,7/(E)*-(2-)&$↓ F)'(&2*610)$1()2↓

F2'(&2*610)$1()2↓ j(/0)2

>$, 31++/3-)&$3 E&( 7(/5/$-)&$ X -(/2-0/$-d

J>8# C;F:JBC>8B;c@Y #k#@^)26/-)' (/-)$&72-., )3 -./ 0&3- '&00&$ '213/ &E6*)$%$/33 )$ 7/&7*/ 2+/% Sa -& lgK B- )3 20)'(&523'1*2( 7(&6*/0Y" ↑ 523'1*2( 7/(0/26)*)-,= 02'1*2( /%/02" P/-)$2* 0)'(&2$/1(,303 X ./0&((.2+/3" f)-(/&13 ./0&((.2+/3" :&&( 7/(E13)&$ &E 6*&&% 5/33/*3" c/&523'1*2()L2-)&$" Z)6(&523'1*2( 7(&*)E/(2-)&$" P/-)$2* %/-2'.0/$-B$ 2%%)-)&$ -& (/-)$&72-.,= -./(/ )3 2*3& 2$)$'(/23/% ()3O &E '2-2(2'- Q*/$3 &72')-)/3RK>$, 31++/3-)&$3 E&( 7(/5/$-)&$ 2$% -(/2-0/$-d

^B>G#8BC ̂ B#8^)/-2(, (/'&00/$%2-)&$3 E&( -,7/ [ %)26/-/3d<&4 )3 -.)3 %)EE/(/$- E(&0 -,7/ S %)26/-/3dB07&(-2$'/ &E +*,'/0)' )$%/9KW.2- '2$ (/2*)3-)'2**, 6/ /97/'-/% E(&0 %)/-2(,-(/2-0/$-d

Page 35: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 35/40

Bc@jJBc 8P#>8F#c8B$31*)$ )3 (/b1)(/% E&( 2** -,7/ [ %)26/-)'3 2$%02$, -,7/ S %)26/-)'3K" 8(2%)-)&$2**,= )$31*)$ )3 )$]/'-/%K" @.&(-"= 0/%)10" 2$% *&$+"2'-)$+7(/72(2-)&$3 2(/ 252)*26*/ E&( 3K'K &( )K0K )$]/'-)&$K" 8)0)$+ 4)-. 0/2*3 )3 /33/$-)2*K" :(&+(20026*/ )$31*)$ 71073 2(/ 6/'&0)$+0&(/ '&00&$K G232* (2-/ &E 26&1- [ j\.= 4)-. 6&*13)$E13)&$3 2- 0/2*3K" >$ 20,*)$ 2$2*&+ '2$ 6/ 2%%/% -& -./ )$31*)$K

;P>J >c8B^B>G#[email protected] 72-)/$-3 2(/ '2$%)%2-/3 E&( &(2* 2$-)%)26/-)'3d<&4 %& &(2* 2$-)%)26/-)' %(1+3 4&(OdW.2- 2(/ -./ 2%52$-2+/3 &E &(2* 2$-)%)26/-)'3dW.2- 2(/ -./ ()3O3d

F#8Z;PFBc" 8.)3 )3 2 6)+12$)%/= E(&0 Z(/$'. *)*2'K" F&3- /EE/'-3 2(/ 0/%)2-/% 6, 2'-)52-)&$ &E

>F:"2'-)52-/% 7(&-/)$ O)$23/K" P/%1'/3 ./72-)' +*1'&$/&+/$/3)3K" @-)01*2-/3 +*1'&3/ 17-2O/ )$ 013'*/ 2$%2%)7&3/ -)331/K" 8.)3 )3 -./ E)(3-"*)$/ %(1+ -(/2-0/$- E&( -,7/ S%)26/-/3= 13/% )$ Z(2$'/ 3)$'/ [vlv= )$ j@ 3)$'/ [vvaK

>C# Bc<BGB8;P@8./3/ %(1+3 Q'27-&7()*= /*2$27()* /-'R )$.)6)-2$+)&-/$3)$ '&$5/(-)$+ /$L,0/ Q>C#RK >C# 2'-)52-/3-./ 523&'&$3-()'-&( 2$+)&-/$3)$ 2$% )$2'-)52-/3 -./523&%)*2-&( 6(2%,O)$)$K

" @.&(-"-/(0 /EE/'- 02)$*, -.(&1+. 6(2%,O)$)$=4.)'. 2'-)52-/3 /$%&-./*)2* c; 3,$-.23/" J&$+"-/(0 /EE/'- -.(&1+. 2$+)&-/$3)$"2*%&3-/(&$/" Z)(3-"*)$/ -(/2-0/$- E&( .,7/(-/$3)&$ Q4)-.-.)2L)%/ %)1(/-)'3R" P/%1'/3 (/$2* +*&0/(1*2( 7(/331(/ /5/$0&(/ -.2$ 3,3-/0)' 2(-/()2* 7(/331(/" j3/% E&( 7(/5/$-)&$ &E %)26/-)' $/7.(&72-.,

O(%0#/+ K+/#( C&(-/9Y ̀ C&$'/$-()' *2,/(3 "C&(-)3&* /9/(-3 $/+2-)5/ *&$+"*&&7 E//%62'O

Page 36: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 36/40

O(%0#/ K /#(

">%(/$2* +*2$%3 2(/ *&'2-/% &$ -&7 &E /2'. O)%$/,

>%(/$2* ̂ /5/*&70/$-"C&(-/9 )3 %/()5/% E(&0 )$-/(0/%)2-/ 0/3&%/(0"F/%1**2 )3 %/()5/% E(&0 /'-&%/(0 $/1(2* '(/3- '/**3"B$ %/5/*&70/$-= '&(-)'2* '/**3 &E E/-13 31((&1$%%/5/*&7)$+ 0/%1**2 2$% -./ 7/(02$/$- '&(-/931((&1$%3 -./ E/-2* '&(-/9 6/E&(/ E/-2* '/**3

%)3277/2(3"?*2$%3 %/5/*&7 6/-4//$ %&(32* 0/3/$-/(, 2$%1(&+/$)-2* ()%+/3907)%*40 $;0 4+&&( 7866+- $& $;0 /(%0#/+ ,+/#(7M/#( *$7 *36&%$/#)0 $& 3/$8%/$*&#` >(-/()/3 -.2- 3177*,Y"B$E/()&( 7.(/$)' 2(-/(, ! @17/()&( 317(2(/$2* 2(-/(,">&(-2 ! F)%%*/ 317(2(/$2* 2(-/(,"P/$2* 2(-/(, ! B$E/()&( 317(2(/$2* 2(-/(,

"` 2(-/()/3 E&(0 316'2731*2( 7*/913! C2731*2( 2(-/()/3

! C&(-)'2* 2(-/()/3 ! '&(-)'2* '27)**2()/3! F/%1**2(, 2(-/()/3 ! 0/%1**2(, '27)**2()/3

UF/%1**2 (/'/)5/3 %12* 3177*,"F/%1**2(, '27)**2()/3 Q$&- 23 ()'.= 3)$'/ *23-)$ 7*/913R"C2731*2( 2(-/(, 6(2$'./3

( () , ([R u&$2 +*&0/(1*&32"

"C&*10$2( &( 7,(20)%2* '/**3"P&1$% &( 2('./% '&(%3"B$%1'/% 6, >C8< 2$% >$+ BB! 0)$/(2*'&(-)'&)%3

"F2)$*, 2*%&3-/(&$/SR u&$2 E23')'1*2-/"

"["S '/** -.)'O 3-(2)+.- '&(%3 -.2- 2(/7/(7/$%)'1*2( -& -./ 31(E2'/"B$%1'/% 6, >C8< ! +*1'&'&(-)'&)%3

"F2)$*, '&(-)3&*`R u&$2 P/-)'1*2()3"

">$23-&0&3)$+ $/-4&(O"J)7&E13')$ +(2$1*/3":,O$&-)' $1'*/) QE()/% /++ 277/2(2$'/R"B$%1'/% 6, >C8< ! @-/(&)% 3/9 .&(0&$/3\W/2O 2$%(&+/$3

"F2)$*, %/.,%(&/7)2$%(&3-/(&$/

"<&(0&$/3 2(/ $&- 3-&(/% )$ 0/06(2$/"6&1$%+(2$1*/3"@,$-./3)L/ 2$% 3/'(/-/ &$*, &$ %/02$%"^)EE13/ 2'(&33 7*2302 0/06(2$/ 3)$'/ -./, 2(/3-/(&)%3"8&+/-./(= @#P 2$% 0)-&'.&$%()2* /$L,0/3 7(&%1'/2%(/$2* .&(0&$/3

?*1'&'&(-)'&)%3"P/+1*2-/ 0/-26&*)30 5)2 +*1'&3/.&0/&3-23)3":(&5)%/ (/3)3-2$'/ -& 3-(/33"^/7(/33 )001$/ (/37&$3/3

( ) ( )&$ 2$-/()&( 7)-1)-2(, 2$% .,7&-.2*2013

>%(/$2* F/%1**2"C&07&3/% &E C.(&02EE)$ '/**3 )$ '&(%3 &( '*1073

"@/'(/-/ $&(/7) 2$% /7)"C&$3)%/(/% 7&3-+2$+*)&$)' 3,072-./-)'$/1(&$3= 61- -./, .25/ $& 29&$3 &( %/$%()-/3"@1((&1$%/% 6, '27)**2()/3"B$$/(52-/% 6, 37*2$'.$)' $/(5/3 6, >'."c&(/7) 2$% /7) %)(/'-*, (/*/23/% )$-&7()02(, '27)**2(, 7*/913"F/%1**2 .23 0/06(2$/"6&1$% 3/'(/-&(,+(2$1*/3 4)-. /)-./( /7) &( $&(/7)

UC2-/'.&*20)$/3 3,$-./3)L/% )$ -./ ',-&3&* 2(/-(2$37&(-/% )$ 5/3)'*/3 5)2 F+"2'-)52-/% >8:23/ )$0/06(2$/ &E 5/3)'*/

@/'(/-)$+ ?(2$1*/3"#7)$/7.()$/

"@02** +(2$1*/3"J/33 %/$3/ -.2$ $&(/7) +(2$1*/3

"c&(/7)$/7.()$/"J2(+/ +(2$1*/3"F&(/ %/$3/ -.2$/ /7) +(2$1*/3"J1'/$- *2,/(

U?*1'&'&(-)'&)%3 Q'&(-)3&*R 3-)01*2-/ :cF8 -& '&$5/(-$&(/7)$/7.()$/ -.2- )3 )$ -./ ',-&3&* )$-& /7)$/7.()$/5)2 '&(-)'2* '27)**2()/3

C*)$)'2* C&((/*2-/":./&'.(&0&',-&02" (2(/ -10&( %/()5/% E(&0'.(&02EE)$ '/**3 -.2- 7(&%1'/3 /9'/33)5/

'2-/'.&*20)$/3

Z/$ /7 /# '#(&)%*#0 W%,/# C*7$ > (*70/707 <&% N;*); ;*,; 70%83 +06$*# +0D0+7 'H6+/*# $;0 6%*3/%- 7&8%)0 &< `^ZA/+6;/ /#( "CAg

Page 37: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 37/40

Z/$ /7 /# #(&)% #0 W%,/#

'H6+/*# ;&N +06$*# N&%I7 *# $;0 J^= $& 7866%077/660$*$0 /#( /<<0)$ 0#0%,- 0H60#(*$8%0"J/7-)$ )$'(/23/3 /$/(+, /97/$%)-1(/ 6, 2'-)52-)$+3,072-./-)' $/1(&$3 -.(&1+. 5/$-(2*\2$-/()&(3-)01*2-)&$

'H6+/*# ;&N 0H)077 /(*6&70 $*7780 )/# )/870;-60%$0#7*&#M &7$0&/%$;%*$*7M /#( *338#0 7-7$03

(*7&%(0%7 C06$*#":(&%1'/% 6, 2%)7&3/ -)331/"J/7-)$ (/'/7-&( 26)%/3 6, p>A\@8>8 72-.42, -&-(2$30)- 3)+$2*3 E(&0 /9-(2'/**1*2( 3-)01*)"J/7-)$ (/'/7-&( D ;6"P6"j312**, %/'(/23/3 E&&% )$-2O/ X )$'(/23/3 /$/(+,/97/$%)-1(/f)2 2('12-/ $1'*/13"B$%1'/3 2$&(/9)+/$)' 7/7-)%/2*7.2"0/*2$&',-/ 3-)01*2-)$+ .&(0&$/ X207./-20)$/"(/*2-/% -(2$3'()7- QC>P8Rf)2 2('12-/ $1'*/13"P/7(/33/3 &(/9)+/$)' 7/7-)%/3

c:k 2$% 2+&13-)"(/*2-/% >+P:= 4.)'. 3-)01*2-/ E&&%)$-2O/ 2$% %/'(/23/ /$/(+, /97/$%)-1(/"@-)01*2-/3 )001$/ (/37&$3/"@-)01*2-/3 716/(-, &$3/-= E/(-)*)-,= X (/7(&%1'-)&$"@-)01*2-/% 6, /3-(&+/$ 2$% 3177(/33/% 6,2$%(&+/$3

"W&0/$ .25/ 0&(/ 2%)7&3/ -)331/U"B$'(/23/3 3,072-./-)' -&$/ )$ Cf@ &(+2$3

! B$'(/23/% */7-)$ '213/3 .,7/(-/$3)&$-.(&1+. O)%$/, 3-)01*2-)&$ ! P/$)$

U"J/7-)$ )3 7(&%1'/% 6, 7*2'/$-2 2$% 2EE/'-3 -./0&-./( ! +/3-2-)&$2* %)26/-/3 2$% 7(//'*2073)2"B$'(/23/% */7-)$ '2$ '213/ &3-/&2(-.()-)3 2$%\&((./102-&)% 2(-.()-)3 %1/ -& */7-)$N3 2'-)5)-, )$'2(-)*2+/ '2-26&*)30K! C213/3 '.(&$%(&',-/ 27&7-&3)3= '.(&$%(&',-/7./$&-,7/ *&33= 2$% 02-()9 %/+(2%2-)&$

[" J/7-)$ 7(&0&-/3 &3-/&'*23- %)EE/(/$-)2-)&$-.(&1+. @c@ 3-)01*2-)&$ ! )$.)6)-3 6&$/E&(02-)&$S" J/7-)$N3 17(/+1*2-)&$ &E C>P8 )$.)6)-3%)EE/(/$-)2-)&$ &E &3-/&'*23-3

"<)+. */7-)$ 233&')2-/% 4)-. -./ E&**&4)$+Y":3&()23)3"J)5/( E)6(&3)3 )$ ./72-)-)3 G">3-.02 3/5/()-, Q233&')2-/% 4\ &6/3)-,R

( )*7 40#0<*)*/+

[R ^/0/$-)2 2$% >*L./)0/(N3 %)3/23/SR #7)*/73,

2K @177(/33/3 ?Jj")$%1'/% /9')-2-&(,7&3-3,$27-)' /5/$- 0/%)2-/% 6,>F:> (/'/7-&(3

'H6+/*# N;/$ </)$&%7 ;/D0 /# *36/)$ &# $;0 70%83/(*6&#0)$*# +0D0+7"J/7-)$= 8cZ"2*7.2= X BJ"h %&4$ (/+1*2-/ 2%)7&$/'-)$"J&4 2%)7&3/ '213/3 */33 2'-)5/ >F:J 2$% )$'(/23/%+*1'&$/&+/$/3)3U<,7&2%)7&$/'-)$/0)2 ! )$31*)$ (/3)3-2$'/ ! 0/-26&*)' 3,$%(&0/ ! 2-./(&3'*/(&3)3"8u^3 )$'(/23/ 2%)7&$/'-)$ 2$% >F:A 6, %/'(/23)$++*1'&$/&+/$/3)3 Q::>P+2002 2'-)52-)&$R 2$% 8cZ"2*7.2 /97(/33)&$ Q%/'(/23/ 2%)7&',-/ 3)L/R

J&36/%0 /#( )&#$%/7$ $;0 0<<0)$ $;/$ +06$*# /#(/(*6&#0)$*# ;/D0 &# </$$- /)*( 7-#$;07*7M </$$-&H*(/$*&#M ,+8)&70 86$/I0M ,+8)&#0&,0#07*7M*#78+*# %07*7$/#)0M /#( *#<+/33/$*&# O(*6&#0)$*# C06$*#B$'(/23/3 +*1'&3/ 17-2O/ ^/'(/23/3 +*1'&3/ 17-2O/^/'(/23/3+*1'&$/&+/$/3)3 Q*)5/(R

B$'(/23/3+*1'&$/&+/$/3)3 Q*)5/(R

B$'(/23/3 E2--, 2')%&9)%2-)&$ Q*)5/(R

d

^/'(/23/3 E2--, 2')%3,$-./3)3 Q*)5/(R

d

P/%1'/3 8cZ= BZc= 2$%BJ"h Q)$E*2002-&(,',-&O)$/3R

@-)01*2-/3 8cZ= BZc= 2$%BJ"h -& )$%1'/)$E*2002-)&$

?/$/(2**, 3177(/33/3

)001$/ (/37&$3/

?/$/(2**, )$%1'/3

)001$/ (/37&$3/B$'(/23/ >F:A d

) ( g$;/$ *7 6%&(8)0( <%&3 /(*6&70 $*7780"F2'(&7.2+/3 7(&%1'/ 8cZ"2*7.2 2$% BJ"h 2E-/(7.2+&',-&3)3 &E */7-)$ )$ %,)$+ 2%)7&3/

'H6+/*# ;&N /(*6&70 $*7780 M N*$; 760)*/+036;/7*7 &# `^ZA/+6;/ /#( "CAgM *7 )/87*#,*#78+*# %07*7$/#)08cZ"2*7.2 X BcZ"h`^ZA/+6;/ "B$%1'/3 )$31*)$ (/3)3-2$'/ 5)2 2'-)52-)$+3/(\-.( O)$23/3 Q:AC= P2E[= X BAA"6/-2R -.2- 2'- &$-./ )$31*)$ (/'/7-&( 2$% BP@"[ 6, 7.&37.&(,*2-)$+/$L,0/3 )$5&*5/% )$ )$31*)$ (/'/7-&( 3-)01*13"CAg" %&4$(/+1*2-/3 BP@"[ 2$% +*1'&3/ -(2$37&(-/(+/$/ /97(/33)&$ )$ 2%)7&',-/3 02O)$+ -./0)$3/$3)-)5/ -& +*1'&3/ Q)$31*)$ (/3)3-2$'/ 2$%.,7/(+*,'/0)2RK BJ"h 2*3& 17(/+1*2-/3 @;C@"`=$/+2-)5/*, 0&%1*2-)$+ )$31*)$ 3)+$2*)$+

`^ZA/+6;/":(&0&-/3 *)7&*,3)3 ! /*/52-/% 3/(10 Z>3"j7(/+1*2-/3 ./72-)' +/$/3 E&( Z> 3,$-./3)3"^&4$(/+1*2-/3 ./72-)' +/$/3 E&( Z> &9)%2-)&$

! <,7/(-()+*,'/()%/0)2 -.(&1+. )$%1'/%fJ^J 3,$-./3)3 )$ *)5/( 2$% )$.)6)-)&$ &E J:J3/'(/-)&$ )$ 2%)7&3/ -)331/

"C&1$-/(3 )$31*)$ )$%1'/% %/+(2%2-)&$ &E >7&G"j7(/+1*2-/3 BJ"[ X BJ"h

"CAg">%)7&3/ '&$-()61-/3 01'. &E ')('1*2-)$+ 20&1$-":(&0&-/3 *)7&*,3)3 ! /*/52-/% 3/(10 Z>3"B$%1'/3 .)+. /$/(+, /97/$%)-1(/ 2$% (/%1'/% 6&%,E2- )$ Cc@= ;::;@B8# )$ 7/()7./(,

O(%0#/+ K+/#( Q*&);03*7$%- `"F)$/(2*'&(-)'&)%3"Z&(0/% 6, 2%(/$2* '&(-/9 X "C&$5/(-3 -/3-&3-/(&$/ -&

Page 38: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 38/40

( ( Q ); $

1_ ./$;N/-7 &< 7$0%&*( ;&%3&#0 7-#$;07*7

@&1('/3 &E '.&*/3-/(&*"J^J X <^J E(&0 -./ 6*&&%"#$%&+/$&13 3,$-./3)3"@-&(/% '.&*/3-/(&* /3-/(3C.&*/3-/(&* ! %/30&*23/ /$L,0/ ! :(/+$/$&*&$/

UP/+1*2-)$+ (/2'-)&$

! :(/+$/$&*&$/ ! ^/.,%(&+/$23/ ! :(&+/3-/(&$/UC.&*/3-/(&* )3 %/*)5/(/% 6, =$O5 -& -./ 0)-&'.&$%()24./(/ %/30&*23/ )3 '&$-2)$/%

2&#&&H-,0#/70 50/)$*&#

@-/(&)%3 2(/ .,%(&9,*2-/% )$ 2 (/2'-)&$ 4)-. 2 37/')E)':"Tag /$L,0/ -.2- )3 '&$-2)$/% )$ #P 2$%0)-(&'.&$%()2K 8.)3 )3 0&(/ 37/')E)' 2$% $&- 23+/$/(2* 23 *)5/(\%/-&9 :"Tag /$L,0/3C,-&'.(&0/ :"Tag )3 ./0/"'&$-2)$)$+ 3161$)- &E/$L,0/

>_ Q*&+&,*)/+ %&+07 &< 7$0%&*( ;&%3&#07C*233/3 &E 3-/(&)% .&(0&$/3[":(&+/3-)$3" E&(0/% 6, '&(713 *1-/10 %1()$+0/$3-(12* ','*/ 2$% 7*2'/$-2 %1()$+ 7(/+$2$',

! )K/K" 7(&+/3-/(&$/

S"?*1'&'&(-)'&)%3" 3-(/33 .&(0&$/3\0/-26&*)'(/+1*2-&(3 7(&%1'/% 6, 2%(/$2* '&(-/9! )K/K" C&(-)3&*

(/+1*2-/ c2e X Ae /9'(/-)&$! >*%&3-/(&$/

T"#3-(&+/$3" Z/02*/ (/7(&%1'-)5/ (/+1*2-&(37(&%1'/% 6, &52()/3 2$% 7*2'/$-2

! #3-(2%)&*a">$%(&+/$3" 5)()*)L)$+ .&(0&$/3 E&(0/% 6, 2%(/$2*'&(-/9

! 8/3-&3-/(&$/U8/3-&3-/(&$/ )3 '&$5/(-/% -& %).,%(&-/3-&3-/(&$/ )$-/3-)3= 4.)'. )3 0&(/ 7&-/$-K 8/3- )3 2*3& '&$5/(-/% -&/3-(2%)&* 6, /%&3/$/70 &( 0/-26&*)L/% )$-& )$2'-)5/7(&%1'-3 Q*)--*/ '&$5/(3)&$ -& /3-(2%)&* )$ -/3-)3RUF)$/(2*'&(-)'&)%3 e +*1'&'&(-)'&)%3 D '&(-)'&3-/(&)%3\_ O(%0#/+A6*$8*$/%- <00(4/)I

[_ O4#&%3/+*$*07 &< /(%0#/+ 7$0%&*(&,0#07*7["C13.)$+3 3,$%(&0/" #9'/33 +*1'&'&(-)'&)%3K C2$ 6/'213/% 6, 2$ >C8<"3/'(/-)$+ 7)-1)-2(, -10&(= 4.)'.4&1*% '213/ C13.)$+3 ^B@#>@#K F&3- &E -./ -)0/= -.)3)3 '213/% 6, /9'/33)5/ 2%0)$)3-(2-)&$ &E+*1'&'&(-)'&)%3 2$% 2EE/'-3 4&0/$ 0&3-*,K

QC&(-)3&*! )$31*)$ 2$-2+&$)3-RU>*3&= )$ 0&3- '23/3 -./ 72-)/$- .23 2%(/$&+/$)-2*3,$%(&0/ 2$% )3 &$ +*1'&'&(-)'&)% -(/2-0/$- -.2-*/2%3 -& C13.)$+N3 3,$%(&0/

S"J)'&()'/")$%1'/% .,7/(-/$3)&$" '&07&$/$- &E*)'&()'/ 7(/5/$-3 &9)%2-)&$Q)$2'-)52-)&$R &E '&(-)3&* -&'&(-)3&$/ 6, 6*&'O)$+ [[6/-2".,%(&9,3-/(&)%%/.,%(&+/$23/ ! C&(-)3&* )$'(/23/3 32*- (/-/$-)&$

`"C&$+/$)-2* 2%(/$2* .,7/(7*23)2 Q2%(/$&+/$)-2*3,$%(&0/R"J2'O &E '&(-)'&3-/(&)%3 */2%3 -& $& (/+1*2-)&$ &E>C8< (/*/23/ ! 2%(/$2* 3-)01*2-)&$T"a"2*7.2"(/%1'-23/ %/E)')/$',

%).,%(&-/3-&3-/(&$/">06)+1&13 /9-/($2* +/$)-2*)2"f)()*)L2-)&$ &''1(3 2- 716/(-,= 3& -./ 72-)/$-)3 &E-/$ (2)3/% 23 2 +)(* 4./$ -./ 277(&7()2-/-/3-3 2(/ $&- '&$%1'-/%

V_ 9*7&%(0%7 &< 70H8/+ (0D0+&630#$ %0+/$0( $&/4#&%3/+ 7$0%&*( 30$/4&+*73

J&#,0#*$/+ O(%0#/+ :-60%6+/7*/BO(%0#&,0#*$/+ =-#(%&30F9*<<0%0#$ 0#L-30 (0<*)*0#)*07

"P/%1'/% '&(-)3&* ! #*/52-/% >C8<">JJ %)3&(%/(3 */2% -& 2%(/$2* +*2$% /$*2(+/0/$- %1/-& )$'(/23/% >C8<UUB$-/(0/%)2-/3 &E -./ 2%(/$2* '&(-/9 (/2'-)&$3 '2$6/ '2(()/% -& 2%(/$2* 0/%1**2 %1/ -& 2((2$+/0/$- &E6*&&% 3177*, '213)$+ &5/(7(&%1'-)&$ &E 2$%(&+/$3

>1/ :-(%&H-+/70 90<*)*0#)- B6%070#$7 U4*%$;F"F)$/(2*'&(-)'&)%3 2$% ?*1'&'&(-)'&)%3 2(/ %/E)')/$-">$%(&+/$3 2(/ &5/(7(&%1'/%"f)()*)L2-)&$"Z/02*/ 73/1%&./(027(&%)-)30"f&*10/ %/7*/-)&$ ! <k:;-/$3)&$"J&4\c& >*%&3-/(&$/ ! <k:#PO2*/0)2"B$'(/23/% (/$)$ ! 32*- '(25)$+

1m/ :-(%&H-+/70 90<*)*0#)-"B$'(/23/% 0)$/(2*'&(-)'&)%3 ! <k:#P-/$3)&$"B$'(/23/% c2e (/263&(7-)&$ ! <k:;O2*/0)2"F2*/3 ! %/'(/23/% ̂ <8 ! 73/1%&./(027(&%)-)30 ! E/02*/ 7./$&-,7/= $&)$-/($2* (/7(&%1'-)5/ 3-(1'-1(/3"Z/02*/3 ! /9-/($2**, 7./$&-,7)' E/02*/ 4\$&(02*

)$-/($2* 3/9 &(+2$3 2$% *2'O3 3/'&$%2(, 3/9'.2(2'-/()3-)'3

1140$/A;-(%&H-+/70 90<*)*0#)-"^/'(/23/% 2*%&3-/(&$/"B$'(/23/% [["%/&9,'&(-)'&3-/(&$/ ! 0)$/(2*'&(-)'&)% ! <k:#P-/$3)&$" B$'(/23/% c2e (/263&(7-)&$ ! <k:;O2*/0)2 X#%/02UP/0/06/( -.2- (/'/7-&(3 (/37&$% -& 2$,'&(-)'&3-/(&)% 4./$ )- )3 )$ /9'/33 )$ -./ 3/(10"f)()*)L2-)&$

"F2*/3 ! 7(/'&')&13 716/(-,"Z/02*/3 ! 73/1%&./(027.(&%)-)30= 5)()*)L2-)&$

W/2O2$%(&+/$3X8/3-&3-/(&$/

U8/3-&3-/(&$/'2$ 6/'&$5/(-/% -&/3-(2%)&* 6,2(&02-23/

O(%0#/+ K+/#( .;-7*&+&,- ./,0 1 ">%(/$2* .&(0&$/3 2(/ -(2$37&(-/% )$ -./ 6*&&% "#$.2$'/3 +*1'2+&$ (/*/23/

Page 39: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 39/40

( ( ; , ,

C2-/'.&*20)$/ @,$-./3)3 )$ >%(/$2* F/%1**2"@,072-./-)' 3-)01*2-)&$ 2$% >C8< 3-)01*2-)&$)$'(/23/ 2'-)5)-, &E %&720)$/ 6/-2".,%(&9,*23/ -&7(&%1'/ $&(/7)$/7.()$/ E(&0 %&720)$/"C&(-)3&* 3-)01*2-)&$ )$'(/23/3 @>F 2$% :"c"F2'-)5)-, -& 7(&%1'/ /7)$/7.()$/ E(&0 $&(/7)$/7.()$/

C2-/'.&*20)$/3

":()02(, c83 E&( 72(2'()$/ 2$% 21-&'()$/ /EE/'-3"@/'(/-/% E(&0 2%(/$2* 0/%1**2 )$-& 3,3-/0)'')('1*2-)&$"^/+(2%/% 2- 3)+.- &E 2'-)&$ 5)2 F>; 2$% C;F8"C*/2(/% )$ *)5/( 6)*/ &E O)%$/, 1()$/">*7.2 2%(/$/(+)' (/'/7-&(3 ! 7(/E/( $&(/7)$/7.()$/"G/-2 2%(/$/(+)' (/'/7-&(3 ! 7(/E/( /7)$/7.()$/

.%*3/%- /(%0#/+ /#(%&,0#7[">$%(&3-/$/%)&$/S"^<#>`"8/3-&3-/(&$/ Q5/(, 302** 20&1$-R

U>$%(& 2$% ̂ <#> 2(/ 4/2O 2$%(&+/$3 2$% 6)$% -&@<G? 4/2O*, ! *2(+/*, 6)&252)*26*/">%(/$2* 2$%(&+/$3 '&$-()61-/ -& ago &E 2$%(&+/$32$% 4&0/$ 2$% 7*2$ 2 (&*/ )$ 0/$&7213/

^/30&*23/ D Ck:[[>["J&'2-/% )$ )$$/( 0)-&'.&$%()2* 0/06(2$/"C&$5/(-3 '.&*/3-/(&* -& 7(/+$/$&*&$/"@->P D @-/(&)%&+/$)' >'1-/ P/+1*2-&(, :(&-/)$

"C2(()/3 '.&*/3-/(&* 2'(&33 &1-/(0)-&'.&$%()2* 0/06(2$/ -& Ck:[[>[

UC&(-)3&* )3 7()02(, 2'-)5/ .&(0&$/ 7(&%1'/% 2$%3/'(/-/% 6, 2%(/$2* ! ̂ <#> )3 3/'(/-/% 61- .23 4/2O6)&*&+)'2* 2'-)5)-,

6&1$% -& '&(-)'&3-/(&)% 6)$%)$+ +*&61*)$ 2$% 2*610)$"G&1$% -& 2*610)$ ! 6)&252)*26*/"C&(-)3&* )3 02)$*, 6&1$% -& CG?= 61- Sao

-.2- )3 E(// &( 6&1$% 2*610)$ )3 '&$3)%/(/% -& 6/ 2$/9'/33 '213)$+ -./ b1/3-)&$ &E 4., -./(/ )3 /5/$ CG?-& (/+1*2-/ )-

O+$0%0( J&%$*7&+ 20$/4&+*73"<,7/()$31*)$/0)2 '2$ )$'(/23/ 1()$2(, /9'(/-)&$ &E'&(-)3&* 0/-26&*)-/3";6/3/ 72-)/$-3 /9'(/-/ +(/2-/( 20&1$-3 &E '&(-)3&*0/-26&*)-/3"<,7/(-.,(&)%)30 )$'(/23/3 '*/2(2$'/ (2-/

"Gj8 )$'(/23/% 2+/ (/31*-3 )$ %/'(/23/%'*/2(2$'/ '213)$+ 2 3.)E- )$ -&-2* '&(-)3&*= 61-2 313-2)$/% */5/* E&( $&(02* E1$'-)&$

>C8< X >%(/$2* @-/(&)%&+/$/3)3"?"7(&-/)$ ! '>F:"@-)01*2-/3 >C8< (/'/7-&( 7(&%1'-)&$"@-)01*2-/3 @->P 7(&-/)$ 7(&%1'-)&$"@-)01*2-/3 Ck:[[>

U>C8< P/'/7-&( 7(&%1'-)&$ )3 (/+1*2-/% 6, -./E&**&4)$+">C8<"?*1'&'&(-)'&)%3">$+)&-/$3)$ BB

":(&+/3-/(&$/= F)$/(2*'&(-)'&)%3= 2$% >$%(&+/$3 2**3.&4 7(&0)3'1)-, )$ 6)$%)$+ -& -./)( (/'/7-&(3 4./$/)-./( &$/ &E -./ 3-/(&)%3 2(/ .)+. )$ '&$-/$- &E')('1*2-)&$

UUU#9'/7- #@8P;?#c

J&%$*7&+ Z8#)$*&#7 "#78+*# /#$/,&#*7$"F2)$*, 2$-)"2$26&*)' 2$% 7/(0)33)5/"C&$5/(-3 7(&-/)$ -& +*,'&+/$

"?*,'&+/$ ! ?*1'&3/ ! Z1/*"B$'(/23/3 7(&-/)$ 0&6)*)L2-)&$ X %/+(2%2-)&$"C&$5/(-3 20)$&3 -& +*1'&3/ 7(/'1(3&(3"B$.)6)-3 7(&-/)$ 3,$-./3)3"B$.)6)-3 +*1'&3/ 17-2O/ 2$% %/'(/23/3 +*1'&3/1-)*)L2-)&$ %1()$+ .,7&+*,'/0)2

J&%$*7&+@7 .0%3*77*D0 0<<0)$7T">07*)E)/3 +*1'2+&$

! @-)01*2-/3 013'*/ +*,'&+/$&*,3)3"P/+1*2-/3 ?Jj8T 7(&-/)$

! P/+1*2-/3 )$31*)$UC2-/'.&*20)$/3 2$% +*1'&'&(-)'&)%3 3177(/33)001$/ 3,3-/0 ! 8.)$O E*)+.-\E)+.- )$ 3-(/33 E&('2-/'.&*20)$/3 X 7(/%$)3&$/N3 /EE/'-3 &E )001$/3,3-/0 E&( +*1'&'&(-)'&)%3

Z&( C&(-)3&* Z1$'-)&$QQ""KQ*&&% 7(/331(/ 02)$-/$2$'/^/'(/23/3 Q&$/ E&(02-)&$>$-)" "$E*2002-&(,B$'(/23/3 "$31*)$ (/3)3-2$'/B$'(/23/3 K*1'&$/&+/$/3)3= *)7&*,3)3= X 7(&-/&*,3)3

>*%&3-/(&$/"P/+1*2-/3 O)%$/,= ?B= @4/2- +*2$%3= X @2*)52(, +*2$%35)2 /7)-./*)2* '/**3"B$'(/23/3 c2e (/263&(7-)&$ )$ '&**/'-)$+ %1'- &E

O)%$/,! B$'(/23/3 Ae X <e /9'(/-)&$

">*%&3-/(&$/ .23 (27)% $&$"+/$&0)' /EE/'-3 23 4/** 23-(2$3'()7-)&$"%)(/'- /EE/'-3 Q#c2C= c2e\Ae >8:23/R

! c2e (/263&(7-)&$ )$'(/23/3 &5/( -)0/ O#,*&$0#7*#&,0#AO^K"AO^K> =-7$03

>c?B ! ̂ /'27/7-)%/= 3-26*/= )$2'-)5/>c?S ! ;'-27/7-)%/

"P/'/7-&(3 &$ 523'1*2( 30&&-. 013'*/3">8[= >8S= >8T ?:CP (/'/7-&(3">8[ (/+1*2-/3 >c?BB E1$'-)&$"B$'(/23/3 523&'&$3-()'-)&$

"@.&(- .2*E"*)E/

O(%0#/+ K+/#( .;-7*&+&,- ./,0 > "W&0/$ 02, /97/()/$'/ %/'(/23/% *)6)%& 2$% .2)( C13.)$+N3 @,$%(&0/" ^)3/23/ )E -10&( &( )E +/$/-)'

Page 40: Endocrine Block Study Products

8/12/2019 Endocrine Block Study Products

http://slidepdf.com/reader/full/endocrine-block-study-products 40/40

( (

U#920 -)7 ! k&1 3.&1*% 6/ 26*/ -& '*/2(*, )%/$-)E,7(/7(&.&(0&$/3= 7(&.&(0&$/3= 2'-)5/ 02-1(/.&(0&$/3= 2$% 6(/2O%&4$ 0/-26&*)-/3 E&( 52()&136)&0&*/'1*/3

Z)+.- &( Z*)+.- P/37&$3/ :.,3)&*&+,>'1-/ #EE/'-3Y[K #7) 2$% c&(/7) ./)+.-/$3 3/$3/3

SK c&(/7) 6)$%3 -& 2*7.2[ (/'/7-&(3! 3-)01*2-/3 +*1'&$/&+/$/3)3`K #7) 6)$%3 -& 6/-2S (/'/7-&(3 &$ 72$'(/2-)' 6/-2'/**3

! @-)01*2-/3 371(-3 &E )$31*)$ (/*/23/! :(&5)%/3 013'*/3 4)-. +*1'&3/ E&( E)+.- &(E*)+.-

#9-/$%/% #EE/'-3YTK CP< 3-2(-3 7&3)-)5/ 1*-(23.&(- E//%62'O *&&7 -&7(&%1'/ 0&(/ CP<

! c&4= CP< )3 (/+1*2-)$+ )-3/*EaK B$'(/23/% >C8< )$'(/23/3 '&(-)3&* -& O//7 -./

3,3-/0 +&)$+

.;0&);%&3&)-$&3/">%(/$2* 0/%1**2 -10&("B$'(/23/% '2-/'.&*20)$/3@,07-&03

"#7)3&%)' .,7/(-/$3)&$"@/5/(/ ./2%2'./"#9'/33)5/ 34/2-)$+":2*7)-2-)&$ 4\ &( 4\& -2'.,'2(%)2

.%*3/%- O(%0#/+ "#78<<*)*0#)-! >%%)3&$N3 ^)3/23/"#*/52-/% >C8<= 61- *&4 2%(/$2* &1-71-

=0)&#(/%- O(%0#/+ "#78<<*)*0#)-"J&4 >C8< 2$% *&4 2%(/$2* &1-71-

O((*7&# 9*70/70@,07-&03"@2*- '(25)$+"^2(O/$)$+ &E 3O)$"c213/2 X 5&0)-)$+"J&4 G: 2$% %)LL)$/33 4./$ 3-2$%)$+ %1/ -&&(-.&3-2-)' .,7&-/$3)&$"F13'*/ 2$% ]&)$- 72)$

7(&%1'-)&$

O((*7&#*/# J%*7*7#0/(+/$- @)-12-)&$"@.&'O

"@/5/(/ %/.,%(2-)&$"f/(, *&4 G:"J&33 &E '&$3')&13$/33"c2e 2$% Ae )062*2$'/

"C&00&$ C213/3"B$E/'-)&$"8(2102"@/5/(/ 3-(/33

;-./( 3,07-&03 -.2- '2$ 7(/3/$-"Z/5/("c213/2 X 5&0)-)$+">6%&0)$2* 72)$"#9-(/0/ 4/2O$/33"C&$E13)&$

^)EE/(/$- C23/3 E&( >%(/$2* <,7/(E1$'-)&$

%/E/'- '213)$+ /$%&+/$&13 %,3E1$'-)&$"F&3- &E-/$ '213/% 6, /9'/33 +*1'&'&(-)'&)%2%0)$)3-(2-)&$